peptide,lca,superkingdom,kingdom,subkingdom,superphylum,phylum,subphylum,superclass,class,subclass,infraclass,superorder,order,suborder,infraorder,parvorder,superfamily,family,subfamily,tribe,subtribe,genus,subgenus,species group,species subgroup,species,subspecies,varietas,forma,EC,EC - names,GO (cellular component),GO (molecular function),GO (biological process),GO (cellular component) - names,GO (molecular function) - names,GO (biological process) - names,InterPro,InterPro - names
LGEHNLDVLEGNEQFLNAAK,Sus scrofa,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Laurasiatheria,Artiodactyla,Suina,,,,Suidae,,,,Sus,,,,Sus scrofa,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (40%),extracellular space (40%),GO:0004252 (100%);GO:0046872 (20%),serine-type endopeptidase activity (100%);metal ion binding (20%),GO:0006508 (40%);GO:0007586 (20%),proteolysis (40%);digestion (20%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
SCLLSGWGNTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSGSSYPSLLQCLK,Sus scrofa,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Laurasiatheria,Artiodactyla,Suina,,,,Suidae,,,,Sus,,,,Sus scrofa,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (40%),extracellular space (40%),GO:0004252 (100%);GO:0046872 (20%),serine-type endopeptidase activity (100%);metal ion binding (20%),GO:0006508 (40%);GO:0007586 (20%),proteolysis (40%);digestion (20%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
SGGGGGGGLGSGGSLR,Hominidae,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea,Hominidae,,,,,,,,,,,,,,GO:0005882 (100%);GO:0005615 (20%);GO:0005634 (20%),intermediate filament (100%);extracellular space (20%);nucleus (20%),GO:0005198 (80%);GO:0005200 (20%),structural molecule activity (80%);structural constituent of cytoskeleton (20%),GO:0043588 (80%);GO:0045109 (80%);GO:0007283 (60%),skin development (80%);intermediate filament organization (80%);spermatogenesis (60%),IPR002957 (100%);IPR039008 (100%);IPR042180 (100%),Keratin, type I (100%);Intermediate filament, rod domain (100%);Intermediate filament, rod domain, coil 1B (100%)
HPYFYAPELLFFAK,Homo sapiens,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea,Hominidae,Homininae,,,Homo,,,,Homo sapiens,,,,,,GO:0005615 (100%);GO:0005783 (50%);GO:0005794 (50%),extracellular space (100%);endoplasmic reticulum (50%);Golgi apparatus (50%),GO:0046872 (50%);GO:0003677 (8%);GO:0005504 (8%),metal ion binding (50%);DNA binding (8%);fatty acid binding (8%),GO:0001895 (8%);GO:0002576 (8%);GO:0006898 (8%),retina homeostasis (8%);platelet degranulation (8%);receptor-mediated endocytosis (8%),IPR000264 (100%);IPR014760 (100%);IPR020858 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin-like (100%)
LLTHPNFNGNTLDNDLMLLK,Sus scrofa,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Laurasiatheria,Artiodactyla,Suina,,,,Suidae,,,,Sus,,,,Sus scrofa,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (40%),extracellular space (40%),GO:0004252 (100%);GO:0046872 (20%),serine-type endopeptidase activity (100%);metal ion binding (20%),GO:0006508 (40%);GO:0007586 (20%),proteolysis (40%);digestion (20%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
SGGGGGGGGCGGGGGVSSLR,Homo sapiens,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea,Hominidae,Homininae,,,Homo,,,,Homo sapiens,,,,,,GO:0001533 (100%);GO:0005615 (100%);GO:0005634 (100%),cornified envelope (100%);extracellular space (100%);nucleus (100%),GO:0030280 (100%);GO:0046982 (100%),structural constituent of skin epidermis (100%);protein heterodimerization activity (100%),GO:0018149 (100%);GO:0030216 (100%);GO:0031424 (100%),peptide cross-linking (100%);keratinocyte differentiation (100%);keratinization (100%),IPR002957 (100%);IPR018039 (100%);IPR039008 (100%),Keratin, type I (100%);Intermediate filament protein, conserved site (100%);Intermediate filament, rod domain (100%)
FSSCGGGGGSFGAGGGFGSR,Hominoidea,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0001533 (27%);GO:0005576 (7%),keratin filament (100%);cornified envelope (27%);extracellular region (7%),GO:0046982 (33%);GO:0030246 (27%);GO:0030280 (27%),protein heterodimerization activity (33%);carbohydrate binding (27%);structural constituent of skin epidermis (27%),GO:0050728 (33%);GO:0051290 (33%);GO:0061436 (33%),negative regulation of inflammatory response (33%);protein heterotetramerization (33%);establishment of skin barrier (33%),IPR003054 (100%);IPR032449 (100%);IPR039008 (100%),Keratin, type II (100%);Keratin type II cytoskeletal 1, tail (100%);Intermediate filament, rod domain (100%)
LDVLEGNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLEGNEQFLNAAK,Catarrhini,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (17%);GO:0005576 (4%);GO:1904724 (4%),extracellular space (17%);extracellular region (4%);tertiary granule lumen (4%),GO:0004252 (100%);GO:0005509 (17%);GO:0008236 (4%),serine-type endopeptidase activity (100%);calcium ion binding (17%);serine-type peptidase activity (4%),GO:0031638 (17%);GO:0043542 (17%);GO:0006508 (13%),zymogen activation (17%);endothelial cell migration (17%);proteolysis (13%),IPR001254 (100%);IPR009003 (100%);IPR001314 (96%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1A, chymotrypsin family (96%)
TNEFVTLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVLEGNEQFLN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GSGGGSSGGSLGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0001533 (42%);GO:0005576 (3%),keratin filament (100%);cornified envelope (42%);extracellular region (3%),GO:0046982 (45%);GO:0030246 (42%);GO:0030280 (42%),protein heterodimerization activity (45%);carbohydrate binding (42%);structural constituent of skin epidermis (42%),GO:0050728 (45%);GO:0051290 (45%);GO:0061436 (45%),negative regulation of inflammatory response (45%);protein heterotetramerization (45%);establishment of skin barrier (45%),IPR032449 (100%);IPR003054 (97%);IPR039008 (97%),Keratin type II cytoskeletal 1, tail (100%);Keratin, type II (97%);Intermediate filament, rod domain (97%)
APVLSDSSCK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (33%),extracellular space (33%),GO:0004252 (100%);GO:0046872 (17%),serine-type endopeptidase activity (100%);metal ion binding (17%),GO:0006508 (33%);GO:0007586 (17%),proteolysis (33%);digestion (17%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
ALEESNYELEGK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005882 (99%);GO:0001533 (43%);GO:0005737 (43%),intermediate filament (99%);cornified envelope (43%);cytoplasm (43%),GO:0005198 (53%);GO:0046982 (44%);GO:0030280 (43%),structural molecule activity (53%);protein heterodimerization activity (44%);structural constituent of skin epidermis (43%),GO:0051290 (44%);GO:0018149 (43%);GO:0030216 (43%),protein heterotetramerization (44%);peptide cross-linking (43%);keratinocyte differentiation (43%),IPR002957 (100%);IPR039008 (100%);IPR042180 (100%),Keratin, type I (100%);Intermediate filament, rod domain (100%);Intermediate filament, rod domain, coil 1B (100%)
SGGGFSSGSAGLLNYQR,Simiiformes,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0001533 (35%);GO:0005576 (5%),keratin filament (100%);cornified envelope (35%);extracellular region (5%),GO:0046982 (40%);GO:0030246 (35%);GO:0030280 (35%),protein heterodimerization activity (40%);carbohydrate binding (35%);structural constituent of skin epidermis (35%),GO:0050728 (40%);GO:0051290 (40%);GO:0061436 (40%),negative regulation of inflammatory response (40%);protein heterotetramerization (40%);establishment of skin barrier (40%),IPR003054 (100%);IPR032449 (100%);IPR039008 (100%),Keratin, type II (100%);Keratin type II cytoskeletal 1, tail (100%);Intermediate filament, rod domain (100%)
NLDVLEGNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLTHPNFNGNTLDND,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAFGGSGGR,Homo sapiens,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea,Hominidae,Homininae,,,Homo,,,,Homo sapiens,,,,,,GO:0001533 (100%);GO:0005615 (100%);GO:0005634 (100%),cornified envelope (100%);extracellular space (100%);nucleus (100%),GO:0005200 (100%);GO:0008092 (100%);GO:0030280 (100%),structural constituent of cytoskeleton (100%);cytoskeletal protein binding (100%);structural constituent of skin epidermis (100%),GO:0003334 (100%);GO:0008544 (100%);GO:0018149 (100%),keratinocyte development (100%);epidermis development (100%);peptide cross-linking (100%),IPR003054 (100%);IPR018039 (100%);IPR032444 (100%),Keratin, type II (100%);Intermediate filament protein, conserved site (100%);Keratin type II head (100%)
GSSSGGGYSSGSSSYGSGGR,Simiiformes,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,,,,,,,,,,,,,,,,,GO:0045095 (86%);GO:0001533 (57%);GO:0005882 (21%),keratin filament (86%);cornified envelope (57%);intermediate filament (21%),GO:0008092 (57%);GO:0030280 (57%);GO:0005200 (7%),cytoskeletal protein binding (57%);structural constituent of skin epidermis (57%);structural constituent of cytoskeleton (7%),GO:0003334 (57%);GO:0018149 (57%);GO:0031424 (57%),keratinocyte development (57%);peptide cross-linking (57%);keratinization (57%),IPR018039 (100%);IPR039008 (100%);IPR032444 (93%),Intermediate filament protein, conserved site (100%);Intermediate filament, rod domain (100%);Keratin type II head (93%)
SCLLSGWGN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VFDEFKPLVEEPQNLLK,Hominoidea,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea,,,,,,,,,,,,,,,GO:0005615 (89%);GO:0005783 (23%);GO:0005794 (23%),extracellular space (89%);endoplasmic reticulum (23%);Golgi apparatus (23%),GO:0046872 (32%);GO:0003677 (13%);GO:0005504 (13%),metal ion binding (32%);DNA binding (13%);fatty acid binding (13%),GO:0009267 (13%);GO:0043066 (13%);GO:0051659 (13%),cellular response to starvation (13%);negative regulation of apoptotic process (13%);maintenance of mitochondrion location (13%),IPR000264 (100%);IPR014760 (100%);IPR020858 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin-like (100%)
LSSPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (14%);GO:0016021 (3%),extracellular space (14%);integral component of membrane (3%),GO:0004252 (100%);GO:0046872 (5%),serine-type endopeptidase activity (100%);metal ion binding (5%),GO:0006508 (14%);GO:0007586 (5%),proteolysis (14%);digestion (5%),IPR001254 (100%);IPR009003 (100%);IPR001314 (97%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1A, chymotrypsin family (97%)
GGSGGSYGGGGSGGGYGGGSGSR,Hominoidea,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea,,,,,,,,,,,,,,,GO:0005882 (100%);GO:0005615 (17%);GO:0005634 (17%),intermediate filament (100%);extracellular space (17%);nucleus (17%),GO:0005198 (83%);GO:0005200 (17%),structural molecule activity (83%);structural constituent of cytoskeleton (17%),GO:0043588 (50%);GO:0045109 (50%);GO:0007283 (33%),skin development (50%);intermediate filament organization (50%);spermatogenesis (33%),IPR002957 (100%);IPR018039 (100%);IPR039008 (100%),Keratin, type I (100%);Intermediate filament protein, conserved site (100%);Intermediate filament, rod domain (100%)
SLDLDSLLAEVK,Sarcopterygii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (94%);GO:0005737 (10%);GO:0001533 (7%),keratin filament (94%);cytoplasm (10%);cornified envelope (7%),GO:0030280 (7%);GO:0046982 (7%);GO:0030246 (7%),structural constituent of skin epidermis (7%);protein heterodimerization activity (7%);carbohydrate binding (7%),GO:0018149 (7%);GO:0051290 (7%);GO:0001867 (7%),peptide cross-linking (7%);protein heterotetramerization (7%);complement activation, lectin pathway (7%),IPR039008 (100%);IPR042180 (99%);IPR003054 (97%),Intermediate filament, rod domain (100%);Intermediate filament, rod domain, coil 1B (99%);Keratin, type II (97%)
LGEHNLDVLEGNEQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVMDDFAAFVEK,Homininae,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea,Hominidae,Homininae,,,,,,,,,,,,,GO:0005615 (94%);GO:0005783 (29%);GO:0005794 (29%),extracellular space (94%);endoplasmic reticulum (29%);Golgi apparatus (29%),GO:0046872 (32%);GO:0003677 (10%);GO:0005504 (10%),metal ion binding (32%);DNA binding (10%);fatty acid binding (10%),GO:0009267 (10%);GO:0043066 (10%);GO:0051659 (10%),cellular response to starvation (10%);negative regulation of apoptotic process (10%);maintenance of mitochondrion location (10%),IPR000264 (100%);IPR014760 (100%);IPR020857 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin, conserved site (100%)
LVGGYTCAANSLPYQVSLNS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNGNTLDNDLMLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAGTECLLSGWGNTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVLEGNEQF,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EGNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
STSSFSCLSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (97%);GO:0001533 (57%);GO:0005882 (6%),keratin filament (97%);cornified envelope (57%);intermediate filament (6%),GO:0008092 (57%);GO:0030280 (57%);GO:0005200 (3%),cytoskeletal protein binding (57%);structural constituent of skin epidermis (57%);structural constituent of cytoskeleton (3%),GO:0003334 (57%);GO:0018149 (57%);GO:0031424 (57%),keratinocyte development (57%);peptide cross-linking (57%);keratinization (57%),IPR018039 (100%);IPR032444 (100%);IPR039008 (100%),Intermediate filament protein, conserved site (100%);Keratin type II head (100%);Intermediate filament, rod domain (100%)
QFSSSYLSR,Simiiformes,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,,,,,,,,,,,,,,,,,GO:0005882 (100%);GO:0005615 (11%);GO:0005634 (11%),intermediate filament (100%);extracellular space (11%);nucleus (11%),GO:0005198 (89%);GO:0005200 (11%),structural molecule activity (89%);structural constituent of cytoskeleton (11%),GO:0043588 (89%);GO:0045109 (89%);GO:0007283 (67%),skin development (89%);intermediate filament organization (89%);spermatogenesis (67%),IPR002957 (100%);IPR039008 (100%);IPR042180 (100%),Keratin, type I (100%);Intermediate filament, rod domain (100%);Intermediate filament, rod domain, coil 1B (100%)
GSSSGGVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (95%);GO:0001533 (44%);GO:0005576 (2%),keratin filament (95%);cornified envelope (44%);extracellular region (2%),GO:0046982 (46%);GO:0030246 (44%);GO:0030280 (44%),protein heterodimerization activity (46%);carbohydrate binding (44%);structural constituent of skin epidermis (44%),GO:0050728 (46%);GO:0051290 (46%);GO:0061436 (46%),negative regulation of inflammatory response (46%);protein heterotetramerization (46%);establishment of skin barrier (46%),IPR032449 (95%);IPR003054 (93%);IPR039008 (93%),Keratin type II cytoskeletal 1, tail (95%);Keratin, type II (93%);Intermediate filament, rod domain (93%)
LGEHNLDVLEGN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVLEGNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEGNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVGGYTCAANSLPYQVSLNSG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SGGGGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.13 (62%);2.7.7.8 (12%);1.3.3.3 (9%),RNA helicase (62%);Polyribonucleotide nucleotidyltransferase (12%);Coproporphyrinogen oxidase (9%),GO:0016021 (18%);GO:0005737 (16%);GO:0045095 (8%),integral component of membrane (18%);cytoplasm (16%);keratin filament (8%),GO:0005524 (31%);GO:0003676 (29%);GO:0003723 (13%),ATP binding (31%);nucleic acid binding (29%);RNA binding (13%),GO:0006260 (5%);GO:0042255 (5%);GO:0006605 (4%),DNA replication (5%);ribosome assembly (5%);protein targeting (4%),IPR027417 (25%);IPR001650 (19%);IPR014001 (19%),P-loop containing nucleoside triphosphate hydrolase (25%);Helicase, C-terminal (19%);Helicase superfamily 1/2, ATP-binding domain (19%)
FSSCG,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003677 (50%);GO:0003700 (50%);GO:0016987 (50%),DNA binding (50%);DNA-binding transcription factor activity (50%);sigma factor activity (50%),GO:0000160 (50%);GO:0006352 (50%),phosphorelay signal transduction system (50%);DNA-templated transcription, initiation (50%),IPR000943 (50%);IPR001789 (50%);IPR007627 (50%),RNA polymerase sigma-70 (50%);Signal transduction response regulator, receiver domain (50%);RNA polymerase sigma-70 region 2 (50%)
YEELQLTAGR,Sarcopterygii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (98%);GO:0001533 (20%);GO:0005829 (2%),keratin filament (98%);cornified envelope (20%);cytosol (2%),GO:0046982 (22%);GO:0030246 (20%);GO:0030280 (20%),protein heterodimerization activity (22%);carbohydrate binding (20%);structural constituent of skin epidermis (20%),GO:0050728 (22%);GO:0051290 (22%);GO:0061436 (22%),negative regulation of inflammatory response (22%);protein heterotetramerization (22%);establishment of skin barrier (22%),IPR039008 (100%);IPR003054 (99%);IPR042180 (99%),Intermediate filament, rod domain (100%);Keratin, type II (99%);Intermediate filament, rod domain, coil 1B (99%)
GGSGGGGGGSSGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0001533 (50%);GO:0005576 (4%),keratin filament (100%);cornified envelope (50%);extracellular region (4%),GO:0030246 (50%);GO:0030280 (50%);GO:0046982 (50%),carbohydrate binding (50%);structural constituent of skin epidermis (50%);protein heterodimerization activity (50%),GO:0001867 (50%);GO:0018149 (50%);GO:0050728 (50%),complement activation, lectin pathway (50%);peptide cross-linking (50%);negative regulation of inflammatory response (50%),IPR032449 (100%);IPR003054 (97%);IPR018039 (97%),Keratin type II cytoskeletal 1, tail (100%);Keratin, type II (97%);Intermediate filament protein, conserved site (97%)
FSSSSGYGGGSSR,Euarchontoglires,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,,,,,,,,,,,,,,,,,,,,GO:0005882 (100%);GO:0005615 (6%);GO:0005634 (6%),intermediate filament (100%);extracellular space (6%);nucleus (6%),GO:0005198 (94%);GO:0005200 (6%),structural molecule activity (94%);structural constituent of cytoskeleton (6%),GO:0043588 (81%);GO:0045109 (81%);GO:0007283 (63%),skin development (81%);intermediate filament organization (81%);spermatogenesis (63%),IPR002957 (100%);IPR039008 (100%);IPR042180 (100%),Keratin, type I (100%);Intermediate filament, rod domain (100%);Intermediate filament, rod domain, coil 1B (100%)
LLTHPNFNGNTLDN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GSLGGGFSSGGFSGGSFSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005882 (100%);GO:0001533 (54%);GO:0005737 (54%),intermediate filament (100%);cornified envelope (54%);cytoplasm (54%),GO:0030280 (54%);GO:0046982 (54%);GO:0005198 (46%),structural constituent of skin epidermis (54%);protein heterodimerization activity (54%);structural molecule activity (46%),GO:0018149 (54%);GO:0030216 (54%);GO:0051290 (54%),peptide cross-linking (54%);keratinocyte differentiation (54%);protein heterotetramerization (54%),IPR002957 (100%);IPR039008 (100%);IPR042180 (100%),Keratin, type I (100%);Intermediate filament, rod domain (100%);Intermediate filament, rod domain, coil 1B (100%)
SCLLS,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.- (50%);2.1.1.- (17%);2.6.1.- (17%),Pentosyltransferases (50%);Methyltransferases (17%);Transaminases (17%),GO:0016020 (21%);GO:0016021 (17%);GO:0005634 (7%),membrane (21%);integral component of membrane (17%);nucleus (7%),GO:0003924 (31%);GO:0005525 (31%);GO:0003950 (14%),GTPase activity (31%);GTP binding (31%);NAD+ ADP-ribosyltransferase activity (14%),GO:0007165 (21%);GO:0007264 (7%);GO:0030837 (7%),signal transduction (21%);small GTPase mediated signal transduction (7%);negative regulation of actin filament polymerization (7%),IPR027417 (30%);IPR001806 (27%);IPR005225 (24%),P-loop containing nucleoside triphosphate hydrolase (30%);Small GTPase (27%);Small GTP-binding protein domain (24%)
FLEQTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.2 (15%);3.6.4.- (13%);3.5.2.3 (6%),GMP synthase (glutamine-hydrolyzing) (15%);Acting on ATP; involved in cellular and subcellular movement (13%);Dihydroorotase (6%),GO:0016021 (28%);GO:0042613 (16%);GO:0005737 (8%),integral component of membrane (28%);MHC class II protein complex (16%);cytoplasm (8%),GO:0005524 (17%);GO:0097367 (8%);GO:0003677 (4%),ATP binding (17%);carbohydrate derivative binding (8%);DNA binding (4%),GO:0006955 (13%);GO:0019882 (13%);GO:1901135 (8%),immune response (13%);antigen processing and presentation (13%);carbohydrate derivative metabolic process (8%),IPR011990 (12%);IPR013026 (12%);IPR019734 (12%),Tetratricopeptide-like helical domain superfamily (12%);Tetratricopeptide repeat-containing domain (12%);Tetratricopeptide repeat (12%)
VLASASTLEAEVR,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (100%),ribosome (100%),GO:0019843 (98%);GO:0003735 (97%),rRNA binding (98%);structural constituent of ribosome (97%),GO:0006412 (100%),translation (100%),IPR004389 (100%);IPR005484 (100%);IPR010908 (0%),Ribosomal protein L18, bacterial-type (100%);Ribosomal protein L18 (100%);Longin domain (0%)
STMSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.2.2.- (29%);4.6.1.1 (11%);6.1.1.3 (7%),Linked to the hydrolysis of a nucleoside triphosphate (29%);Adenylate cyclase (11%);Threonine--tRNA ligase (7%),GO:0016021 (27%);GO:0005840 (7%);GO:0005737 (4%),integral component of membrane (27%);ribosome (7%);cytoplasm (4%),GO:0003677 (15%);GO:0016849 (13%);GO:0005524 (11%),DNA binding (15%);phosphorus-oxygen lyase activity (13%);ATP binding (11%),GO:0035556 (15%);GO:0009190 (14%);GO:0006355 (11%),intracellular signal transduction (15%);cyclic nucleotide biosynthetic process (14%);regulation of transcription, DNA-templated (11%),IPR029016 (16%);IPR029787 (13%);IPR001054 (13%),GAF-like domain superfamily (16%);Nucleotide cyclase (13%);Adenylyl cyclase class-3/4/guanylyl cyclase (13%)
LLTHPNFNGN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLVNLGGSK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (98%);GO:0001533 (42%);GO:0005886 (3%),keratin filament (98%);cornified envelope (42%);plasma membrane (3%),GO:0046982 (45%);GO:0030246 (42%);GO:0030280 (42%),protein heterodimerization activity (45%);carbohydrate binding (42%);structural constituent of skin epidermis (42%),GO:0051290 (45%);GO:0001867 (42%);GO:0018149 (42%),protein heterotetramerization (45%);complement activation, lectin pathway (42%);peptide cross-linking (42%),IPR003054 (100%);IPR032444 (100%);IPR039008 (100%),Keratin, type II (100%);Keratin type II head (100%);Intermediate filament, rod domain (100%)
AEAESLYQSK,Simiiformes,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0001533 (46%);GO:0005576 (3%),keratin filament (100%);cornified envelope (46%);extracellular region (3%),GO:0046982 (49%);GO:0030246 (46%);GO:0030280 (46%),protein heterodimerization activity (49%);carbohydrate binding (46%);structural constituent of skin epidermis (46%),GO:0050728 (49%);GO:0051290 (49%);GO:0061436 (49%),negative regulation of inflammatory response (49%);protein heterotetramerization (49%);establishment of skin barrier (49%),IPR003054 (100%);IPR032449 (100%);IPR039008 (100%),Keratin, type II (100%);Keratin type II cytoskeletal 1, tail (100%);Intermediate filament, rod domain (100%)
GGGGGGGLGSGGSLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLTHPNFN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WVVSAAHCYK,Craniata,Eukaryota,Metazoa,,,Chordata,Craniata,,,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (3%),extracellular space (3%),GO:0004252 (100%);GO:0003676 (3%);GO:0004386 (3%),serine-type endopeptidase activity (100%);nucleic acid binding (3%);helicase activity (3%),GO:0006508 (3%);GO:0007596 (3%),proteolysis (3%);blood coagulation (3%),IPR001254 (100%);IPR009003 (100%);IPR018114 (100%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Serine proteases, trypsin family, histidine active site (100%)
VCNYVNWLQQTLAAN,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (33%),extracellular space (33%),GO:0004252 (100%);GO:0046872 (17%),serine-type endopeptidase activity (100%);metal ion binding (17%),GO:0006508 (33%);GO:0007586 (17%),proteolysis (33%);digestion (17%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
LLTHPNFNGNTLD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVLEGNE,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PELQER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004497 (100%);GO:0005506 (100%);GO:0016705 (100%),monooxygenase activity (100%);iron ion binding (100%);oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (100%),,,IPR001128 (50%);IPR002403 (50%);IPR017972 (50%),Cytochrome P450 (50%);Cytochrome P450, E-class, group IV (50%);Cytochrome P450, conserved site (50%)
DAEAWFNEK,Sarcopterygii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,,,,,,,,,,,,,,,,,,,,,,,,GO:0005882 (100%);GO:0005737 (14%);GO:0001533 (12%),intermediate filament (100%);cytoplasm (14%);cornified envelope (12%),GO:0005198 (86%);GO:0046982 (25%);GO:0030280 (12%),structural molecule activity (86%);protein heterodimerization activity (25%);structural constituent of skin epidermis (12%),GO:0031069 (22%);GO:0045109 (13%);GO:0007568 (12%),hair follicle morphogenesis (22%);intermediate filament organization (13%);aging (12%),IPR002957 (100%);IPR039008 (100%);IPR042180 (99%),Keratin, type I (100%);Intermediate filament, rod domain (100%);Intermediate filament, rod domain, coil 1B (99%)
SLNFASFLDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVGGYTCAAN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SCLLSGW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVNWLQQTLAAN,Rodentia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Rodentia,,,,,,,,,,,,,,,,,,,GO:0005615 (67%),extracellular space (67%),GO:0004252 (100%),serine-type endopeptidase activity (100%),GO:0006508 (67%),proteolysis (67%),IPR001254 (100%);IPR009003 (100%);IPR033116 (100%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Serine proteases, trypsin family, serine active site (100%)
KPLPFLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005623 (50%);GO:0005739 (50%);GO:0016021 (50%),cell (50%);mitochondrion (50%);integral component of membrane (50%),GO:0004674 (50%);GO:0005524 (50%);GO:0030170 (50%),protein serine/threonine kinase activity (50%);ATP binding (50%);pyridoxal phosphate binding (50%),GO:0006879 (50%);GO:0031921 (50%),cellular iron ion homeostasis (50%);pyridoxal phosphate transport (50%),IPR000719 (25%);IPR001279 (25%);IPR005475 (25%),Protein kinase domain (25%);Metallo-beta-lactamase (25%);Transketolase-like, pyrimidine-binding domain (25%)
LVGGYTCAANSLPY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLTHPNFNGNTL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AQQTADEANER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (100%);GO:0019867 (100%),cell outer membrane (100%);outer membrane (100%),,,,,IPR021793 (100%),Major outer membrane lipoprotein Oprl (100%)
VATVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (29%),extracellular space (29%),GO:0004252 (100%);GO:0046872 (14%),serine-type endopeptidase activity (100%);metal ion binding (14%),GO:0006508 (29%);GO:0007586 (14%),proteolysis (29%);digestion (14%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
TLLEGEESR,Sarcopterygii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (95%);GO:0001533 (17%);GO:0005882 (4%),keratin filament (95%);cornified envelope (17%);intermediate filament (4%),GO:0046982 (18%);GO:0030246 (17%);GO:0030280 (17%),protein heterodimerization activity (18%);carbohydrate binding (17%);structural constituent of skin epidermis (17%),GO:0051290 (18%);GO:0050728 (17%);GO:0061436 (17%),protein heterotetramerization (18%);negative regulation of inflammatory response (17%);establishment of skin barrier (17%),IPR039008 (100%);IPR018039 (99%);IPR042180 (99%),Intermediate filament, rod domain (100%);Intermediate filament protein, conserved site (99%);Intermediate filament, rod domain, coil 1B (99%)
GNTLDNDLMLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVGGYTCGANTVPYQVSLNSG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTATEDAAAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (100%);GO:0019867 (100%),cell outer membrane (100%);outer membrane (100%),,,,,IPR021793 (100%),Major outer membrane lipoprotein Oprl (100%)
NEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSSSGSVGESSSK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005882 (100%);GO:0001533 (64%);GO:0005737 (64%),intermediate filament (100%);cornified envelope (64%);cytoplasm (64%),GO:0030280 (64%);GO:0046982 (64%);GO:0005198 (36%),structural constituent of skin epidermis (64%);protein heterodimerization activity (64%);structural molecule activity (36%),GO:0018149 (64%);GO:0030216 (64%);GO:0051290 (64%),peptide cross-linking (64%);keratinocyte differentiation (64%);protein heterotetramerization (64%),IPR002957 (100%);IPR018039 (100%);IPR039008 (100%),Keratin, type I (100%);Intermediate filament protein, conserved site (100%);Intermediate filament, rod domain (100%)
AEYEDLATR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGFAGDDAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.- (20%);2.7.10.2 (20%);3.1.2.15 (20%),Pentosyltransferases (20%);Non-specific protein-tyrosine kinase (20%);Deleted entry (20%),GO:0005856 (91%);GO:0005737 (91%);GO:0005884 (4%),cytoskeleton (91%);cytoplasm (91%);actin filament (4%),GO:0005524 (98%);GO:0042802 (3%);GO:0005200 (3%),ATP binding (98%);identical protein binding (3%);structural constituent of cytoskeleton (3%),GO:0010628 (4%);GO:0090131 (3%);GO:0006897 (3%),positive regulation of gene expression (4%);mesenchyme migration (3%);endocytosis (3%),IPR004000 (100%);IPR004001 (62%);IPR020902 (58%),Actin family (100%);Actin, conserved site (62%);Actin/actin-like conserved site (58%)
GENALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.2 (58%);2.7.9.2 (10%);2.7.4.6 (6%),DNA ligase (NAD(+)) (58%);Pyruvate, water dikinase (10%);Nucleoside-diphosphate kinase (6%),GO:0045095 (36%);GO:0016021 (16%);GO:0001533 (9%),keratin filament (36%);integral component of membrane (16%);cornified envelope (9%),GO:0005524 (16%);GO:0030280 (9%);GO:0046872 (9%),ATP binding (16%);structural constituent of skin epidermis (9%);metal ion binding (9%),GO:0018149 (9%);GO:0051290 (8%);GO:0050728 (8%),peptide cross-linking (9%);protein heterotetramerization (8%);negative regulation of inflammatory response (8%),IPR018039 (31%);IPR039008 (31%);IPR003054 (30%),Intermediate filament protein, conserved site (31%);Intermediate filament, rod domain (31%);Keratin, type II (30%)
STMELNSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLLVLPGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0043531 (75%);GO:0003677 (25%),ADP binding (75%);DNA binding (25%),,,IPR002182 (50%);IPR027417 (50%);IPR032675 (50%),NB-ARC (50%);P-loop containing nucleoside triphosphate hydrolase (50%);Leucine-rich repeat domain superfamily (50%)
VTMNLNDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HPDYSVVLLLR,Euarchontoglires,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,,,,,,,,,,,,,,,,,,,,GO:0005615 (83%);GO:0005783 (27%);GO:0005794 (27%),extracellular space (83%);endoplasmic reticulum (27%);Golgi apparatus (27%),GO:0046872 (38%);GO:0003677 (20%);GO:0005504 (20%),metal ion binding (38%);DNA binding (20%);fatty acid binding (20%),GO:0009267 (20%);GO:0043066 (20%);GO:0051659 (20%),cellular response to starvation (20%);negative regulation of apoptotic process (20%);maintenance of mitochondrion location (20%),IPR000264 (100%);IPR014760 (100%);IPR020858 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin-like (100%)
VVTVVDPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SQYEQLAEQNR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005882 (100%);GO:0001533 (56%);GO:0005737 (56%),intermediate filament (100%);cornified envelope (56%);cytoplasm (56%),GO:0030280 (56%);GO:0046982 (56%);GO:0005198 (44%),structural constituent of skin epidermis (56%);protein heterodimerization activity (56%);structural molecule activity (44%),GO:0018149 (56%);GO:0030216 (56%);GO:0051290 (56%),peptide cross-linking (56%);keratinocyte differentiation (56%);protein heterotetramerization (56%),IPR002957 (100%);IPR039008 (100%);IPR042180 (100%),Keratin, type I (100%);Intermediate filament, rod domain (100%);Intermediate filament, rod domain, coil 1B (100%)
VTMDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.2.12 (30%);6.1.1.5 (11%);2.5.1.7 (9%),Phosphoglycerate mutase (2,3-diphosphoglycerate-independent) (30%);Isoleucine--tRNA ligase (11%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (9%),GO:0005737 (25%);GO:0016021 (18%);GO:0005886 (4%),cytoplasm (25%);integral component of membrane (18%);plasma membrane (4%),GO:0005524 (11%);GO:0004619 (11%);GO:0030145 (11%),ATP binding (11%);phosphoglycerate mutase activity (11%);manganese ion binding (11%),GO:0006007 (11%);GO:0006096 (10%);GO:0007049 (5%),glucose catabolic process (11%);glycolytic process (10%);cell cycle (5%),IPR017850 (11%);IPR005995 (11%);IPR006124 (11%),Alkaline-phosphatase-like, core domain superfamily (11%);Phosphoglycerate mutase, 2,3-bisphosphoglycerate-independent (11%);Metalloenzyme (11%)
ALEEANADLEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005882 (90%);GO:0045095 (10%);GO:0005634 (9%),intermediate filament (90%);keratin filament (10%);nucleus (9%),GO:0005198 (94%);GO:1990254 (8%);GO:0097110 (7%),structural molecule activity (94%);keratin filament binding (8%);scaffold protein binding (7%),GO:0007568 (15%);GO:0042633 (15%);GO:0045110 (8%),aging (15%);hair cycle (15%);intermediate filament bundle assembly (8%),IPR002957 (100%);IPR039008 (100%);IPR042180 (100%),Keratin, type I (100%);Intermediate filament, rod domain (100%);Intermediate filament, rod domain, coil 1B (100%)
GTECLLSGWGNTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CLLSGWGNTK,Camelus,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Laurasiatheria,Artiodactyla,Tylopoda,,,,Camelidae,,,,Camelus,,,,,,,,,,,,GO:0004252 (100%);GO:0005509 (100%),serine-type endopeptidase activity (100%);calcium ion binding (100%),GO:0007596 (100%),blood coagulation (100%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
VELEVVGTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (87%);GO:0009279 (87%);GO:0016020 (13%),integral component of membrane (87%);cell outer membrane (87%);membrane (13%),GO:0015288 (0%),porin activity (0%),,,IPR006664 (100%);IPR006665 (100%);IPR036737 (100%),Outer membrane protein, bacterial (100%);OmpA-like domain (100%);OmpA-like domain superfamily (100%)
VVSLSELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (50%),cytoplasm (50%),GO:0003824 (50%);GO:0005525 (50%);GO:0016149 (50%),catalytic activity (50%);GTP binding (50%);translation release factor activity, codon specific (50%),GO:0006449 (50%),regulation of translational termination (50%),IPR006442 (40%);IPR027417 (40%);IPR036165 (40%),Type II toxin-antitoxin system, antitoxin Phd/YefM (40%);P-loop containing nucleoside triphosphate hydrolase (40%);YefM-like superfamily (40%)
LASYLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.88 (17%);4.6.1.12 (17%);1.1.1.154 (8%),L-glutamate gamma-semialdehyde dehydrogenase (17%);2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (17%);Ureidoglycolate dehydrogenase (8%),GO:0005882 (88%);GO:0005737 (7%);GO:0071944 (4%),intermediate filament (88%);cytoplasm (7%);cell periphery (4%),GO:0005198 (83%);GO:0003677 (5%);GO:0000166 (4%),structural molecule activity (83%);DNA binding (5%);nucleotide binding (4%),GO:0007568 (5%);GO:0042633 (5%);GO:0031424 (4%),aging (5%);hair cycle (5%);keratinization (4%),IPR039008 (90%);IPR042180 (90%);IPR002957 (90%),Intermediate filament, rod domain (90%);Intermediate filament, rod domain, coil 1B (90%);Keratin, type I (90%)
SHFCGGSLLNSQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGHHTAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSGSSYPSLLQLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EGTDLFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0015935 (90%);GO:0005840 (10%);GO:0022627 (0%),small ribosomal subunit (90%);ribosome (10%);cytosolic small ribosomal subunit (0%),GO:0019843 (96%);GO:0003735 (90%);GO:0016787 (0%),rRNA binding (96%);structural constituent of ribosome (90%);hydrolase activity (0%),GO:0006412 (95%);GO:0045903 (0%);GO:0006353 (0%),translation (95%);positive regulation of translational fidelity (0%);DNA-templated transcription, termination (0%),IPR001912 (100%);IPR005709 (99%);IPR022801 (99%),Ribosomal protein S4/S9, N-terminal (100%);Ribosomal protein S4, bacterial-type (99%);Ribosomal protein S4/S9 (99%)
SSPATLNSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPLLSTTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%);GO:0005634 (33%);GO:0005667 (33%),integral component of membrane (67%);nucleus (33%);transcription factor complex (33%),GO:0009002 (67%);GO:0003677 (33%);GO:0003700 (33%),serine-type D-Ala-D-Ala carboxypeptidase activity (67%);DNA binding (33%);DNA-binding transcription factor activity (33%),GO:0051726 (33%),regulation of cell cycle (33%),IPR001967 (67%);IPR012338 (67%);IPR018044 (67%),Peptidase S11, D-alanyl-D-alanine carboxypeptidase A, N-terminal (67%);Beta-lactamase/transpeptidase-like (67%);Peptidase S11, D-alanyl-D-alanine carboxypeptidase A (67%)
LGEHNLDVLEGNEQFLNAA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GFSSGGFSGGSFSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VAQVALLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.2.6 (100%),Hydroxyacylglutathione hydrolase (100%),GO:0016021 (33%),integral component of membrane (33%),GO:0004416 (33%);GO:0008289 (33%);GO:0022857 (33%),hydroxyacylglutathione hydrolase activity (33%);lipid binding (33%);transmembrane transporter activity (33%),GO:0006744 (33%);GO:0019243 (33%),ubiquinone biosynthetic process (33%);methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (33%),IPR013877 (50%);IPR016024 (50%);IPR019516 (50%),YAP-binding/ALF4/Glomulin (50%);Armadillo-type fold (50%);Glomulin/ALF4 (50%)
LAADDFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.2.10 (33%);2.7.7.18 (33%);2.7.7.59 (33%),Aminomethyltransferase (33%);Nicotinate-nucleotide adenylyltransferase (33%);[Protein-PII] uridylyltransferase (33%),GO:0005882 (96%);GO:0005737 (4%);GO:0071944 (3%),intermediate filament (96%);cytoplasm (4%);cell periphery (3%),GO:0005198 (92%);GO:0030280 (3%);GO:0097110 (2%),structural molecule activity (92%);structural constituent of skin epidermis (3%);scaffold protein binding (2%),GO:0007568 (3%);GO:0042633 (3%);GO:0031424 (2%),aging (3%);hair cycle (3%);keratinization (2%),IPR039008 (99%);IPR002957 (99%);IPR042180 (99%),Intermediate filament, rod domain (99%);Keratin, type I (99%);Intermediate filament, rod domain, coil 1B (99%)
AQYEELAQR,Sarcopterygii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (94%);GO:0005882 (8%);GO:0009986 (7%),keratin filament (94%);intermediate filament (8%);cell surface (7%),GO:0030280 (7%);GO:0008092 (6%);GO:0005200 (1%),structural constituent of skin epidermis (7%);cytoskeletal protein binding (6%);structural constituent of cytoskeleton (1%),GO:0007010 (8%);GO:0031424 (8%);GO:0018149 (7%),cytoskeleton organization (8%);keratinization (8%);peptide cross-linking (7%),IPR039008 (100%);IPR042180 (100%);IPR003054 (95%),Intermediate filament, rod domain (100%);Intermediate filament, rod domain, coil 1B (100%);Keratin, type II (95%)
GFAGDDAPR,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR004000 (100%);IPR004001 (17%);IPR020902 (14%),Actin family (100%);Actin, conserved site (17%);Actin/actin-like conserved site (14%)
LVGGYTCGANTVPYQVSLNS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSSGSAVVSGGSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSGQSSAK,Fungi,Eukaryota,Fungi,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,
YENEVALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005882 (98%);GO:0001533 (28%);GO:0005737 (28%),intermediate filament (98%);cornified envelope (28%);cytoplasm (28%),GO:0005198 (71%);GO:0030280 (28%);GO:0046982 (28%),structural molecule activity (71%);structural constituent of skin epidermis (28%);protein heterodimerization activity (28%),GO:0018149 (28%);GO:0030216 (28%);GO:0051290 (28%),peptide cross-linking (28%);keratinocyte differentiation (28%);protein heterotetramerization (28%),IPR002957 (97%);IPR039008 (97%);IPR042180 (97%),Keratin, type I (97%);Intermediate filament, rod domain (97%);Intermediate filament, rod domain, coil 1B (97%)
EESNYELEGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLSGNEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.2.4 (53%);6.3.4.- (17%);6.1.1.14 (13%),Deoxyribose-phosphate aldolase (53%);Other carbon--nitrogen ligases (17%);Glycine--tRNA ligase (13%),GO:0005737 (34%);GO:0016021 (25%);GO:0005886 (14%),cytoplasm (34%);integral component of membrane (25%);plasma membrane (14%),GO:0004139 (20%);GO:0005524 (15%);GO:0005509 (11%),deoxyribose-phosphate aldolase activity (20%);ATP binding (15%);calcium ion binding (11%),GO:0009264 (20%);GO:0046386 (20%);GO:0007156 (11%),deoxyribonucleotide catabolic process (20%);deoxyribose phosphate catabolic process (20%);homophilic cell adhesion via plasma membrane adhesion molecules (11%),IPR002915 (18%);IPR011343 (18%);IPR013785 (18%),DeoC/FbaB/LacD aldolase (18%);Deoxyribose-phosphate aldolase (18%);Aldolase-type TIM barrel (18%)
SLSLSVAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.99.2 (100%),Aminopyrimidine aminohydrolase (100%),GO:0045095 (98%);GO:0001533 (45%);GO:0005576 (2%),keratin filament (98%);cornified envelope (45%);extracellular region (2%),GO:0030280 (45%);GO:0046982 (43%);GO:0030246 (41%),structural constituent of skin epidermis (45%);protein heterodimerization activity (43%);carbohydrate binding (41%),GO:0018149 (45%);GO:0051290 (43%);GO:0001867 (41%),peptide cross-linking (45%);protein heterotetramerization (43%);complement activation, lectin pathway (41%),IPR032444 (97%);IPR003054 (95%);IPR039008 (95%),Keratin type II head (97%);Keratin, type II (95%);Intermediate filament, rod domain (95%)
NSLPYQVSLNSG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFLLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (39%);2.7.7.7 (11%);2.3.1.234 (7%),Endopeptidase La (39%);DNA-directed DNA polymerase (11%);N(6)-L-threonylcarbamoyladenine synthase (7%),GO:0005840 (87%);GO:0016021 (8%);GO:0005737 (1%),ribosome (87%);integral component of membrane (8%);cytoplasm (1%),GO:0019843 (84%);GO:0003735 (77%);GO:0005524 (2%),rRNA binding (84%);structural constituent of ribosome (77%);ATP binding (2%),GO:0006412 (86%);GO:0006515 (1%);GO:0034605 (1%),translation (86%);protein quality control for misfolded or incompletely synthesized proteins (1%);cellular response to heat (1%),IPR000244 (90%);IPR036935 (90%);IPR009027 (90%),Ribosomal protein L9 (90%);Ribosomal protein L9, N-terminal domain superfamily (90%);Ribosomal protein L9/RNase H1, N-terminal (90%)
NPLLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.98 (32%);6.1.1.23 (19%);3.6.1.54 (6%),UDP-N-acetylmuramate dehydrogenase (32%);Aspartate--tRNA(Asn) ligase (19%);UDP-2,3-diacylglucosamine diphosphatase (6%),GO:0005737 (21%);GO:0016021 (20%);GO:0005634 (3%),cytoplasm (21%);integral component of membrane (20%);nucleus (3%),GO:0005524 (22%);GO:0003676 (11%);GO:0071949 (9%),ATP binding (22%);nucleic acid binding (11%);FAD binding (9%),GO:0009252 (9%);GO:0051301 (9%);GO:0071555 (9%),peptidoglycan biosynthetic process (9%);cell division (9%);cell wall organization (9%),IPR027417 (13%);IPR016166 (7%);IPR016169 (7%),P-loop containing nucleoside triphosphate hydrolase (13%);FAD-binding domain, PCMH-type (7%);FAD-binding, type PCMH, subdomain 2 (7%)
VATDLALR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016740 (100%),transferase activity (100%),,,IPR001296 (33%);IPR003785 (33%);IPR012685 (33%),Glycosyl transferase, family 1 (33%);Creatininase/formamide hydrolase (33%);Conserved hypothetical protein CHP02304, F390 synthetase-related (33%)
GGGFSSGGFSGGSFSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FQNALLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005615 (82%);GO:0005783 (26%);GO:0005794 (26%),extracellular space (82%);endoplasmic reticulum (26%);Golgi apparatus (26%),GO:0046872 (38%);GO:1903981 (21%);GO:0003677 (20%),metal ion binding (38%);enterobactin binding (21%);DNA binding (20%),GO:0009267 (20%);GO:0043066 (20%);GO:0051659 (20%),cellular response to starvation (20%);negative regulation of apoptotic process (20%);maintenance of mitochondrion location (20%),IPR000264 (99%);IPR014760 (99%);IPR020858 (99%),ALB/AFP/VDB (99%);Serum albumin, N-terminal (99%);Serum albumin-like (99%)
VAEVSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVGGYTCAA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPLVAFTA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QALEELAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.18 (82%);2.5.1.54 (14%);3.4.24.- (5%),5-(carboxyamino)imidazole ribonucleotide synthase (82%);3-deoxy-7-phosphoheptulonate synthase (14%);Metalloendopeptidases (5%),GO:0016021 (22%);GO:0019012 (11%);GO:0005886 (2%),integral component of membrane (22%);virion (11%);plasma membrane (2%),GO:0005524 (48%);GO:0034028 (33%);GO:0046872 (33%),ATP binding (48%);5-(carboxyamino)imidazole ribonucleotide synthase activity (33%);metal ion binding (33%),GO:0006189 (33%);GO:0055114 (31%);GO:0006935 (19%),'de novo' IMP biosynthetic process (33%);oxidation-reduction process (31%);chemotaxis (19%),IPR003135 (31%);IPR005875 (31%);IPR011054 (31%),ATP-grasp fold, ATP-dependent carboxylate-amine ligase-type (31%);Phosphoribosylaminoimidazole carboxylase, ATPase subunit (31%);Rudiment single hybrid motif (31%)
SSGSSYPSLLQC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LATVSLPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016787 (100%),hydrolase activity (100%),GO:0016042 (100%),lipid catabolic process (100%),IPR000014 (50%);IPR000780 (50%);IPR013767 (50%),PAS domain (50%);MCP methyltransferase, CheR-type (50%);PAS fold (50%)
YLYELAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.35 (50%);2.5.1.7 (17%);2.7.1.49 (17%),Pyridoxal kinase (50%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (17%);Hydroxymethylpyrimidine kinase (17%),GO:0005615 (83%);GO:0005737 (30%);GO:0032991 (12%),extracellular space (83%);cytoplasm (30%);protein-containing complex (12%),GO:0046872 (44%);GO:0005504 (20%);GO:0008270 (16%),metal ion binding (44%);fatty acid binding (20%);zinc ion binding (16%),GO:0001542 (17%);GO:0042448 (17%);GO:0060395 (17%),ovulation from ovarian follicle (17%);progesterone metabolic process (17%);SMAD protein signal transduction (17%),IPR000264 (89%);IPR014760 (89%);IPR020858 (89%),ALB/AFP/VDB (89%);Serum albumin, N-terminal (89%);Serum albumin-like (89%)
SPATLNSR,Dipodomys ordii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Rodentia,Castorimorpha,,,,Heteromyidae,Dipodomyinae,,,Dipodomys,,,,Dipodomys ordii,,,,,,,,GO:0004252 (100%),serine-type endopeptidase activity (100%),,,IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
LSGWGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.-.- (17%);2.3.1.180 (17%);2.4.1.- (17%),Acting on paired donors, with incorporation or reduction of molecular oxygen. The oxygen incorporated need not be derived from O(2) (17%);Beta-ketoacyl-[acyl-carrier-protein] synthase III (17%);Hexosyltransferases (17%),GO:0016021 (28%);GO:0005737 (8%);GO:0005634 (5%),integral component of membrane (28%);cytoplasm (8%);nucleus (5%),GO:0003676 (12%);GO:0008408 (12%);GO:0000166 (11%),nucleic acid binding (12%);3'-5' exonuclease activity (12%);nucleotide binding (11%),GO:0006282 (7%);GO:0006351 (5%);GO:0005975 (2%),regulation of DNA repair (7%);transcription, DNA-templated (5%);carbohydrate metabolic process (2%),IPR002562 (11%);IPR012337 (11%);IPR036397 (11%),3'-5' exonuclease domain (11%);Ribonuclease H-like superfamily (11%);Ribonuclease H superfamily (11%)
PELQVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVGGYTCVSLNSG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLSGWGNTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GPAALQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.12 (100%),tRNA pseudouridine(38-40) synthase (100%),GO:0005882 (67%);GO:0005615 (17%);GO:0005634 (17%),intermediate filament (67%);extracellular space (17%);nucleus (17%),GO:0005198 (50%);GO:0003723 (17%);GO:0005200 (17%),structural molecule activity (50%);RNA binding (17%);structural constituent of cytoskeleton (17%),GO:0043588 (50%);GO:0045109 (50%);GO:0007283 (33%),skin development (50%);intermediate filament organization (50%);spermatogenesis (33%),IPR005064 (50%);IPR042100 (50%);IPR002957 (29%),Bordetella uptake gene (50%);Bordetella uptake gene, domain 1 (50%);Keratin, type I (29%)
HGLAAGFAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NDLMLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (67%);3.4.21.4 (33%),DNA helicase (67%);Trypsin (33%),GO:0005794 (5%);GO:0016021 (5%);GO:0030141 (3%),Golgi apparatus (5%);integral component of membrane (5%);secretory granule (3%),GO:0004252 (95%);GO:0005524 (2%);GO:0003676 (2%),serine-type endopeptidase activity (95%);ATP binding (2%);nucleic acid binding (2%),GO:0006281 (2%);GO:0006310 (2%);GO:0007533 (1%),DNA repair (2%);DNA recombination (2%);mating type switching (1%),IPR001254 (93%);IPR009003 (93%);IPR001314 (87%),Serine proteases, trypsin domain (93%);Peptidase S1, PA clan (93%);Peptidase S1A, chymotrypsin family (87%)
YTAPVLALSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QFLNAAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.7 (100%),Cysteine desulfurase (100%),GO:0016021 (22%),integral component of membrane (22%),GO:0016616 (33%);GO:0051287 (33%);GO:0003677 (11%),oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (33%);NAD binding (33%);DNA binding (11%),GO:0006310 (11%);GO:0006534 (11%);GO:0015074 (11%),DNA recombination (11%);cysteine metabolic process (11%);DNA integration (11%),IPR000014 (31%);IPR000160 (31%);IPR000700 (31%),PAS domain (31%);GGDEF domain (31%);PAS-associated, C-terminal (31%)
NDDLMLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VNWLQQTLAAN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VSSCYLALANTDLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FSSCGG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TNAENEFVTLK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (99%);GO:0001533 (39%);GO:0016020 (4%),keratin filament (99%);cornified envelope (39%);membrane (4%),GO:0046982 (42%);GO:0030246 (39%);GO:0030280 (39%),protein heterodimerization activity (42%);carbohydrate binding (39%);structural constituent of skin epidermis (39%),GO:0051290 (42%);GO:0050728 (40%);GO:0061436 (40%),protein heterotetramerization (42%);negative regulation of inflammatory response (40%);establishment of skin barrier (40%),IPR003054 (100%);IPR039008 (100%);IPR042180 (100%),Keratin, type II (100%);Intermediate filament, rod domain (100%);Intermediate filament, rod domain, coil 1B (100%)
VPQVSTPTLVEVSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005615 (81%);GO:0005783 (24%);GO:0005794 (24%),extracellular space (81%);endoplasmic reticulum (24%);Golgi apparatus (24%),GO:0046872 (54%);GO:1903981 (23%);GO:0003677 (22%),metal ion binding (54%);enterobactin binding (23%);DNA binding (22%),GO:0009267 (22%);GO:0043066 (22%);GO:0051659 (22%),cellular response to starvation (22%);negative regulation of apoptotic process (22%);maintenance of mitochondrion location (22%),IPR000264 (100%);IPR014760 (100%);IPR020858 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin-like (100%)
WLQQTLAAN,Simiiformes,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,,,,,,,,,,,,,,,,,GO:0005615 (9%),extracellular space (9%),GO:0004252 (100%),serine-type endopeptidase activity (100%),GO:0006508 (9%),proteolysis (9%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
LGEHNLDVL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WGDDSQELLNSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLLFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (17%);3.1.26.- (10%);1.13.11.11 (7%),Peptidylprolyl isomerase (17%);Endoribonucleases producing 5'-phosphomonoesters (10%);Tryptophan 2,3-dioxygenase (7%),GO:0016021 (35%);GO:0005886 (8%);GO:0005737 (7%),integral component of membrane (35%);plasma membrane (8%);cytoplasm (7%),GO:0005524 (12%);GO:0046872 (12%);GO:0019843 (8%),ATP binding (12%);metal ion binding (12%);rRNA binding (8%),GO:0000027 (5%);GO:0006412 (5%);GO:0030001 (3%),ribosomal large subunit assembly (5%);translation (5%);metal ion transport (3%),IPR027417 (6%);IPR005813 (5%);IPR035566 (5%),P-loop containing nucleoside triphosphate hydrolase (6%);Ribosomal protein L20 (5%);Ribosomal protein L20, C-terminal (5%)
LLLLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.1.3 (16%);2.7.7.85 (11%);6.1.1.21 (7%),Histidine ammonia-lyase (16%);Diadenylate cyclase (11%);Histidine--tRNA ligase (7%),GO:0016021 (43%);GO:0005737 (7%);GO:0005886 (6%),integral component of membrane (43%);cytoplasm (7%);plasma membrane (6%),GO:0005524 (25%);GO:0016887 (10%);GO:0003677 (7%),ATP binding (25%);ATPase activity (10%);DNA binding (7%),GO:0015833 (8%);GO:0019556 (2%);GO:0019557 (2%),peptide transport (8%);histidine catabolic process to glutamate and formamide (2%);histidine catabolic process to glutamate and formate (2%),IPR027417 (18%);IPR003593 (13%);IPR003439 (10%),P-loop containing nucleoside triphosphate hydrolase (18%);AAA+ ATPase domain (13%);ABC transporter-like (10%)
HGDSTGPLK,Planctomycetes,Bacteria,,,,Planctomycetes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR006311 (100%);IPR011447 (100%),Twin-arginine translocation pathway, signal sequence (100%);Protein of unknown function DUF1552 (100%)
SLNQFASFLDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVSADEAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPQAVHR,Gemmatimonadetes bacterium,Bacteria,,,,Gemmatimonadetes,,,,,,,,,,,,,,,,,,,,Gemmatimonadetes bacterium,,,,4.2.99.20 (100%),2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase (100%),,,GO:0070205 (100%),2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase activity (100%),GO:0009234 (100%),menaquinone biosynthetic process (100%),IPR000073 (100%);IPR022485 (100%);IPR029058 (100%),Alpha/beta hydrolase fold-1 (100%);2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase (100%);Alpha/Beta hydrolase fold (100%)
LATVDVPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%),integral component of membrane (67%),,,GO:0006865 (33%),amino acid transport (33%),IPR028081 (88%);IPR028082 (88%);IPR007383 (13%),Leucine-binding protein domain (88%);Periplasmic binding protein-like I (88%);Protein of unknown function DUF445 (13%)
LELSELNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (94%);GO:0001533 (23%);GO:0005882 (3%),keratin filament (94%);cornified envelope (23%);intermediate filament (3%),GO:0030280 (23%);GO:0008092 (13%);GO:0046982 (11%),structural constituent of skin epidermis (23%);cytoskeletal protein binding (13%);protein heterodimerization activity (11%),GO:0018149 (23%);GO:0031424 (14%);GO:0003334 (13%),peptide cross-linking (23%);keratinization (14%);keratinocyte development (13%),IPR039008 (95%);IPR042180 (94%);IPR003054 (93%),Intermediate filament, rod domain (95%);Intermediate filament, rod domain, coil 1B (94%);Keratin, type II (93%)
ALPVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.- (56%);2.7.7.72 (9%);1.2.1.41 (4%),With NAD(+) or NADP(+) as acceptor (56%);CCA tRNA nucleotidyltransferase (9%);Glutamate-5-semialdehyde dehydrogenase (4%),GO:0016021 (18%);GO:0005737 (6%);GO:0005886 (2%),integral component of membrane (18%);cytoplasm (6%);plasma membrane (2%),GO:0016620 (29%);GO:0050661 (28%);GO:0051287 (28%),oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (29%);NADP binding (28%);NAD binding (28%),GO:0006006 (26%);GO:0001680 (4%);GO:0042245 (4%),glucose metabolic process (26%);tRNA 3'-terminal CCA addition (4%);RNA repair (4%),IPR036291 (27%);IPR020829 (25%);IPR020831 (25%),NAD(P)-binding domain superfamily (27%);Glyceraldehyde 3-phosphate dehydrogenase, catalytic domain (25%);Glyceraldehyde/Erythrose phosphate dehydrogenase family (25%)
ANSLPYQVSLNSG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APDGYNLEK,Firmicutes,Bacteria,,,,Firmicutes,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR013783 (100%);IPR041033 (100%);IPR013378 (67%),Immunoglobulin-like fold (100%);Prealbumin-like fold domain (100%);Listeria/Bacterioides repeat (67%)
APALLLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (33%),nucleus (33%),GO:0004252 (33%);GO:0005049 (33%);GO:0008536 (33%),serine-type endopeptidase activity (33%);nuclear export signal receptor activity (33%);Ran GTPase binding (33%),GO:0006886 (33%),intracellular protein transport (33%),IPR001810 (40%);IPR032675 (40%);IPR001254 (20%),F-box domain (40%);Leucine-rich repeat domain superfamily (40%);Serine proteases, trypsin domain (20%)
VEVEVVSVQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FTPTSLVMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSDDATLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005634 (50%);GO:0016021 (50%);GO:1990904 (50%),nucleus (50%);integral component of membrane (50%);ribonucleoprotein complex (50%),GO:0003723 (50%),RNA binding (50%),GO:0006396 (50%),RNA processing (50%),IPR036388 (40%);IPR036390 (40%);IPR000504 (20%),Winged helix-like DNA-binding domain superfamily (40%);Winged helix DNA-binding domain superfamily (40%);RNA recognition motif domain (20%)
DVFLGMFLYEYAR,Catarrhini,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,,,,,,,,,,,,,,,,GO:0005615 (79%);GO:0005783 (30%);GO:0005794 (30%),extracellular space (79%);endoplasmic reticulum (30%);Golgi apparatus (30%),GO:0046872 (45%);GO:1903981 (26%);GO:0003677 (24%),metal ion binding (45%);enterobactin binding (26%);DNA binding (24%),GO:0009267 (24%);GO:0043066 (24%);GO:0051659 (24%),cellular response to starvation (24%);negative regulation of apoptotic process (24%);maintenance of mitochondrion location (24%),IPR000264 (100%);IPR014760 (100%);IPR020858 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin-like (100%)
GGGGGGLGSGGSLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVEASLPR,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016740 (50%);GO:0004497 (25%);GO:0016301 (25%),transferase activity (50%);monooxygenase activity (25%);kinase activity (25%),,,IPR001296 (50%);IPR028098 (50%);IPR002938 (25%),Glycosyl transferase, family 1 (50%);Glycosyltransferase subfamily 4-like, N-terminal domain (50%);FAD-binding domain (25%)
FSSCGGGGG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NTFGGLSVQNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLGLTPPLL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GGGGGSFGAGGGFGSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EFHPGALR,Kryptolebias marmoratus,Eukaryota,Metazoa,,,Chordata,Craniata,Actinopterygii,Actinopteri,Neopterygii,Teleostei,Atherinomorphae,Cyprinodontiformes,Aplocheiloidei,,,,Rivulidae,,,,Kryptolebias,,,,Kryptolebias marmoratus,,,,,,,,GO:0004843 (100%),thiol-dependent ubiquitin-specific protease activity (100%),,,IPR006615 (100%);IPR035927 (100%),Peptidase C19, ubiquitin-specific peptidase, DUSP domain (100%);DUSP-like superfamily (100%)
LVAASQAALGL,Hominoidea,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Primates,Haplorrhini,Simiiformes,Catarrhini,Hominoidea,,,,,,,,,,,,,,,GO:0005615 (88%);GO:0005783 (24%);GO:0005794 (24%),extracellular space (88%);endoplasmic reticulum (24%);Golgi apparatus (24%),GO:0046872 (24%);GO:0003677 (14%);GO:0005504 (14%),metal ion binding (24%);DNA binding (14%);fatty acid binding (14%),GO:0009267 (14%);GO:0043066 (14%);GO:0051659 (14%),cellular response to starvation (14%);negative regulation of apoptotic process (14%);maintenance of mitochondrion location (14%),IPR000264 (100%);IPR014760 (100%);IPR020857 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin, conserved site (100%)
LDVLEGNEQFLN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VKPDLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (2%),cytoplasm (2%),GO:0003677 (98%);GO:0005524 (2%);GO:0008233 (2%),DNA binding (98%);ATP binding (2%);peptidase activity (2%),GO:0006310 (98%);GO:0015074 (92%);GO:0030163 (2%),DNA recombination (98%);DNA integration (92%);protein catabolic process (2%),IPR002104 (99%);IPR011010 (99%);IPR013762 (99%),Integrase, catalytic domain (99%);DNA breaking-rejoining enzyme, catalytic core (99%);Integrase-like, catalytic domain superfamily (99%)
LALSSTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.179 (95%);2.3.1.41 (3%);3.4.24.- (1%),Beta-ketoacyl-[acyl-carrier-protein] synthase II (95%);Beta-ketoacyl-[acyl-carrier-protein] synthase I (3%);Metalloendopeptidases (1%),GO:0016021 (2%);GO:0005737 (1%);GO:0005886 (1%),integral component of membrane (2%);cytoplasm (1%);plasma membrane (1%),GO:0033817 (78%);GO:0016740 (6%);GO:0016747 (4%),beta-ketoacyl-acyl-carrier-protein synthase II activity (78%);transferase activity (6%);transferase activity, transferring acyl groups other than amino-acyl groups (4%),GO:0006633 (80%);GO:0009072 (2%);GO:0006355 (0%),fatty acid biosynthetic process (80%);aromatic amino acid family metabolic process (2%);regulation of transcription, DNA-templated (0%),IPR000794 (89%);IPR016039 (89%);IPR014031 (89%),Beta-ketoacyl synthase (89%);Thiolase-like (89%);Beta-ketoacyl synthase, C-terminal (89%)
GGGGGLGSGGSLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVDGAYMTK,Sarcopterygii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (95%);GO:0001533 (25%);GO:0005576 (5%),keratin filament (95%);cornified envelope (25%);extracellular region (5%),GO:0046982 (30%);GO:0030246 (25%);GO:0030280 (25%),protein heterodimerization activity (30%);carbohydrate binding (25%);structural constituent of skin epidermis (25%),GO:0050728 (30%);GO:0051290 (30%);GO:0061436 (30%),negative regulation of inflammatory response (30%);protein heterotetramerization (30%);establishment of skin barrier (30%),IPR003054 (100%);IPR039008 (100%);IPR042180 (100%),Keratin, type II (100%);Intermediate filament, rod domain (100%);Intermediate filament, rod domain, coil 1B (100%)
APHEMTLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LATQSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.4.11 (23%);1.1.1.267 (8%);2.4.1.246 (8%),Peptide-methionine (S)-S-oxide reductase (23%);1-deoxy-D-xylulose-5-phosphate reductoisomerase (8%);Mannosylfructose-phosphate synthase (8%),GO:0016021 (37%);GO:0005634 (10%);GO:0016020 (4%),integral component of membrane (37%);nucleus (10%);membrane (4%),GO:0003677 (13%);GO:0022857 (11%);GO:0005524 (7%),DNA binding (13%);transmembrane transporter activity (11%);ATP binding (7%),GO:0007165 (7%);GO:0005975 (5%);GO:0006304 (4%),signal transduction (7%);carbohydrate metabolic process (5%);DNA modification (4%),IPR005829 (9%);IPR011701 (9%);IPR020846 (9%),Sugar transporter, conserved site (9%);Major facilitator superfamily (9%);Major facilitator superfamily domain (9%)
NPALLVFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVEVLSPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (100%),ribosome (100%),GO:0003735 (100%),structural constituent of ribosome (100%),GO:0006412 (100%),translation (100%),IPR000456 (100%);IPR036373 (100%),Ribosomal protein L17 (100%);Ribosomal protein L17 superfamily (100%)
VCQTLAAN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VATVDLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016491 (100%),oxidoreductase activity (100%),,,IPR002937 (100%);IPR036188 (100%),Amine oxidase (100%);FAD/NAD(P)-binding domain superfamily (100%)
NGVLYAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.- (100%),Acting on polysaccharides (100%),GO:0016021 (47%);GO:0005887 (5%),integral component of membrane (47%);integral component of plasma membrane (5%),GO:0016491 (21%);GO:0003677 (11%);GO:0003824 (5%),oxidoreductase activity (21%);DNA binding (11%);catalytic activity (5%),GO:0000160 (11%);GO:0005975 (5%);GO:0006355 (5%),phosphorelay signal transduction system (11%);carbohydrate metabolic process (5%);regulation of transcription, DNA-templated (5%),IPR008619 (49%);IPR010069 (49%);IPR025157 (49%),Filamentous haemagglutinin repeat (49%);Filamentous haemagglutinin, 20-residue x2 repeat (49%);Hemagglutinin repeat (49%)
GLGVAEPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LATVLPSR,Amycolatopsis antarctica,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Pseudonocardiales,,,,,Pseudonocardiaceae,,,,Amycolatopsis,,,,Amycolatopsis antarctica,,,,,,,,GO:0016620 (100%),oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (100%),,,IPR015590 (100%);IPR016161 (100%);IPR016162 (100%),Aldehyde dehydrogenase domain (100%);Aldehyde/histidinol dehydrogenase (100%);Aldehyde dehydrogenase, N-terminal (100%)
LLLPSTTK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0008168 (92%);GO:0003677 (6%);GO:0003887 (6%),methyltransferase activity (92%);DNA binding (6%);DNA-directed DNA polymerase activity (6%),GO:0032259 (92%);GO:0006261 (6%);GO:0015074 (3%),methylation (92%);DNA-dependent DNA replication (6%);DNA integration (3%),IPR027266 (89%);IPR017703 (75%);IPR012337 (8%),GTP-binding protein TrmE/Glycine cleavage system T protein, domain 1 (89%);YgfZ/GcvT conserved site (75%);Ribonuclease H-like superfamily (8%)
SSGSAVVSGGSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VSLVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (67%);GO:0005634 (11%);GO:1990904 (11%),integral component of membrane (67%);nucleus (11%);ribonucleoprotein complex (11%),GO:0003723 (33%),RNA binding (33%),GO:0006396 (11%),RNA processing (11%),IPR004474 (67%);IPR012677 (25%);IPR035979 (25%),Cell envelope-related transcriptional attenuator domain (67%);Nucleotide-binding alpha-beta plait domain superfamily (25%);RNA-binding domain superfamily (25%)
TAEQMGSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.2 (8%);6.1.1.21 (5%);3.6.4.12 (4%),Tryptophan--tRNA ligase (8%);Histidine--tRNA ligase (5%);DNA helicase (4%),GO:0016021 (20%);GO:0005737 (15%);GO:0005886 (4%),integral component of membrane (20%);cytoplasm (15%);plasma membrane (4%),GO:0005524 (21%);GO:0003677 (12%);GO:0046872 (6%),ATP binding (21%);DNA binding (12%);metal ion binding (6%),GO:0006355 (3%);GO:0006457 (2%);GO:0006436 (2%),regulation of transcription, DNA-templated (3%);protein folding (2%);tryptophanyl-tRNA aminoacylation (2%),IPR027417 (9%);IPR036388 (5%);IPR036291 (4%),P-loop containing nucleoside triphosphate hydrolase (9%);Winged helix-like DNA-binding domain superfamily (5%);NAD(P)-binding domain superfamily (4%)
VSSLFLVLFKPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTLVLGPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVLEG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEVMTANLPYTMNVVLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TGLDLDNLLQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NHVMLLLFVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLSFSFSLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GAPGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.13 (60%);1.4.4.2 (4%);6.3.5.1 (2%),UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase (60%);Glycine dehydrogenase (aminomethyl-transferring) (4%);NAD(+) synthase (glutamine-hydrolyzing) (2%),GO:0016021 (19%);GO:0005634 (18%);GO:0005737 (15%),integral component of membrane (19%);nucleus (18%);cytoplasm (15%),GO:0005524 (21%);GO:0046872 (20%);GO:0003677 (20%),ATP binding (21%);metal ion binding (20%);DNA binding (20%),GO:0007275 (16%);GO:0051301 (12%);GO:0008360 (11%),multicellular organism development (16%);cell division (12%);regulation of cell shape (11%),IPR013783 (17%);IPR003523 (16%);IPR014756 (15%),Immunoglobulin-like fold (17%);Transcription factor COE (16%);Immunoglobulin E-set (15%)
EFSVNTLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLDDTFTLNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVGGMTLPR,Chloroflexi bacterium,Bacteria,,,,Chloroflexi,,,,,,,,,,,,,,,,,,,,Chloroflexi bacterium,,,,,,,,,,,,,
GAAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.21 (15%);3.6.4.12 (7%);4.1.1.49 (3%),D-amino-acid transaminase (15%);DNA helicase (7%);Phosphoenolpyruvate carboxykinase (ATP) (3%),GO:0016021 (25%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (25%);cytoplasm (5%);plasma membrane (3%),GO:0005524 (14%);GO:0003677 (10%);GO:0046872 (5%),ATP binding (14%);DNA binding (10%);metal ion binding (5%),GO:0006355 (3%);GO:0046416 (2%);GO:0055085 (2%),regulation of transcription, DNA-templated (3%);D-amino acid metabolic process (2%);transmembrane transport (2%),IPR027417 (9%);IPR001544 (4%);IPR036038 (4%),P-loop containing nucleoside triphosphate hydrolase (9%);Aminotransferase class IV (4%);Aminotransferase-like, PLP-dependent enzymes (4%)
LLSGENK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.1.24 (33%);2.3.1.51 (18%);2.10.1.1 (9%),Phenylalanine ammonia-lyase (33%);1-acylglycerol-3-phosphate O-acyltransferase (18%);Molybdopterin molybdotransferase (9%),GO:0016021 (24%);GO:0005737 (21%);GO:0016020 (6%),integral component of membrane (24%);cytoplasm (21%);membrane (6%),GO:0045548 (16%);GO:0005524 (12%);GO:0003677 (9%),phenylalanine ammonia-lyase activity (16%);ATP binding (12%);DNA binding (9%),GO:0006559 (18%);GO:0009800 (16%);GO:0008654 (9%),L-phenylalanine catabolic process (18%);cinnamic acid biosynthetic process (16%);phospholipid biosynthetic process (9%),IPR001106 (15%);IPR008948 (15%);IPR005922 (14%),Aromatic amino acid lyase (15%);L-Aspartase-like (15%);Phenylalanine ammonia-lyase (14%)
AANSLPYQVSLNSG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SHFCGGSLLNS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HNSLSDVALLEHAVR,Verrucomicrobia,Bacteria,,,,Verrucomicrobia,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.18 (100%),Glutamine--tRNA ligase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0004819 (100%);GO:0005524 (100%),glutamine-tRNA ligase activity (100%);ATP binding (100%),GO:0006425 (100%);GO:0006424 (83%),glutaminyl-tRNA aminoacylation (100%);glutamyl-tRNA aminoacylation (83%),IPR000924 (100%);IPR004514 (100%);IPR011035 (100%),Glutamyl/glutaminyl-tRNA synthetase (100%);Glutamine-tRNA synthetase (100%);Ribosomal protein L25/Gln-tRNA synthetase, anti-codon-binding domain superfamily (100%)
DGGLLSGNEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSGWGNTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLLTADEK,Calothrix,Bacteria,,,,Cyanobacteria,,,,,,,Nostocales,,,,,Calotrichaceae,,,,Calothrix,,,,,,,,,,,,,,,,,
LLTADEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.10.1 (66%);6.2.1.5 (18%);3.4.24.- (6%),Receptor protein-tyrosine kinase (66%);Succinate--CoA ligase (ADP-forming) (18%);Metalloendopeptidases (6%),GO:0016021 (56%);GO:0005739 (12%);GO:0005886 (5%),integral component of membrane (56%);mitochondrion (12%);plasma membrane (5%),GO:0005524 (68%);GO:0004714 (42%);GO:0000287 (14%),ATP binding (68%);transmembrane receptor protein tyrosine kinase activity (42%);magnesium ion binding (14%),GO:0007169 (42%);GO:0006099 (14%);GO:0000917 (8%),transmembrane receptor protein tyrosine kinase signaling pathway (42%);tricarboxylic acid cycle (14%);division septum assembly (8%),IPR000719 (44%);IPR001245 (44%);IPR008266 (44%),Protein kinase domain (44%);Serine-threonine/tyrosine-protein kinase, catalytic domain (44%);Tyrosine-protein kinase, active site (44%)
VLLMLLLEQTVLVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LENLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.15 (40%);2.5.1.- (9%);6.1.1.19 (8%),Proline--tRNA ligase (40%);Transferring alkyl or aryl groups, other than methyl groups (9%);Arginine--tRNA ligase (8%),GO:0005737 (32%);GO:0016021 (15%);GO:0005886 (11%),cytoplasm (32%);integral component of membrane (15%);plasma membrane (11%),GO:0005524 (45%);GO:0004827 (15%);GO:0046872 (15%),ATP binding (45%);proline-tRNA ligase activity (15%);metal ion binding (15%),GO:0006433 (15%);GO:0006605 (11%);GO:0065002 (11%),prolyl-tRNA aminoacylation (15%);protein targeting (11%);intracellular protein transmembrane transport (11%),IPR027417 (21%);IPR006195 (14%);IPR002316 (13%),P-loop containing nucleoside triphosphate hydrolase (21%);Aminoacyl-tRNA synthetase, class II (14%);Proline-tRNA ligase, class IIa (13%)
LPGNGFFK,Clavibacter michiganensis,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Micrococcales,,,,,Microbacteriaceae,,,,Clavibacter,,,,Clavibacter michiganensis,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),,,GO:0055085 (100%),transmembrane transport (100%),IPR000515 (100%);IPR035906 (100%),ABC transporter type 1, transmembrane domain MetI-like (100%);MetI-like superfamily (100%)
CLLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.- (21%);2.7.1.21 (12%);2.1.1.228 (6%),Protein-serine/threonine kinases (21%);Thymidine kinase (12%);tRNA (guanine(37)-N(1))-methyltransferase (6%),GO:0016021 (18%);GO:0005737 (5%);GO:0005634 (3%),integral component of membrane (18%);cytoplasm (5%);nucleus (3%),GO:0005524 (14%);GO:0004061 (8%);GO:0003677 (7%),ATP binding (14%);arylformamidase activity (8%);DNA binding (7%),GO:0019441 (8%);GO:0006412 (4%);GO:0007165 (3%),tryptophan catabolic process to kynurenine (8%);translation (4%);signal transduction (3%),IPR027417 (8%);IPR037175 (7%);IPR007325 (7%),P-loop containing nucleoside triphosphate hydrolase (8%);Kynurenine formamidase superfamily (7%);Kynurenine formamidase/cyclase-like (7%)
PELQNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFTAVGAPFVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLTANEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.10.1 (43%);3.4.24.- (22%);2.7.8.7 (13%),Receptor protein-tyrosine kinase (43%);Metalloendopeptidases (22%);Holo-[acyl-carrier-protein] synthase (13%),GO:0016021 (48%);GO:0005737 (13%);GO:0005886 (13%),integral component of membrane (48%);cytoplasm (13%);plasma membrane (13%),GO:0005524 (40%);GO:0004714 (25%);GO:0004222 (13%),ATP binding (40%);transmembrane receptor protein tyrosine kinase activity (25%);metalloendopeptidase activity (13%),GO:0007169 (25%);GO:0030163 (13%);GO:0051301 (10%),transmembrane receptor protein tyrosine kinase signaling pathway (25%);protein catabolic process (13%);cell division (10%),IPR000494 (21%);IPR000719 (21%);IPR001245 (21%),Receptor L-domain (21%);Protein kinase domain (21%);Serine-threonine/tyrosine-protein kinase, catalytic domain (21%)
TAFVTLQDSDELMSLDLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMTLQDMLNVLEENR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLVLDVGQGDALLVEGGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVLE,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLDELAELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.2.- (100%),Aldehyde-lyases (100%),,,GO:0003824 (33%);GO:0008484 (33%);GO:0016832 (33%),catalytic activity (33%);sulfuric ester hydrolase activity (33%);aldehyde-lyase activity (33%),GO:0005975 (33%),carbohydrate metabolic process (33%),IPR000917 (25%);IPR005593 (25%);IPR007197 (25%),Sulfatase, N-terminal (25%);Xylulose 5-phosphate/Fructose 6-phosphate phosphoketolase (25%);Radical SAM (25%)
RPLVSLFV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELQELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.27 (18%);2.3.1.29 (10%);3.6.4.12 (7%),RING-type E3 ubiquitin transferase (18%);Glycine C-acetyltransferase (10%);DNA helicase (7%),GO:0016021 (19%);GO:0005634 (13%);GO:0005874 (7%),integral component of membrane (19%);nucleus (13%);microtubule (7%),GO:0005524 (22%);GO:0003677 (12%);GO:0003700 (9%),ATP binding (22%);DNA binding (12%);DNA-binding transcription factor activity (9%),GO:0007018 (8%);GO:0010390 (3%);GO:0007131 (3%),microtubule-based movement (8%);histone monoubiquitination (3%);reciprocal meiotic recombination (3%),IPR027417 (17%);IPR009057 (8%);IPR025258 (7%),P-loop containing nucleoside triphosphate hydrolase (17%);Homeobox-like domain superfamily (8%);Putative zinc-RING and/or ribbon (7%)
TVTLPQLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%);GO:0005886 (50%),integral component of membrane (100%);plasma membrane (50%),,,,,IPR000515 (33%);IPR002999 (33%);IPR035437 (33%),ABC transporter type 1, transmembrane domain MetI-like (33%);Tudor domain (33%);SNase-like, OB-fold superfamily (33%)
VVSLLSPR,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.3 (100%),Glutamate racemase (100%),GO:0016021 (50%),integral component of membrane (50%),GO:0008881 (50%),glutamate racemase activity (50%),GO:0008360 (50%);GO:0009252 (50%);GO:0071555 (50%),regulation of cell shape (50%);peptidoglycan biosynthetic process (50%);cell wall organization (50%),IPR001920 (50%);IPR003838 (50%);IPR004391 (50%),Asp/Glu racemase (50%);ABC transporter permease protein domain (50%);Glutamate racemase (50%)
LTVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.19.12 (12%);2.1.2.11 (11%);3.4.16.4 (8%),Ubiquitinyl hydrolase 1 (12%);3-methyl-2-oxobutanoate hydroxymethyltransferase (11%);Serine-type D-Ala-D-Ala carboxypeptidase (8%),GO:0016021 (18%);GO:0019028 (14%);GO:0005737 (9%),integral component of membrane (18%);viral capsid (14%);cytoplasm (9%),GO:0005524 (10%);GO:0046872 (7%);GO:0003677 (6%),ATP binding (10%);metal ion binding (7%);DNA binding (6%),GO:0006511 (3%);GO:0016579 (3%);GO:0006384 (3%),ubiquitin-dependent protein catabolic process (3%);protein deubiquitination (3%);transcription initiation from RNA polymerase III promoter (3%),IPR001849 (11%);IPR011993 (11%);IPR001592 (10%),Pleckstrin homology domain (11%);PH-like domain superfamily (11%);Potyvirus coat protein (10%)
SGVTTVGLQGNDGFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YTMLLNELASGDL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LYSLGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (18%);2.7.13.3 (9%);1.6.2.2 (6%),Transferring other groups (18%);Histidine kinase (9%);Cytochrome-b5 reductase (6%),GO:0016021 (25%);GO:0005737 (4%);GO:0005615 (3%),integral component of membrane (25%);cytoplasm (4%);extracellular space (3%),GO:0008270 (39%);GO:0004181 (38%);GO:0003677 (6%),zinc ion binding (39%);metallocarboxypeptidase activity (38%);DNA binding (6%),GO:0006396 (4%);GO:0006355 (3%);GO:0006518 (3%),RNA processing (4%);regulation of transcription, DNA-templated (3%);peptide metabolic process (3%),IPR000834 (32%);IPR008969 (26%);IPR033814 (25%),Peptidase M14, carboxypeptidase A (32%);Carboxypeptidase-like, regulatory domain superfamily (26%);Carboxypeptidase N, N-terminal domain (25%)
LMELLNLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005623 (36%);GO:0016021 (27%),cell (36%);integral component of membrane (27%),GO:0009055 (36%);GO:0015035 (36%);GO:0005524 (18%),electron transfer activity (36%);protein disulfide oxidoreductase activity (36%);ATP binding (18%),GO:0045454 (36%);GO:0006310 (9%);GO:0015074 (9%),cell redox homeostasis (36%);DNA recombination (9%);DNA integration (9%),IPR002109 (29%);IPR011911 (29%);IPR036249 (29%),Glutaredoxin (29%);Glutaredoxin-like protein, YruB (29%);Thioredoxin-like superfamily (29%)
TVLEAAQDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ENGFVWNAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GELSLETFSLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CFELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.7.1.13 (11%);2.1.1.195 (9%);3.6.4.12 (9%),PreQ(1) synthase (11%);Cobalt-precorrin-5B (C(1))-methyltransferase (9%);DNA helicase (9%),GO:0016021 (33%);GO:0030173 (7%);GO:0005737 (6%),integral component of membrane (33%);integral component of Golgi membrane (7%);cytoplasm (6%),GO:0005524 (16%);GO:0003677 (11%);GO:0047186 (7%),ATP binding (16%);DNA binding (11%);N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity (7%),GO:0005975 (8%);GO:0030301 (4%);GO:0006260 (3%),carbohydrate metabolic process (8%);cholesterol transport (4%);DNA replication (3%),IPR012419 (19%);IPR027417 (13%);IPR036915 (11%),Cas1p 10 TM acyl transferase domain (19%);P-loop containing nucleoside triphosphate hydrolase (13%);Cyclin-like superfamily (11%)
LDAFSDAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVMVALVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QMEELLSDVTEVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EHNLDVLEGNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVLTADEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.13.11.- (100%),With incorporation of two atoms of oxygen (100%),GO:0005886 (76%);GO:0016021 (76%);GO:0009898 (6%),plasma membrane (76%);integral component of membrane (76%);cytoplasmic side of plasma membrane (6%),GO:0022857 (65%);GO:0003676 (12%);GO:0004386 (12%),transmembrane transporter activity (65%);nucleic acid binding (12%);helicase activity (12%),GO:0031408 (6%);GO:0043093 (6%),oxylipin biosynthetic process (6%);FtsZ-dependent cytokinesis (6%),IPR001851 (76%);IPR017779 (71%);IPR001650 (12%),ABC transporter, permease (76%);ABC transporter, urea permease protein UrtB, bacterial-type (71%);Helicase, C-terminal (12%)
GVEAHLEDDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FQEGDLTEAQAMYAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TSNSSELLFTPDPEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YGGTGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.24 (77%);2.4.1.18 (12%);6.3.2.25 (7%),Phosphoribosylanthranilate isomerase (77%);1,4-alpha-glucan branching enzyme (12%);Tubulin--tyrosine ligase (7%),GO:0016021 (29%);GO:0005737 (7%);GO:0005634 (3%),integral component of membrane (29%);cytoplasm (7%);nucleus (3%),GO:0004640 (32%);GO:0005524 (15%);GO:0003677 (7%),phosphoribosylanthranilate isomerase activity (32%);ATP binding (15%);DNA binding (7%),GO:0000162 (31%);GO:0005978 (5%);GO:0006265 (4%),tryptophan biosynthetic process (31%);glycogen biosynthetic process (5%);DNA topological change (4%),IPR001240 (27%);IPR011060 (27%);IPR013785 (27%),N-(5'phosphoribosyl) anthranilate isomerase (PRAI) (27%);Ribulose-phosphate binding barrel (27%);Aldolase-type TIM barrel (27%)
NYHLEDSVLLGNGYKPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNLVSSTPFFSASCPSVELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLVQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.5 (3%);2.7.7.6 (3%);2.7.7.7 (3%),Isoleucine--tRNA ligase (3%);DNA-directed RNA polymerase (3%);DNA-directed DNA polymerase (3%),GO:0016021 (22%);GO:0005737 (10%);GO:0005634 (6%),integral component of membrane (22%);cytoplasm (10%);nucleus (6%),GO:0005524 (16%);GO:0003677 (11%);GO:0005096 (4%),ATP binding (16%);DNA binding (11%);GTPase activator activity (4%),GO:0035556 (4%);GO:2000431 (4%);GO:0006537 (3%),intracellular signal transduction (4%);regulation of cytokinesis, actomyosin contractile ring assembly (4%);glutamate biosynthetic process (3%),IPR027417 (12%);IPR036291 (4%);IPR036388 (4%),P-loop containing nucleoside triphosphate hydrolase (12%);NAD(P)-binding domain superfamily (4%);Winged helix-like DNA-binding domain superfamily (4%)
LLTHPNFNGNLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSGSSYPSLLQCL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVGGYTCSLPYQVSLNSG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LQLSNVPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005777 (88%),peroxisome (88%),GO:0003723 (100%);GO:0009982 (13%),RNA binding (100%);pseudouridine synthase activity (13%),GO:0010468 (88%);GO:0001522 (13%),regulation of gene expression (88%);pseudouridine synthesis (13%),IPR000504 (88%);IPR012677 (88%);IPR021139 (88%),RNA recognition motif domain (88%);Nucleotide-binding alpha-beta plait domain superfamily (88%);NYN domain, limkain-b1-type (88%)
TCAANSLPYQVSLNSG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASSSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.18 (17%);6.1.1.6 (6%);5.6.2.1 (5%),Anthranilate phosphoribosyltransferase (17%);Lysine--tRNA ligase (6%);DNA topoisomerase (5%),GO:0016021 (19%);GO:0005634 (6%);GO:0005737 (3%),integral component of membrane (19%);nucleus (6%);cytoplasm (3%),GO:0003677 (16%);GO:0005524 (14%);GO:0003899 (7%),DNA binding (16%);ATP binding (14%);DNA-directed 5'-3' RNA polymerase activity (7%),GO:0006351 (7%);GO:0009116 (2%);GO:0006355 (2%),transcription, DNA-templated (7%);nucleoside metabolic process (2%);regulation of transcription, DNA-templated (2%),IPR027417 (8%);IPR015712 (5%);IPR007645 (5%),P-loop containing nucleoside triphosphate hydrolase (8%);DNA-directed RNA polymerase, subunit 2 (5%);RNA polymerase Rpb2, domain 3 (5%)
LPALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.20 (10%);1.13.11.27 (8%);5.6.2.1 (4%),Tryptophan synthase (10%);4-hydroxyphenylpyruvate dioxygenase (8%);DNA topoisomerase (4%),GO:0016021 (25%);GO:0005737 (6%);GO:0000159 (2%),integral component of membrane (25%);cytoplasm (6%);protein phosphatase type 2A complex (2%),GO:0005524 (14%);GO:0046872 (9%);GO:0003677 (8%),ATP binding (14%);metal ion binding (9%);DNA binding (8%),GO:0009072 (5%);GO:0055085 (5%);GO:0007165 (3%),aromatic amino acid family metabolic process (5%);transmembrane transport (5%);signal transduction (3%),IPR027417 (10%);IPR013785 (5%);IPR003593 (4%),P-loop containing nucleoside triphosphate hydrolase (10%);Aldolase-type TIM barrel (5%);AAA+ ATPase domain (4%)
NVELDPELQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VCNYVNWLQQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EQLALVNLLLAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSGGFSGGSFSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPDADLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.99.3 (25%);2.6.1.- (25%);2.7.1.130 (25%),Gluconate 2-dehydrogenase (acceptor) (25%);Transaminases (25%);Tetraacyldisaccharide 4'-kinase (25%),GO:0016021 (16%);GO:0005737 (3%);GO:0016020 (3%),integral component of membrane (16%);cytoplasm (3%);membrane (3%),GO:0003723 (31%);GO:0009982 (28%);GO:0003677 (9%),RNA binding (31%);pseudouridine synthase activity (28%);DNA binding (9%),GO:0001522 (28%);GO:0006310 (9%);GO:0007018 (6%),pseudouridine synthesis (28%);DNA recombination (9%);microtubule-based movement (6%),IPR011989 (38%);IPR016024 (38%);IPR021133 (38%),Armadillo-like helical (38%);Armadillo-type fold (38%);HEAT, type 2 (38%)
SYSLSAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%);GO:0005886 (38%),integral component of membrane (50%);plasma membrane (38%),GO:0003677 (25%);GO:0000150 (13%);GO:0003723 (13%),DNA binding (25%);recombinase activity (13%);RNA binding (13%),GO:0009306 (38%),protein secretion (38%),IPR006144 (33%);IPR010129 (33%);IPR039562 (33%),Secretion protein HlyD, conserved site (33%);Type I secretion membrane fusion protein, HlyD family (33%);Membrane fusion protein, biotin-lipoyl like domain (33%)
DWAVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.52 (50%);3.4.21.- (50%),Cyclic-guanylate-specific phosphodiesterase (50%);Serine endopeptidases (50%),GO:0016021 (49%);GO:0016020 (17%);GO:0005886 (5%),integral component of membrane (49%);membrane (17%);plasma membrane (5%),GO:0022857 (17%);GO:0004252 (10%);GO:0003824 (7%),transmembrane transporter activity (17%);serine-type endopeptidase activity (10%);catalytic activity (7%),GO:0006571 (5%);GO:0000256 (2%);GO:0009847 (2%),tyrosine biosynthetic process (5%);allantoin catabolic process (2%);spore germination (2%),IPR006143 (14%);IPR027417 (14%);IPR032317 (14%),RND efflux pump, membrane fusion protein (14%);P-loop containing nucleoside triphosphate hydrolase (14%);RND efflux pump, membrane fusion protein, barrel-sandwich domain (14%)
LLQFLAVAK,Bdellovibrionales bacterium,Bacteria,,,,Proteobacteria,,,Oligoflexia,,,,Bdellovibrionales,,,,,,,,,,,,,Bdellovibrionales bacterium,,,,3.4.21.53 (100%),Endopeptidase La (100%),GO:0005737 (100%),cytoplasm (100%),GO:0004176 (100%);GO:0004252 (100%);GO:0005524 (100%),ATP-dependent peptidase activity (100%);serine-type endopeptidase activity (100%);ATP binding (100%),GO:0006515 (100%);GO:0034605 (100%),protein quality control for misfolded or incompletely synthesized proteins (100%);cellular response to heat (100%),IPR003111 (100%);IPR003593 (100%);IPR003959 (100%),Lon, substrate-binding domain (100%);AAA+ ATPase domain (100%);ATPase, AAA-type, core (100%)
AVEPPVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGEHNLDVLEGNEQFLNA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLALSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.1 (35%);3.6.5.- (17%);5.3.1.9 (8%),Polyphosphate kinase (35%);Acting on GTP; involved in cellular and subcellular movement (17%);Glucose-6-phosphate isomerase (8%),GO:0016021 (15%);GO:0005737 (8%);GO:0009358 (4%),integral component of membrane (15%);cytoplasm (8%);polyphosphate kinase complex (4%),GO:0005524 (37%);GO:0000155 (23%);GO:0046872 (10%),ATP binding (37%);phosphorelay sensor kinase activity (23%);metal ion binding (10%),GO:0006799 (6%);GO:0042254 (3%);GO:0006541 (2%),polyphosphate biosynthetic process (6%);ribosome biogenesis (3%);glutamine metabolic process (2%),IPR003594 (20%);IPR036890 (20%);IPR004358 (20%),Histidine kinase/HSP90-like ATPase (20%);Histidine kinase/HSP90-like ATPase superfamily (20%);Signal transduction histidine kinase-related protein, C-terminal (20%)
EPDGLAR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.1 (96%);1.1.1.264 (4%),Pantoate--beta-alanine ligase (AMP-forming) (96%);L-idonate 5-dehydrogenase (NAD(P)(+)) (4%),GO:0005737 (52%);GO:0016021 (40%);GO:0005886 (38%),cytoplasm (52%);integral component of membrane (40%);plasma membrane (38%),GO:0004592 (55%);GO:0005524 (54%);GO:0022857 (37%),pantoate-beta-alanine ligase activity (55%);ATP binding (54%);transmembrane transporter activity (37%),GO:0015940 (55%);GO:0006635 (2%);GO:0055114 (2%),pantothenate biosynthetic process (55%);fatty acid beta-oxidation (2%);oxidation-reduction process (2%),IPR003721 (55%);IPR014729 (55%);IPR042176 (54%),Pantoate-beta-alanine ligase (55%);Rossmann-like alpha/beta/alpha sandwich fold (55%);Pantoate-beta-alanine ligase, C-terminal domain (54%)
GAAQAQPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GVGASALSSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.3 (22%);3.6.4.- (13%);2.1.1.14 (10%),Phosphoglycerate kinase (22%);Acting on ATP; involved in cellular and subcellular movement (13%);5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (10%),GO:0016021 (25%);GO:0005737 (15%);GO:0005886 (3%),integral component of membrane (25%);cytoplasm (15%);plasma membrane (3%),GO:0005524 (23%);GO:0003677 (9%);GO:0004618 (5%),ATP binding (23%);DNA binding (9%);phosphoglycerate kinase activity (5%),GO:0006096 (5%);GO:0006355 (5%);GO:0032259 (4%),glycolytic process (5%);regulation of transcription, DNA-templated (5%);methylation (4%),IPR027417 (11%);IPR013783 (4%);IPR001576 (4%),P-loop containing nucleoside triphosphate hydrolase (11%);Immunoglobulin-like fold (4%);Phosphoglycerate kinase (4%)
SSGSSYPSLL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GTALDPSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR014810 (78%);IPR039883 (78%);IPR002347 (11%),Fcf2 pre-rRNA processing, C-terminal (78%);Fcf2/DNTTIP2 (78%);Short-chain dehydrogenase/reductase SDR (11%)
APVTAATFGDG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VHVVELFVVGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SFSCLSR,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (29%);GO:0045095 (29%);GO:0005886 (14%),integral component of membrane (29%);keratin filament (29%);plasma membrane (14%),GO:0003676 (29%);GO:0004674 (29%);GO:0005524 (29%),nucleic acid binding (29%);protein serine/threonine kinase activity (29%);ATP binding (29%),GO:0007010 (14%);GO:0018105 (14%);GO:0035556 (14%),cytoskeleton organization (14%);peptidyl-serine phosphorylation (14%);intracellular signal transduction (14%),IPR000719 (29%);IPR003054 (29%);IPR008271 (29%),Protein kinase domain (29%);Keratin, type II (29%);Serine/threonine-protein kinase, active site (29%)
GRPQLHGHALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELGDELK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.11 (43%);5.2.1.8 (27%);6.1.1.3 (14%),Serine--tRNA ligase (43%);Peptidylprolyl isomerase (27%);Threonine--tRNA ligase (14%),GO:0005737 (40%);GO:0005886 (5%);GO:0045261 (5%),cytoplasm (40%);plasma membrane (5%);proton-transporting ATP synthase complex, catalytic core F(1) (5%),GO:0005524 (48%);GO:0004828 (27%);GO:0003755 (16%),ATP binding (48%);serine-tRNA ligase activity (27%);peptidyl-prolyl cis-trans isomerase activity (16%),GO:0006434 (27%);GO:0016260 (27%);GO:0097056 (27%),seryl-tRNA aminoacylation (27%);selenocysteine biosynthetic process (27%);selenocysteinyl-tRNA(Sec) biosynthetic process (27%),IPR002314 (27%);IPR006195 (27%);IPR002317 (20%),Aminoacyl-tRNA synthetase, class II (G/ P/ S/T) (27%);Aminoacyl-tRNA synthetase, class II (27%);Serine-tRNA ligase, type1 (20%)
SELDNVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (100%),Peptidylprolyl isomerase (100%),GO:0045095 (78%);GO:0001533 (21%);GO:0005886 (13%),keratin filament (78%);cornified envelope (21%);plasma membrane (13%),GO:0046982 (22%);GO:0030246 (21%);GO:0030280 (21%),protein heterodimerization activity (22%);carbohydrate binding (21%);structural constituent of skin epidermis (21%),GO:0051290 (22%);GO:0001867 (21%);GO:0018149 (21%),protein heterotetramerization (22%);complement activation, lectin pathway (21%);peptide cross-linking (21%),IPR039008 (82%);IPR018039 (78%);IPR003054 (74%),Intermediate filament, rod domain (82%);Intermediate filament protein, conserved site (78%);Keratin, type II (74%)
VVVLFPLLSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEVMTANVVLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FGTLNGVGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVMNSMSGGTLEEQQDNLDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYNMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (11%);5.4.99.12 (9%);1.1.1.292 (7%),Peptidylprolyl isomerase (11%);tRNA pseudouridine(38-40) synthase (9%);1,5-anhydro-D-fructose reductase (1,5-anhydro-D-mannitol-forming) (7%),GO:0016021 (21%);GO:0019028 (5%);GO:0005737 (3%),integral component of membrane (21%);viral capsid (5%);cytoplasm (3%),GO:0016491 (15%);GO:0016810 (14%);GO:0046872 (8%),oxidoreductase activity (15%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (14%);metal ion binding (8%),GO:0005975 (17%);GO:0007420 (10%);GO:0032053 (10%),carbohydrate metabolic process (17%);brain development (10%);ciliary basal body organization (10%),IPR027968 (20%);IPR036291 (13%);IPR000683 (11%),Jhy protein (20%);NAD(P)-binding domain superfamily (13%);Oxidoreductase, N-terminal (11%)
SLLAEVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.20 (32%);1.3.1.- (23%);2.8.4.3 (14%),Long-chain-fatty-acid--[acyl-carrier-protein] ligase (32%);With NAD(+) or NADP(+) as acceptor (23%);tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase (14%),GO:0016021 (18%);GO:0005737 (11%);GO:0017053 (2%),integral component of membrane (18%);cytoplasm (11%);transcriptional repressor complex (2%),GO:0005524 (25%);GO:0003910 (15%);GO:0016746 (10%),ATP binding (25%);DNA ligase (ATP) activity (15%);transferase activity, transferring acyl groups (10%),GO:0006310 (15%);GO:0051103 (14%);GO:0055085 (9%),DNA recombination (15%);DNA ligation involved in DNA repair (14%);transmembrane transport (9%),IPR012340 (16%);IPR012309 (12%);IPR012310 (12%),Nucleic acid-binding, OB-fold (16%);DNA ligase, ATP-dependent, C-terminal (12%);DNA ligase, ATP-dependent, central (12%)
APTLLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.99.6 (50%);1.2.4.1 (25%);3.5.4.2 (25%),NAD(P)H-hydrate epimerase (50%);Pyruvate dehydrogenase (acetyl-transferring) (25%);Adenine deaminase (25%),GO:0016021 (38%);GO:0005623 (3%);GO:0043190 (3%),integral component of membrane (38%);cell (3%);ATP-binding cassette (ABC) transporter complex (3%),GO:0003677 (14%);GO:0005524 (14%);GO:0030983 (10%),DNA binding (14%);ATP binding (14%);mismatched DNA binding (10%),GO:0006298 (10%);GO:0006355 (10%);GO:0000184 (3%),mismatch repair (10%);regulation of transcription, DNA-templated (10%);nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (3%),IPR027417 (23%);IPR000792 (13%);IPR007595 (13%),P-loop containing nucleoside triphosphate hydrolase (23%);Transcription regulator LuxR, C-terminal (13%);Csa family (13%)
TANSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.45 (27%);3.4.24.- (13%);6.3.1.2 (9%),Thymidylate synthase (27%);Metalloendopeptidases (13%);Glutamine synthetase (9%),GO:0016021 (23%);GO:0005737 (17%);GO:0034464 (17%),integral component of membrane (23%);cytoplasm (17%);BBSome (17%),GO:0005524 (11%);GO:0003677 (5%);GO:0046872 (4%),ATP binding (11%);DNA binding (5%);metal ion binding (4%),GO:0015031 (6%);GO:0055085 (5%);GO:0030030 (4%),protein transport (6%);transmembrane transport (5%);cell projection organization (4%),IPR006606 (15%);IPR014003 (15%);IPR030804 (14%),Bardet-Biedl syndrome 5 protein (15%);DM16 repeat (15%);Bardet-Biedl syndrome 5 protein/sex-determination protein fem-3 (14%)
HLFPGFNR,Proteobacteria bacterium,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,Proteobacteria bacterium,,,,,,,,GO:0003677 (100%),DNA binding (100%),GO:0006310 (100%);GO:0015074 (100%),DNA recombination (100%);DNA integration (100%),IPR002104 (100%);IPR004107 (100%);IPR010998 (100%),Integrase, catalytic domain (100%);Integrase, SAM-like, N-terminal (100%);Integrase/recombinase, N-terminal (100%)
GFSGGSFSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFSNSLNNLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSVNEQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.16 (86%);3.-.-.- (14%),Cysteine--tRNA ligase (86%);Hydrolases (14%),GO:0005737 (27%);GO:0016021 (5%),cytoplasm (27%);integral component of membrane (5%),GO:0016810 (41%);GO:0004817 (27%);GO:0005524 (27%),hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (41%);cysteine-tRNA ligase activity (27%);ATP binding (27%),GO:0005975 (41%);GO:0006423 (27%),carbohydrate metabolic process (41%);cysteinyl-tRNA aminoacylation (27%),IPR002509 (36%);IPR011330 (36%);IPR009080 (24%),NodB homology domain (36%);Glycoside hydrolase/deacetylase, beta/alpha-barrel (36%);Aminoacyl-tRNA synthetase, class Ia, anticodon-binding (24%)
PLTHSSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALLVFLLVAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVSAAAMTPSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPSGLTADVTYNLPTSQGGAGQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.94 (6%);2.7.2.8 (6%);2.7.1.39 (4%),Glycerol-3-phosphate dehydrogenase (NAD(P)(+)) (6%);Acetylglutamate kinase (6%);Homoserine kinase (4%),GO:0016021 (25%);GO:0019013 (10%);GO:0030430 (10%),integral component of membrane (25%);viral nucleocapsid (10%);host cell cytoplasm (10%),GO:0005524 (12%);GO:0003723 (12%);GO:0003677 (8%),ATP binding (12%);RNA binding (12%);DNA binding (8%),GO:0005975 (3%);GO:0000184 (2%);GO:0006355 (2%),carbohydrate metabolic process (3%);nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (2%);regulation of transcription, DNA-templated (2%),IPR004930 (9%);IPR027417 (7%);IPR003593 (3%),Pneumovirus nucleocapsid protein (9%);P-loop containing nucleoside triphosphate hydrolase (7%);AAA+ ATPase domain (3%)
VATLDPVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (100%),DNA-directed DNA polymerase (100%),,,GO:0003887 (50%);GO:0004591 (50%);GO:0005524 (50%),DNA-directed DNA polymerase activity (50%);oxoglutarate dehydrogenase (succinyl-transferring) activity (50%);ATP binding (50%),GO:0006099 (50%);GO:0006260 (50%),tricarboxylic acid cycle (50%);DNA replication (50%),IPR001017 (50%);IPR003593 (50%);IPR005475 (50%),Dehydrogenase, E1 component (50%);AAA+ ATPase domain (50%);Transketolase-like, pyrimidine-binding domain (50%)
MLLKPLGSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLEPLFTTK,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (6%),integral component of membrane (6%),GO:0005524 (94%);GO:0000155 (91%);GO:0016301 (6%),ATP binding (94%);phosphorelay sensor kinase activity (91%);kinase activity (6%),GO:0016310 (3%),phosphorylation (3%),IPR003594 (100%);IPR004358 (100%);IPR005467 (100%),Histidine kinase/HSP90-like ATPase (100%);Signal transduction histidine kinase-related protein, C-terminal (100%);Histidine kinase domain (100%)
GVPQPFLAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DVGVVFAAVFQLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLWFVGFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HPLDLMGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SHFQPLGSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LMSYSLPEPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLVTLFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%);GO:0031251 (33%),integral component of membrane (33%);PAN complex (33%),GO:0003723 (33%);GO:0004672 (33%);GO:0005524 (33%),RNA binding (33%);protein kinase activity (33%);ATP binding (33%),GO:0000289 (33%);GO:0006397 (33%),nuclear-transcribed mRNA poly(A) tail shortening (33%);mRNA processing (33%),IPR000109 (25%);IPR000571 (25%);IPR000719 (25%),Proton-dependent oligopeptide transporter family (25%);Zinc finger, CCCH-type (25%);Protein kinase domain (25%)
TLTVFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.41 (41%);1.1.1.42 (41%);2.10.1.1 (6%),Isocitrate dehydrogenase (NAD(+)) (41%);Isocitrate dehydrogenase (NADP(+)) (41%);Molybdopterin molybdotransferase (6%),GO:0016021 (13%);GO:0000938 (2%);GO:0005634 (2%),integral component of membrane (13%);GARP complex (2%);nucleus (2%),GO:0000287 (50%);GO:0051287 (50%);GO:0016616 (37%),magnesium ion binding (50%);NAD binding (50%);oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (37%),GO:0009058 (4%);GO:0001503 (3%);GO:0007155 (3%),biosynthetic process (4%);ossification (3%);cell adhesion (3%),IPR019818 (40%);IPR024084 (40%);IPR006094 (7%),Isocitrate/isopropylmalate dehydrogenase, conserved site (40%);Isopropylmalate dehydrogenase-like domain (40%);FAD linked oxidase, N-terminal (7%)
LVKPVELR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.2.0 (50%);3.5.1.108 (50%), (50%);UDP-3-O-acyl-N-acetylglucosamine deacetylase (50%),GO:0016021 (25%),integral component of membrane (25%),GO:0002161 (25%);GO:0008759 (25%);GO:0016787 (25%),aminoacyl-tRNA editing activity (25%);UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity (25%);hydrolase activity (25%),GO:0006412 (25%);GO:0009245 (25%);GO:0009691 (25%),translation (25%);lipid A biosynthetic process (25%);cytokinin biosynthetic process (25%),IPR004463 (25%);IPR005269 (25%);IPR007214 (25%),UDP-3-O-acyl N-acetylglucosamine deacetylase (25%);Cytokinin riboside 5'-monophosphate phosphoribohydrolase LOG (25%);YbaK/aminoacyl-tRNA synthetase-associated domain (25%)
QFVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (22%);6.1.1.20 (8%);3.1.26.3 (4%),DNA helicase (22%);Phenylalanine--tRNA ligase (8%);Ribonuclease III (4%),GO:0016021 (25%);GO:0005737 (5%);GO:0019867 (2%),integral component of membrane (25%);cytoplasm (5%);outer membrane (2%),GO:0005524 (20%);GO:0003677 (11%);GO:0003824 (11%),ATP binding (20%);DNA binding (11%);catalytic activity (11%),GO:0055085 (3%);GO:0006281 (2%);GO:0071709 (2%),transmembrane transport (3%);DNA repair (2%);membrane assembly (2%),IPR027417 (13%);IPR013785 (8%);IPR007197 (8%),P-loop containing nucleoside triphosphate hydrolase (13%);Aldolase-type TIM barrel (8%);Radical SAM (8%)
FLPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.4.11 (36%);3.6.4.- (15%);2.7.7.50 (9%),Peptide-methionine (S)-S-oxide reductase (36%);Acting on ATP; involved in cellular and subcellular movement (15%);mRNA guanylyltransferase (9%),GO:0015935 (21%);GO:0016021 (18%);GO:0030286 (6%),small ribosomal subunit (21%);integral component of membrane (18%);dynein complex (6%),GO:0003735 (24%);GO:0003723 (23%);GO:0005524 (19%),structural constituent of ribosome (24%);RNA binding (23%);ATP binding (19%),GO:0006412 (24%);GO:0007018 (8%);GO:0006464 (7%),translation (24%);microtubule-based movement (8%);cellular protein modification process (7%),IPR023575 (20%);IPR002222 (20%);IPR005713 (20%),Ribosomal protein S19, superfamily (20%);Ribosomal protein S19/S15 (20%);Ribosomal protein S19A/S15e (20%)
HGLLEHTLR,Verrucomicrobia,Bacteria,,,,Verrucomicrobia,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003676 (80%);GO:0016787 (60%),nucleic acid binding (80%);hydrolase activity (60%),,,IPR003607 (100%);IPR006674 (100%);IPR006675 (90%),HD/PDEase domain (100%);HD domain (100%);HDIG domain (90%)
LLEEPVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.12 (50%);2.5.1.32 (25%);6.2.1.12 (25%),Dihydrolipoyllysine-residue acetyltransferase (50%);15-cis-phytoene synthase (25%);4-coumarate--CoA ligase (25%),GO:0016021 (22%);GO:0005737 (11%);GO:0032153 (9%),integral component of membrane (22%);cytoplasm (11%);cell division site (9%),GO:0009055 (18%);GO:0016625 (18%);GO:0051536 (18%),electron transfer activity (18%);oxidoreductase activity, acting on the aldehyde or oxo group of donors, iron-sulfur protein as acceptor (18%);iron-sulfur cluster binding (18%),GO:0000917 (11%);GO:0043093 (9%);GO:0051258 (9%),division septum assembly (11%);FtsZ-dependent cytokinesis (9%);protein polymerization (9%),IPR001203 (15%);IPR013983 (15%);IPR013984 (15%),Aldehyde ferredoxin oxidoreductase, C-terminal (15%);Aldehyde ferredoxin oxidoreductase, N-terminal (15%);Aldehyde ferredoxin oxidoreductase, domain 2 (15%)
LATVTLPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),GO:0015299 (100%),solute:proton antiporter activity (100%),GO:0006813 (100%),potassium ion transport (100%),IPR003148 (33%);IPR004771 (33%);IPR006037 (33%),Regulator of K+ conductance, N-terminal (33%);K+/H+ exchanger (33%);Regulator of K+ conductance, C-terminal (33%)
NPVVTLDFNNN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTGELLNLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLTELVVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.182 (100%),Lipid-A-disaccharide synthase (100%),,,GO:0003677 (33%);GO:0008170 (33%);GO:0008915 (33%),DNA binding (33%);N-methyltransferase activity (33%);lipid-A-disaccharide synthase activity (33%),GO:0006306 (33%);GO:0009245 (33%),DNA methylation (33%);lipid A biosynthetic process (33%),IPR001227 (25%);IPR002052 (25%);IPR002295 (25%),Acyl transferase domain superfamily (25%);DNA methylase, N-6 adenine-specific, conserved site (25%);N6 adenine-specific DNA methyltransferase, D21 class (25%)
GHNTSALAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSLLPALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.1 (60%);6.3.4.19 (40%),Polyphosphate kinase (60%);tRNA(Ile)-lysidine synthetase (40%),GO:0005737 (25%);GO:0009358 (25%);GO:0016021 (13%),cytoplasm (25%);polyphosphate kinase complex (25%);integral component of membrane (13%),GO:0005524 (75%);GO:0046872 (50%);GO:0008976 (38%),ATP binding (75%);metal ion binding (50%);polyphosphate kinase activity (38%),GO:0006799 (38%);GO:0006400 (25%),polyphosphate biosynthetic process (38%);tRNA modification (25%),IPR001736 (27%);IPR003414 (27%);IPR024953 (27%),Phospholipase D/Transphosphatidylase (27%);Polyphosphate kinase (27%);Polyphosphate kinase middle domain (27%)
LKPLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.190 (17%);3.6.4.12 (16%);7.-.-.- (10%),23S rRNA (uracil(1939)-C(5))-methyltransferase (17%);DNA helicase (16%);Translocases (10%),GO:0016021 (26%);GO:0005886 (13%);GO:0005737 (7%),integral component of membrane (26%);plasma membrane (13%);cytoplasm (7%),GO:0005524 (17%);GO:0003677 (13%);GO:0008270 (8%),ATP binding (17%);DNA binding (13%);zinc ion binding (8%),GO:0006935 (7%);GO:0071973 (6%);GO:0055085 (3%),chemotaxis (7%);bacterial-type flagellum-dependent cell motility (6%);transmembrane transport (3%),IPR027417 (13%);IPR001689 (6%);IPR028976 (6%),P-loop containing nucleoside triphosphate hydrolase (13%);Flagellar motor switch protein FliM (6%);CheC-like superfamily (6%)
CHALAQSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPAFL,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.2 (25%);2.4.1.- (25%);3.7.1.14 (25%),Transferred entry: 1.17.1.9 (25%);Hexosyltransferases (25%);2-hydroxy-6-oxonona-2,4-dienedioate hydrolase (25%),GO:0016021 (50%);GO:0005886 (19%),integral component of membrane (50%);plasma membrane (19%),GO:0004930 (19%);GO:0004984 (19%);GO:0016491 (13%),G protein-coupled receptor activity (19%);olfactory receptor activity (19%);oxidoreductase activity (13%),GO:0006313 (6%);GO:0009089 (6%),transposition, DNA-mediated (6%);lysine biosynthetic process via diaminopimelate (6%),IPR000073 (22%);IPR029058 (22%);IPR000276 (17%),Alpha/beta hydrolase fold-1 (22%);Alpha/Beta hydrolase fold (22%);G protein-coupled receptor, rhodopsin-like (17%)
MTLDDFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.- (38%);5.4.99.12 (25%);1.1.1.100 (13%),With NAD(+) or NADP(+) as acceptor (38%);tRNA pseudouridine(38-40) synthase (25%);3-oxoacyl-[acyl-carrier-protein] reductase (13%),GO:0005882 (32%);GO:0016021 (5%);GO:0005615 (1%),intermediate filament (32%);integral component of membrane (5%);extracellular space (1%),GO:0016491 (45%);GO:0005198 (31%);GO:0016787 (3%),oxidoreductase activity (45%);structural molecule activity (31%);hydrolase activity (3%),GO:0043588 (16%);GO:0045109 (16%);GO:0007283 (9%),skin development (16%);intermediate filament organization (16%);spermatogenesis (9%),IPR002347 (49%);IPR036291 (49%);IPR020904 (44%),Short-chain dehydrogenase/reductase SDR (49%);NAD(P)-binding domain superfamily (49%);Short-chain dehydrogenase/reductase, conserved site (44%)
LASFSDSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EATVLLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (100%),DNA-directed RNA polymerase (100%),,,GO:0003677 (100%);GO:0003899 (40%);GO:0046983 (40%),DNA binding (100%);DNA-directed 5'-3' RNA polymerase activity (40%);protein dimerization activity (40%),GO:0006351 (40%),transcription, DNA-templated (40%),IPR010093 (43%);IPR041657 (43%);IPR011260 (29%),SinI-like, DNA-binding domain (43%);Helix-turn-helix domain, group 17 (43%);RNA polymerase, alpha subunit, C-terminal (29%)
VHGLSAYLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLDELTLTK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005882 (100%);GO:0001533 (30%);GO:0005737 (30%),intermediate filament (100%);cornified envelope (30%);cytoplasm (30%),GO:0005198 (64%);GO:0046982 (31%);GO:0030280 (30%),structural molecule activity (64%);protein heterodimerization activity (31%);structural constituent of skin epidermis (30%),GO:0051290 (31%);GO:0018149 (30%);GO:0030216 (30%),protein heterotetramerization (31%);peptide cross-linking (30%);keratinocyte differentiation (30%),IPR002957 (100%);IPR039008 (100%);IPR042180 (100%),Keratin, type I (100%);Intermediate filament, rod domain (100%);Intermediate filament, rod domain, coil 1B (100%)
TPSAPMMR,Chlorobium,Bacteria,,,,Chlorobi,,,Chlorobia,,,,Chlorobiales,,,,,Chlorobiaceae,,,,Chlorobium,,,,,,,,,,GO:0016020 (100%),membrane (100%),GO:0015159 (100%),polysaccharide transmembrane transporter activity (100%),,,IPR003715 (100%);IPR019554 (100%),Polysaccharide export protein (100%);Soluble ligand binding domain (100%)
TLDNDLMLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (11%);GO:0005737 (3%);GO:0016021 (3%),extracellular space (11%);cytoplasm (3%);integral component of membrane (3%),GO:0004252 (92%);GO:0005524 (3%);GO:0003723 (2%),serine-type endopeptidase activity (92%);ATP binding (3%);RNA binding (2%),GO:0006508 (11%);GO:0006000 (2%);GO:0007346 (2%),proteolysis (11%);fructose metabolic process (2%);regulation of mitotic cell cycle (2%),IPR001254 (100%);IPR009003 (100%);IPR001314 (97%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1A, chymotrypsin family (97%)
LLLLSYGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.14 (100%),Procollagen N-endopeptidase (100%),GO:0062023 (93%);GO:0005576 (1%);GO:0016021 (1%),collagen-containing extracellular matrix (93%);extracellular region (1%);integral component of membrane (1%),GO:0004222 (97%);GO:0008270 (93%);GO:0008237 (2%),metalloendopeptidase activity (97%);zinc ion binding (93%);metallopeptidase activity (2%),GO:0007229 (41%);GO:0007283 (22%);GO:0016485 (22%),integrin-mediated signaling pathway (41%);spermatogenesis (22%);protein processing (22%),IPR024079 (99%);IPR001590 (98%);IPR041645 (95%),Metallopeptidase, catalytic domain superfamily (99%);Peptidase M12B, ADAM/reprolysin (98%);ADAM cysteine-rich domain 2 (95%)
LLPGHGTVLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NYLNLRPLGLNSQELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVAVSDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.- (50%);6.1.1.5 (50%),Acting on polysaccharides (50%);Isoleucine--tRNA ligase (50%),GO:0016021 (60%);GO:0005737 (7%);GO:0005815 (7%),integral component of membrane (60%);cytoplasm (7%);microtubule organizing center (7%),GO:0005524 (13%);GO:0000049 (7%);GO:0002161 (7%),ATP binding (13%);tRNA binding (7%);aminoacyl-tRNA editing activity (7%),GO:0006281 (7%);GO:0006338 (7%);GO:0006351 (7%),DNA repair (7%);chromatin remodeling (7%);transcription, DNA-templated (7%),IPR001611 (30%);IPR003591 (30%);IPR028640 (30%),Leucine-rich repeat (30%);Leucine-rich repeat, typical subtype (30%);Centriolin (30%)
NLYQTQASFNQTQENK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVLDATPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0006281 (100%),DNA repair (100%),IPR036188 (75%);IPR039650 (50%);IPR001126 (25%),FAD/NAD(P)-binding domain superfamily (75%);H(2):CoB-CoM heterodisulfide,ferredoxin reductase subunit A-like (50%);UmuC domain (25%)
LLRPVLSY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLANPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.1.9 (35%);3.6.4.12 (24%);1.1.99.- (6%),Thioredoxin-disulfide reductase (35%);DNA helicase (24%);With other acceptors (6%),GO:0016021 (21%);GO:0005737 (17%);GO:0009279 (3%),integral component of membrane (21%);cytoplasm (17%);cell outer membrane (3%),GO:0005524 (16%);GO:0003677 (13%);GO:0004791 (10%),ATP binding (16%);DNA binding (13%);thioredoxin-disulfide reductase activity (10%),GO:0019430 (9%);GO:0009306 (4%);GO:0006012 (1%),removal of superoxide radicals (9%);protein secretion (4%);galactose metabolic process (1%),IPR036188 (15%);IPR027417 (10%);IPR023753 (8%),FAD/NAD(P)-binding domain superfamily (15%);P-loop containing nucleoside triphosphate hydrolase (10%);FAD/NAD(P)-binding domain (8%)
AGAGLGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (25%);GO:0005737 (13%),integral component of membrane (25%);cytoplasm (13%),GO:0003677 (50%);GO:0005524 (25%);GO:0003700 (13%),DNA binding (50%);ATP binding (25%);DNA-binding transcription factor activity (13%),GO:0006355 (25%);GO:0000184 (13%);GO:0000272 (13%),regulation of transcription, DNA-templated (25%);nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (13%);polysaccharide catabolic process (13%),IPR036388 (30%);IPR000792 (20%);IPR016032 (20%),Winged helix-like DNA-binding domain superfamily (30%);Transcription regulator LuxR, C-terminal (20%);Signal transduction response regulator, C-terminal effector (20%)
LNELLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.92 (22%);2.5.1.114 (7%);2.7.7.7 (6%),Endopeptidase Clp (22%);tRNA(Phe) (4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase (7%);DNA-directed DNA polymerase (6%),GO:0019028 (26%);GO:0016021 (15%);GO:0005737 (11%),viral capsid (26%);integral component of membrane (15%);cytoplasm (11%),GO:0005524 (55%);GO:0004386 (26%);GO:0003968 (26%),ATP binding (55%);helicase activity (26%);RNA-directed 5'-3' RNA polymerase activity (26%),GO:0006351 (22%);GO:0018144 (22%);GO:0039694 (22%),transcription, DNA-templated (22%);RNA-protein covalent cross-linking (22%);viral RNA genome replication (22%),IPR027417 (45%);IPR001456 (24%);IPR002540 (24%),P-loop containing nucleoside triphosphate hydrolase (45%);Helper component proteinase (24%);Peptidase S30, polyprotein P1, potyvirus (24%)
PATLNSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VAAEAVPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (100%),Oxidoreductases (100%),,,GO:0000155 (50%);GO:0016491 (50%),phosphorelay sensor kinase activity (50%);oxidoreductase activity (50%),,,IPR001789 (50%);IPR002347 (50%);IPR003594 (50%),Signal transduction response regulator, receiver domain (50%);Short-chain dehydrogenase/reductase SDR (50%);Histidine kinase/HSP90-like ATPase (50%)
WVVSAAH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HELALAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.21.3 (25%);3.5.1.108 (25%);2.1.2.9 (13%),Type I site-specific deoxyribonuclease (25%);UDP-3-O-acyl-N-acetylglucosamine deacetylase (25%);Methionyl-tRNA formyltransferase (13%),GO:0016021 (31%);GO:0005737 (14%);GO:0005623 (12%),integral component of membrane (31%);cytoplasm (14%);cell (12%),GO:0005524 (21%);GO:0003677 (19%);GO:0003824 (10%),ATP binding (21%);DNA binding (19%);catalytic activity (10%),GO:0045454 (12%);GO:0006304 (10%);GO:0000160 (7%),cell redox homeostasis (12%);DNA modification (10%);phosphorelay signal transduction system (7%),IPR027417 (16%);IPR011990 (12%);IPR004146 (10%),P-loop containing nucleoside triphosphate hydrolase (16%);Tetratricopeptide-like helical domain superfamily (12%);DC1 (10%)
QGLVSGFCGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VSDVLLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016853 (83%);GO:0009055 (17%);GO:0051536 (17%),isomerase activity (83%);electron transfer activity (17%);iron-sulfur cluster binding (17%),,,IPR010706 (50%);IPR020556 (30%);IPR023631 (30%),Fatty acid cis-trans isomerase (50%);Amidase, conserved site (30%);Amidase signature domain (30%)
TNSNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.3.15 (27%);4.2.3.5 (11%);2.7.1.180 (7%),Acetyl-CoA carboxytransferase (27%);Chorismate synthase (11%);FAD:protein FMN transferase (7%),GO:0016021 (34%);GO:0005634 (5%);GO:0009279 (5%),integral component of membrane (34%);nucleus (5%);cell outer membrane (5%),GO:0005524 (13%);GO:0046872 (9%);GO:0000155 (7%),ATP binding (13%);metal ion binding (9%);phosphorelay sensor kinase activity (7%),GO:0006633 (5%);GO:2001295 (4%);GO:0010033 (4%),fatty acid biosynthetic process (5%);malonyl-CoA biosynthetic process (4%);response to organic substance (4%),IPR036890 (7%);IPR001789 (7%);IPR003594 (7%),Histidine kinase/HSP90-like ATPase superfamily (7%);Signal transduction response regulator, receiver domain (7%);Histidine kinase/HSP90-like ATPase (7%)
VPHTLFR,Pajaroellobacter abortibovis,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,Myxococcales,Sorangiineae,,,,Polyangiaceae,,,,Pajaroellobacter,,,,Pajaroellobacter abortibovis,,,,1.1.1.49 (100%),Glucose-6-phosphate dehydrogenase (NADP(+)) (100%),,,GO:0004345 (100%);GO:0050661 (100%),glucose-6-phosphate dehydrogenase activity (100%);NADP binding (100%),GO:0006006 (100%);GO:0006098 (100%),glucose metabolic process (100%);pentose-phosphate shunt (100%),IPR001282 (100%);IPR019796 (100%);IPR022674 (100%),Glucose-6-phosphate dehydrogenase (100%);Glucose-6-phosphate dehydrogenase, active site (100%);Glucose-6-phosphate dehydrogenase, NAD-binding (100%)
TETPHVYGPGSPYSQQPMMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMGVPEEK,Anaerolineaceae,Bacteria,,,,Chloroflexi,,,Anaerolineae,,,,Anaerolineales,,,,,Anaerolineaceae,,,,,,,,,,,,,,,,GO:0003824 (100%),catalytic activity (100%),,,IPR000891 (100%);IPR003379 (100%),Pyruvate carboxyltransferase (100%);Carboxylase, conserved domain (100%)
LSAVLESK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.180 (67%);3.6.4.12 (33%),FAD:protein FMN transferase (67%);DNA helicase (33%),GO:0005886 (40%),plasma membrane (40%),GO:0046872 (60%);GO:0005524 (40%);GO:0016740 (40%),metal ion binding (60%);ATP binding (40%);transferase activity (40%),GO:0017013 (40%);GO:0006207 (20%);GO:0006541 (20%),protein flavinylation (40%);'de novo' pyrimidine nucleobase biosynthetic process (20%);glutamine metabolic process (20%),IPR003374 (40%);IPR024932 (40%);IPR042159 (40%),ApbE-like superfamily (40%);Flavin transferase ApbE (40%);Flavin-trafficking protein ApbE (40%)
NMLLLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (50%);2.4.2.1 (50%),Hexosyltransferases (50%);Purine-nucleoside phosphorylase (50%),GO:0016021 (27%);GO:0005840 (18%);GO:0000139 (9%),integral component of membrane (27%);ribosome (18%);Golgi membrane (9%),GO:0003735 (18%);GO:0019843 (18%);GO:0000981 (9%),structural constituent of ribosome (18%);rRNA binding (18%);DNA-binding transcription factor activity, RNA polymerase II-specific (9%),GO:0006355 (18%);GO:0006412 (18%);GO:0006351 (9%),regulation of transcription, DNA-templated (18%);translation (18%);transcription, DNA-templated (9%),IPR011990 (26%);IPR022812 (26%);IPR027417 (26%),Tetratricopeptide-like helical domain superfamily (26%);Dynamin superfamily (26%);P-loop containing nucleoside triphosphate hydrolase (26%)
QFPLSSK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004519 (50%);GO:0008168 (50%),endonuclease activity (50%);methyltransferase activity (50%),GO:0032259 (50%),methylation (50%),IPR005135 (33%);IPR019642 (33%);IPR024096 (33%),Endonuclease/exonuclease/phosphatase (33%);Protein of unknown function DUF2507 (33%);NO signalling/Golgi transport ligand-binding domain superfamily (33%)
LQVPVDFTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MAPTYLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.23 (95%);2.1.1.172 (5%),Histidinol dehydrogenase (95%);16S rRNA (guanine(1207)-N(2))-methyltransferase (5%),GO:0016021 (42%);GO:0005737 (3%),integral component of membrane (42%);cytoplasm (3%),GO:0004399 (53%);GO:0008270 (53%);GO:0051287 (53%),histidinol dehydrogenase activity (53%);zinc ion binding (53%);NAD binding (53%),GO:0000105 (53%);GO:0030001 (42%),histidine biosynthetic process (53%);metal ion transport (42%),IPR001692 (53%);IPR012131 (53%);IPR016161 (53%),Histidinol dehydrogenase, conserved site (53%);Histidinol dehydrogenase (53%);Aldehyde/histidinol dehydrogenase (53%)
LVLLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.2 (24%);1.13.11.11 (12%);6.1.1.21 (12%),DNA topoisomerase (ATP-hydrolyzing) (24%);Tryptophan 2,3-dioxygenase (12%);Histidine--tRNA ligase (12%),GO:0016021 (38%);GO:0005737 (10%);GO:0005886 (7%),integral component of membrane (38%);cytoplasm (10%);plasma membrane (7%),GO:0005524 (22%);GO:0003677 (16%);GO:0046872 (10%),ATP binding (22%);DNA binding (16%);metal ion binding (10%),GO:0006265 (5%);GO:0006261 (4%);GO:0019441 (3%),DNA topological change (5%);DNA-dependent DNA replication (4%);tryptophan catabolic process to kynurenine (3%),IPR027417 (12%);IPR036388 (5%);IPR002205 (4%),P-loop containing nucleoside triphosphate hydrolase (12%);Winged helix-like DNA-binding domain superfamily (5%);DNA topoisomerase, type IIA, subunit A/C-terminal (4%)
QFLQQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (18%);2.7.11.1 (12%);3.4.16.4 (12%),Peptidylprolyl isomerase (18%);Non-specific serine/threonine protein kinase (12%);Serine-type D-Ala-D-Ala carboxypeptidase (12%),GO:0016021 (18%);GO:0005737 (2%);GO:0005783 (2%),integral component of membrane (18%);cytoplasm (2%);endoplasmic reticulum (2%),GO:0004674 (47%);GO:0005524 (40%);GO:0031177 (7%),protein serine/threonine kinase activity (47%);ATP binding (40%);phosphopantetheine binding (7%),GO:0000271 (4%);GO:0009058 (4%);GO:0006310 (3%),polysaccharide biosynthetic process (4%);biosynthetic process (4%);DNA recombination (3%),IPR022165 (43%);IPR011009 (32%);IPR000719 (31%),Polo kinase kinase (43%);Protein kinase-like domain superfamily (32%);Protein kinase domain (31%)
AQAGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.99.17 (16%);2.3.1.- (16%);5.6.2.2 (6%),Phosphomethylpyrimidine synthase (16%);Transferring groups other than amino-acyl groups (16%);DNA topoisomerase (ATP-hydrolyzing) (6%),GO:0016021 (27%);GO:0005737 (8%);GO:0005886 (2%),integral component of membrane (27%);cytoplasm (8%);plasma membrane (2%),GO:0005524 (18%);GO:0016787 (8%);GO:0008270 (5%),ATP binding (18%);hydrolase activity (8%);zinc ion binding (5%),GO:0009228 (4%);GO:0009229 (4%);GO:0055085 (2%),thiamine biosynthetic process (4%);thiamine diphosphate biosynthetic process (4%);transmembrane transport (2%),IPR003399 (14%);IPR027417 (9%);IPR023213 (4%),Mce/MlaD (14%);P-loop containing nucleoside triphosphate hydrolase (9%);Chloramphenicol acetyltransferase-like domain superfamily (4%)
AQELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.47 (8%);6.5.1.2 (7%);1.1.1.25 (5%),Cysteine synthase (8%);DNA ligase (NAD(+)) (7%);Shikimate dehydrogenase (5%),GO:0016021 (21%);GO:0005737 (9%);GO:0005840 (6%),integral component of membrane (21%);cytoplasm (9%);ribosome (6%),GO:0005524 (13%);GO:0003677 (11%);GO:0046872 (8%),ATP binding (13%);DNA binding (11%);metal ion binding (8%),GO:0006412 (6%);GO:0055085 (2%);GO:0006281 (2%),translation (6%);transmembrane transport (2%);DNA repair (2%),IPR027417 (13%);IPR036049 (4%);IPR001854 (4%),P-loop containing nucleoside triphosphate hydrolase (13%);Ribosomal protein L29/L35 superfamily (4%);Ribosomal protein L29/L35 (4%)
TVTVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (83%),integral component of membrane (83%),GO:0000155 (8%);GO:0003700 (8%);GO:0003993 (8%),phosphorelay sensor kinase activity (8%);DNA-binding transcription factor activity (8%);acid phosphatase activity (8%),,,IPR004474 (75%);IPR003594 (8%);IPR003599 (8%),Cell envelope-related transcriptional attenuator domain (75%);Histidine kinase/HSP90-like ATPase (8%);Immunoglobulin subtype (8%)
GALNEFGDVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HATQYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR000210 (67%);IPR000408 (67%);IPR009091 (67%),BTB/POZ domain (67%);Regulator of chromosome condensation, RCC1 (67%);Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II (67%)
LLMLLLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.- (100%),Transferring groups other than amino-acyl groups (100%),GO:0016021 (80%),integral component of membrane (80%),GO:0000104 (10%);GO:0003824 (10%);GO:0008381 (10%),succinate dehydrogenase activity (10%);catalytic activity (10%);mechanosensitive ion channel activity (10%),GO:0055085 (20%);GO:0006099 (10%);GO:0071470 (10%),transmembrane transport (20%);tricarboxylic acid cycle (10%);cellular response to osmotic stress (10%),IPR011989 (47%);IPR016024 (47%);IPR001660 (35%),Armadillo-like helical (47%);Armadillo-type fold (47%);Sterile alpha motif domain (35%)
SNPSVELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VALQPLVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLLNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.11.- (26%);2.7.7.6 (17%);2.7.7.7 (6%),With 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (26%);DNA-directed RNA polymerase (17%);DNA-directed DNA polymerase (6%),GO:0016021 (23%);GO:0009507 (4%);GO:0005886 (4%),integral component of membrane (23%);chloroplast (4%);plasma membrane (4%),GO:0003677 (20%);GO:0005524 (15%);GO:0046872 (7%),DNA binding (20%);ATP binding (15%);metal ion binding (7%),GO:0045892 (7%);GO:0006351 (6%);GO:0019477 (4%),negative regulation of transcription, DNA-templated (7%);transcription, DNA-templated (6%);L-lysine catabolic process (4%),IPR036388 (10%);IPR027417 (10%);IPR036390 (8%),Winged helix-like DNA-binding domain superfamily (10%);P-loop containing nucleoside triphosphate hydrolase (10%);Winged helix DNA-binding domain superfamily (8%)
LFVVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.3 (48%);3.5.4.1 (5%);3.5.1.88 (3%),Long-chain-fatty-acid--CoA ligase (48%);Cytosine deaminase (5%);Peptide deformylase (3%),GO:0016021 (20%);GO:0016020 (3%);GO:0005886 (3%),integral component of membrane (20%);membrane (3%);plasma membrane (3%),GO:0016874 (17%);GO:0003824 (7%);GO:0003996 (7%),ligase activity (17%);catalytic activity (7%);acyl-CoA ligase activity (7%),GO:0045892 (3%);GO:0055085 (3%);GO:0009416 (2%),negative regulation of transcription, DNA-templated (3%);transmembrane transport (3%);response to light stimulus (2%),IPR025110 (23%);IPR000873 (23%);IPR020845 (23%),AMP-binding enzyme, C-terminal domain (23%);AMP-dependent synthetase/ligase (23%);AMP-binding, conserved site (23%)
VLLTALPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.1.61 (100%),Protein-glutamate methylesterase (100%),GO:0005737 (25%);GO:0016021 (25%),cytoplasm (25%);integral component of membrane (25%),GO:0071949 (50%);GO:0000156 (25%);GO:0008984 (25%),FAD binding (50%);phosphorelay response regulator activity (25%);protein-glutamate methylesterase activity (25%),GO:0006935 (25%),chemotaxis (25%),IPR002938 (50%);IPR036188 (50%);IPR000673 (25%),FAD-binding domain (50%);FAD/NAD(P)-binding domain superfamily (50%);Signal transduction response regulator, chemotaxis, protein-glutamate methylesterase (25%)
NGATLEALHANR,Alphaproteobacteria bacterium,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,,,,,,,,,,,,,,Alphaproteobacteria bacterium,,,,,,,,GO:0016740 (100%),transferase activity (100%),,,IPR004045 (100%);IPR004046 (100%);IPR010987 (100%),Glutathione S-transferase, N-terminal (100%);Glutathione S-transferase, C-terminal (100%);Glutathione S-transferase, C-terminal-like (100%)
AHDFAELNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVLPPVLVRPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PLPTLPPYVNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GAVQLVAGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (10%);2.7.1.17 (7%);3.1.22.4 (4%),Endopeptidase La (10%);Xylulokinase (7%);Crossover junction endodeoxyribonuclease (4%),GO:0016021 (27%);GO:0005737 (17%);GO:0005886 (5%),integral component of membrane (27%);cytoplasm (17%);plasma membrane (5%),GO:0005524 (14%);GO:0003677 (13%);GO:0003700 (6%),ATP binding (14%);DNA binding (13%);DNA-binding transcription factor activity (6%),GO:0051301 (4%);GO:0007049 (3%);GO:0007059 (3%),cell division (4%);cell cycle (3%);chromosome segregation (3%),IPR027417 (7%);IPR037914 (3%);IPR007159 (3%),P-loop containing nucleoside triphosphate hydrolase (7%);SpoVT-AbrB domain superfamily (3%);SpoVT-AbrB domain (3%)
LSNESVLK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.12 (67%);6.1.1.23 (33%),Aspartate--tRNA ligase (67%);Aspartate--tRNA(Asn) ligase (33%),GO:0005737 (75%),cytoplasm (75%),GO:0004815 (75%);GO:0005524 (75%);GO:0003676 (50%),aspartate-tRNA ligase activity (75%);ATP binding (75%);nucleic acid binding (50%),GO:0006422 (75%),aspartyl-tRNA aminoacylation (75%),IPR002312 (75%);IPR004115 (75%);IPR004364 (75%),Aspartyl/Asparaginyl-tRNA synthetase, class IIb (75%);GAD-like domain superfamily (75%);Aminoacyl-tRNA synthetase, class II (D/K/N) (75%)
VFVLLLFTGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAFDMGLSNFNVEAQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLVLLLGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.5 (100%),Isoleucine--tRNA ligase (100%),GO:0005737 (50%);GO:0005886 (25%);GO:0016021 (25%),cytoplasm (50%);plasma membrane (25%);integral component of membrane (25%),GO:0005524 (75%);GO:0000049 (50%);GO:0002161 (50%),ATP binding (75%);tRNA binding (50%);aminoacyl-tRNA editing activity (50%),GO:0006428 (50%);GO:0015031 (25%),isoleucyl-tRNA aminoacylation (50%);protein transport (25%),IPR001412 (50%);IPR002300 (50%);IPR002301 (50%),Aminoacyl-tRNA synthetase, class I, conserved site (50%);Aminoacyl-tRNA synthetase, class Ia (50%);Isoleucine-tRNA ligase (50%)
AGVLGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.42 (23%);2.7.7.89 (23%);1.1.1.42 (8%),[Glutamine synthetase] adenylyltransferase (23%);[Glutamine synthetase]-adenylyl-L-tyrosine phosphorylase (23%);Isocitrate dehydrogenase (NADP(+)) (8%),GO:0016021 (23%);GO:0005634 (6%);GO:0005886 (6%),integral component of membrane (23%);nucleus (6%);plasma membrane (6%),GO:0016740 (26%);GO:0005524 (12%);GO:0004930 (5%),transferase activity (26%);ATP binding (12%);G protein-coupled receptor activity (5%),GO:0007166 (5%);GO:0008152 (4%);GO:0007156 (4%),cell surface receptor signaling pathway (5%);metabolic process (4%);homophilic cell adhesion via plasma membrane adhesion molecules (4%),IPR028098 (29%);IPR001296 (27%);IPR036291 (10%),Glycosyltransferase subfamily 4-like, N-terminal domain (29%);Glycosyl transferase, family 1 (27%);NAD(P)-binding domain superfamily (10%)
LTALLAVPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVTDLTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.15 (45%);3.1.1.61 (27%);1.1.1.100 (9%),Glutamate decarboxylase (45%);Protein-glutamate methylesterase (27%);3-oxoacyl-[acyl-carrier-protein] reductase (9%),GO:0005615 (64%);GO:0005783 (19%);GO:0005794 (19%),extracellular space (64%);endoplasmic reticulum (19%);Golgi apparatus (19%),GO:0046872 (49%);GO:0003677 (23%);GO:0030170 (22%),metal ion binding (49%);DNA binding (23%);pyridoxal phosphate binding (22%),GO:0009267 (19%);GO:0043066 (19%);GO:0051659 (19%),cellular response to starvation (19%);negative regulation of apoptotic process (19%);maintenance of mitochondrion location (19%),IPR000264 (70%);IPR014760 (70%);IPR020858 (70%),ALB/AFP/VDB (70%);Serum albumin, N-terminal (70%);Serum albumin-like (70%)
QQQLFQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (100%),Endopeptidase La (100%),GO:0016020 (17%),membrane (17%),GO:0003700 (17%);GO:0004176 (17%);GO:0004252 (17%),DNA-binding transcription factor activity (17%);ATP-dependent peptidase activity (17%);serine-type endopeptidase activity (17%),GO:0007155 (33%);GO:0000160 (17%);GO:0030163 (17%),cell adhesion (33%);phosphorelay signal transduction system (17%);protein catabolic process (17%),IPR000034 (33%);IPR000742 (33%);IPR001791 (33%),Laminin IV (33%);EGF-like domain (33%);Laminin G domain (33%)
FVVLPSVR,Bacteroidetes bacterium,Bacteria,,,,Bacteroidetes,,,,,,,,,,,,,,,,,,,,Bacteroidetes bacterium,,,,,,GO:0009279 (100%);GO:0016021 (100%),cell outer membrane (100%);integral component of membrane (100%),,,,,IPR000531 (100%);IPR012910 (100%);IPR036942 (100%),TonB-dependent receptor-like, beta-barrel (100%);TonB-dependent receptor, plug domain (100%);TonB-dependent receptor-like, beta-barrel domain superfamily (100%)
VAVWLMR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003677 (50%),DNA binding (50%),GO:0006355 (50%),regulation of transcription, DNA-templated (50%),IPR000595 (100%);IPR012318 (100%);IPR014710 (100%),Cyclic nucleotide-binding domain (100%);Crp-type HTH domain (100%);RmlC-like jelly roll fold (100%)
YLVEAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.3.8 (14%);3.1.-.- (14%);4.1.1.9 (14%),Acetate CoA-transferase (14%);Acting on ester bonds (14%);Malonyl-CoA decarboxylase (14%),GO:0005634 (29%);GO:0016021 (20%);GO:0005576 (1%),nucleus (29%);integral component of membrane (20%);extracellular region (1%),GO:0005524 (35%);GO:0003677 (33%);GO:0004677 (28%),ATP binding (35%);DNA binding (33%);DNA-dependent protein kinase activity (28%),GO:0006303 (28%);GO:0006633 (7%);GO:0005975 (2%),double-strand break repair via nonhomologous end joining (28%);fatty acid biosynthetic process (7%);carbohydrate metabolic process (2%),IPR016024 (26%);IPR012582 (24%);IPR011009 (17%),Armadillo-type fold (26%);NUC194 (24%);Protein kinase-like domain superfamily (17%)
NNALDLALAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDLLPGGTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (11%);2.4.2.10 (6%);1.9.3.1 (3%),Methyltransferases (11%);Orotate phosphoribosyltransferase (6%);Cytochrome-c oxidase (3%),GO:0016021 (31%);GO:0005737 (7%);GO:0042613 (2%),integral component of membrane (31%);cytoplasm (7%);MHC class II protein complex (2%),GO:0003677 (14%);GO:0005524 (10%);GO:0016740 (6%),DNA binding (14%);ATP binding (10%);transferase activity (6%),GO:0006355 (5%);GO:0002250 (2%);GO:0002504 (2%),regulation of transcription, DNA-templated (5%);adaptive immune response (2%);antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (2%),IPR027417 (8%);IPR036365 (5%);IPR002477 (5%),P-loop containing nucleoside triphosphate hydrolase (8%);PGBD-like superfamily (5%);Peptidoglycan binding-like (5%)
VGATLGSLALP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FVVGLGLLSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GDGPTQAVR,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003824 (100%);GO:0046872 (100%),catalytic activity (100%);metal ion binding (100%),,,IPR005000 (100%);IPR015813 (100%);IPR040442 (100%),HpcH/HpaI aldolase/citrate lyase domain (100%);Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (100%);Pyruvate kinase-like domain superfamily (100%)
YWGVTQQEYYQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDGANLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.30 (20%);3.2.1.136 (20%);3.6.3.- (20%),Serine O-acetyltransferase (20%);Glucuronoarabinoxylan endo-1,4-beta-xylanase (20%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (20%),GO:0016021 (60%);GO:0005737 (12%);GO:0005576 (4%),integral component of membrane (60%);cytoplasm (12%);extracellular region (4%),GO:0005524 (24%);GO:0016887 (16%);GO:0042626 (16%),ATP binding (24%);ATPase activity (16%);ATPase-coupled transmembrane transporter activity (16%),GO:0005975 (8%);GO:0006535 (8%);GO:0051409 (8%),carbohydrate metabolic process (8%);cysteine biosynthetic process from serine (8%);response to nitrosative stress (8%),IPR032036 (73%);IPR038316 (73%);IPR001646 (8%),Protein of unknown function DUF5062 (73%);DUF5062 superfamily (73%);Pentapeptide repeat (8%)
QLSGWNPTS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLPTLNSSFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLLLPVVK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.3.2 (95%);6.1.1.9 (5%),5-formyltetrahydrofolate cyclo-ligase (95%);Valine--tRNA ligase (5%),GO:0005737 (5%),cytoplasm (5%),GO:0005524 (95%);GO:0030272 (95%);GO:0046872 (89%),ATP binding (95%);5-formyltetrahydrofolate cyclo-ligase activity (95%);metal ion binding (89%),GO:0006438 (5%),valyl-tRNA aminoacylation (5%),IPR002698 (95%);IPR024185 (95%);IPR037171 (95%),5-formyltetrahydrofolate cyclo-ligase (95%);5-formyltetrahydrofolate cyclo-ligase-like domain superfamily (95%);NagB/RpiA transferase-like (95%)
FNGNTLDND,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTLVPALK,Candidatus Uhrbacteria,Bacteria,,,,Candidatus Uhrbacteria,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (100%),Peptidylprolyl isomerase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0003755 (100%),peptidyl-prolyl cis-trans isomerase activity (100%),GO:0006457 (100%);GO:0007049 (100%);GO:0015031 (100%),protein folding (100%);cell cycle (100%);protein transport (100%),IPR005215 (100%);IPR008880 (100%);IPR008881 (100%),Trigger factor (100%);Trigger factor, C-terminal (100%);Trigger factor, ribosome-binding, bacterial (100%)
LQQTLAAN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLLPLAFAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVVHAFLTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEGEESR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.-.-.- (33%);2.7.7.- (33%);4.1.3.27 (33%),Oxidoreductases (33%);Nucleotidyltransferases (33%);Anthranilate synthase (33%),GO:0016021 (24%);GO:0005634 (6%);GO:0005886 (6%),integral component of membrane (24%);nucleus (6%);plasma membrane (6%),GO:0000977 (6%);GO:0003676 (6%);GO:0003677 (6%),RNA polymerase II regulatory region sequence-specific DNA binding (6%);nucleic acid binding (6%);DNA binding (6%),GO:0006886 (29%);GO:0006011 (6%);GO:0006396 (6%),intracellular protein transport (29%);UDP-glucose metabolic process (6%);RNA processing (6%),IPR014752 (21%);IPR028934 (21%);IPR041181 (11%),Arrestin, C-terminal (21%);Vacuolar protein sorting protein 26 related (21%);DR2241 stabilising domain (11%)
LTLATVLPSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSQLNEHAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QHALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.42 (11%);1.1.1.22 (10%);2.7.7.89 (9%),[Glutamine synthetase] adenylyltransferase (11%);UDP-glucose 6-dehydrogenase (10%);[Glutamine synthetase]-adenylyl-L-tyrosine phosphorylase (9%),GO:0016021 (25%);GO:0005737 (5%);GO:0005634 (2%),integral component of membrane (25%);cytoplasm (5%);nucleus (2%),GO:0005524 (14%);GO:0005525 (11%);GO:0003677 (7%),ATP binding (14%);GTP binding (11%);DNA binding (7%),GO:0000271 (2%);GO:0008152 (1%);GO:0005975 (1%),polysaccharide biosynthetic process (2%);metabolic process (1%);carbohydrate metabolic process (1%),IPR027417 (16%);IPR030381 (9%);IPR022812 (9%),P-loop containing nucleoside triphosphate hydrolase (16%);Dynamin-type guanine nucleotide-binding (G) domain (9%);Dynamin superfamily (9%)
APAAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.6.2.1 (13%);4.1.1.48 (11%);6.1.1.9 (10%),DNA topoisomerase (13%);Indole-3-glycerol-phosphate synthase (11%);Valine--tRNA ligase (10%),GO:0016021 (13%);GO:0005737 (11%);GO:0005634 (7%),integral component of membrane (13%);cytoplasm (11%);nucleus (7%),GO:0003677 (27%);GO:0005524 (14%);GO:0046872 (8%),DNA binding (27%);ATP binding (14%);metal ion binding (8%),GO:0006265 (6%);GO:0006334 (5%);GO:0030261 (5%),DNA topological change (6%);nucleosome assembly (5%);chromosome condensation (5%),IPR036388 (7%);IPR027417 (6%);IPR006171 (5%),Winged helix-like DNA-binding domain superfamily (7%);P-loop containing nucleoside triphosphate hydrolase (6%);TOPRIM  domain (5%)
GDVLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.31 (23%);6.3.2.34 (21%);1.3.8.- (21%),Coenzyme F420-0:L-glutamate ligase (23%);Coenzyme F420-1:gamma-L-glutamate ligase (21%);With a flavin as acceptor (21%),GO:0016021 (21%);GO:0005737 (6%);GO:0005886 (3%),integral component of membrane (21%);cytoplasm (6%);plasma membrane (3%),GO:0005524 (13%);GO:0046872 (12%);GO:0004491 (8%),ATP binding (13%);metal ion binding (12%);methylmalonate-semialdehyde dehydrogenase (acylating) activity (8%),GO:0009108 (5%);GO:0052645 (5%);GO:0019563 (4%),coenzyme biosynthetic process (5%);F420-0 metabolic process (5%);glycerol catabolic process (4%),IPR016161 (8%);IPR016162 (8%);IPR015590 (8%),Aldehyde/histidinol dehydrogenase (8%);Aldehyde dehydrogenase, N-terminal (8%);Aldehyde dehydrogenase domain (8%)
VVAAGAVVGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLAGLLPGK,Thermodesulfobacteria bacterium,Bacteria,,,,Thermodesulfobacteria,,,,,,,,,,,,,,,,,,,,Thermodesulfobacteria bacterium,,,,,,,,GO:0003677 (100%),DNA binding (100%),,,IPR009057 (100%),Homeobox-like domain superfamily (100%)
VPLALATK,Pseudomonas,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Pseudomonadales,,,,,Pseudomonadaceae,,,,Pseudomonas,,,,,,,,,,,,GO:0004842 (100%),ubiquitin-protein transferase activity (100%),,,IPR001611 (100%);IPR003591 (100%);IPR029487 (100%),Leucine-rich repeat (100%);Leucine-rich repeat, typical subtype (100%);Novel E3 ligase domain (100%)
SLAQHPAGHR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANSLPYQVSLNS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLLSENGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (33%);GO:0016021 (33%),cell outer membrane (33%);integral component of membrane (33%),GO:0003676 (33%);GO:0008168 (33%);GO:0008556 (33%),nucleic acid binding (33%);methyltransferase activity (33%);potassium transmembrane transporter activity, phosphorylative mechanism (33%),GO:0009306 (33%);GO:0032259 (33%),protein secretion (33%);methylation (33%),IPR020941 (40%);IPR037181 (40%);IPR001775 (20%),Suppressor of fused-like domain (40%);Suppressor of fused, N-terminal (40%);GspD/PilQ family (20%)
ANGFDALAPANVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGLDPHQVVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSLQGLHR,Neognathae,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Aves,,Neognathae,,,,,,,,,,,,,,,,,,,,,GO:0005829 (100%),cytosol (100%),GO:0019902 (100%),phosphatase binding (100%),GO:0010923 (100%),negative regulation of phosphatase activity (100%),IPR000980 (100%);IPR036860 (100%),SH2 domain (100%);SH2 domain superfamily (100%)
CLDGLLLLVLGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DELVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.48 (23%);1.20.4.1 (9%);4.2.99.18 (8%),RNA-directed RNA polymerase (23%);Arsenate reductase (glutaredoxin) (9%);DNA-(apurinic or apyrimidinic site) lyase (8%),GO:0016021 (14%);GO:0005737 (7%);GO:0019012 (6%),integral component of membrane (14%);cytoplasm (7%);virion (6%),GO:0005524 (23%);GO:0003723 (23%);GO:0003968 (19%),ATP binding (23%);RNA binding (23%);RNA-directed 5'-3' RNA polymerase activity (19%),GO:0006351 (18%);GO:0039694 (12%);GO:0019079 (6%),transcription, DNA-templated (18%);viral RNA genome replication (12%);viral genome replication (6%),IPR027417 (16%);IPR001205 (10%);IPR007094 (10%),P-loop containing nucleoside triphosphate hydrolase (16%);RNA-directed RNA polymerase,  C-terminal domain (10%);RNA-directed RNA polymerase,  catalytic domain (10%)
GYGPVCPPG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAVSGVVLGVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HKPTFS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAQGFTGSADWTWLSELK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFQNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.2.10 (22%);6.5.1.1 (10%);3.6.4.12 (6%),Imidazole glycerol-phosphate synthase (22%);DNA ligase (ATP) (10%);DNA helicase (6%),GO:0016021 (25%);GO:0030126 (19%);GO:0000139 (19%),integral component of membrane (25%);COPI vesicle coat (19%);Golgi membrane (19%),GO:0005198 (19%);GO:0005524 (10%);GO:0005507 (5%),structural molecule activity (19%);ATP binding (10%);copper ion binding (5%),GO:0016192 (20%);GO:0006886 (20%);GO:0046688 (5%),vesicle-mediated transport (20%);intracellular protein transport (20%);response to copper ion (5%),IPR006533 (18%);IPR017847 (18%);IPR037026 (18%),Type VI secretion system, RhsGE-associated Vgr protein (18%);Type VI secretion system, RhsGE-associated Vgr  family subset (18%);Vgr protein, OB-fold domain superfamily (18%)
AVCAVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.3.7 (43%);1.17.1.4 (14%);1.3.1.98 (14%),4-hydroxy-tetrahydrodipicolinate synthase (43%);Xanthine dehydrogenase (14%);UDP-N-acetylmuramate dehydrogenase (14%),GO:0005739 (21%);GO:0005737 (6%);GO:0016021 (6%),mitochondrion (21%);cytoplasm (6%);integral component of membrane (6%),GO:0003951 (16%);GO:0016740 (15%);GO:0031177 (10%),NAD+ kinase activity (16%);transferase activity (15%);phosphopantetheine binding (10%),GO:0000959 (21%);GO:0007165 (8%);GO:0032259 (6%),mitochondrial RNA metabolic process (21%);signal transduction (8%);methylation (6%),IPR018708 (42%);IPR013943 (11%);IPR001206 (7%),Protein of unknown function DUF2225 (42%);Mitochondrial protein Pet127 (11%);Diacylglycerol kinase, catalytic domain (7%)
LQMFVLVLLY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLLVALSLVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YAVYDGDQPALNLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLSALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.98 (16%);3.4.24.- (11%);5.1.3.14 (5%),4-hydroxy-3-polyprenylbenzoate decarboxylase (16%);Metalloendopeptidases (11%);UDP-N-acetylglucosamine 2-epimerase (non-hydrolyzing) (5%),GO:0016021 (23%);GO:0005737 (15%);GO:0005886 (11%),integral component of membrane (23%);cytoplasm (15%);plasma membrane (11%),GO:0005524 (24%);GO:0046872 (16%);GO:0003677 (14%),ATP binding (24%);metal ion binding (16%);DNA binding (14%),GO:0006744 (5%);GO:0051301 (2%);GO:0005975 (2%),ubiquinone biosynthetic process (5%);cell division (2%);carbohydrate metabolic process (2%),IPR027417 (16%);IPR003593 (6%);IPR036388 (5%),P-loop containing nucleoside triphosphate hydrolase (16%);AAA+ ATPase domain (6%);Winged helix-like DNA-binding domain superfamily (5%)
FVLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.1 (53%);2.7.7.7 (6%);3.6.4.- (5%),Transketolase (53%);DNA-directed DNA polymerase (6%);Acting on ATP; involved in cellular and subcellular movement (5%),GO:0016021 (23%);GO:0005737 (5%);GO:0005886 (2%),integral component of membrane (23%);cytoplasm (5%);plasma membrane (2%),GO:0005525 (17%);GO:0003924 (17%);GO:0005524 (12%),GTP binding (17%);GTPase activity (17%);ATP binding (12%),GO:0006260 (2%);GO:0006355 (2%);GO:0006281 (1%),DNA replication (2%);regulation of transcription, DNA-templated (2%);DNA repair (1%),IPR029061 (45%);IPR005474 (45%);IPR027417 (16%),Thiamin diphosphate-binding fold (45%);Transketolase, N-terminal (45%);P-loop containing nucleoside triphosphate hydrolase (16%)
YLKPLVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.130 (50%);2.7.1.90 (17%);3.5.3.1 (17%),Tetraacyldisaccharide 4'-kinase (50%);Diphosphate--fructose-6-phosphate 1-phosphotransferase (17%);Arginase (17%),GO:0016021 (25%);GO:0005576 (5%);GO:0005623 (5%),integral component of membrane (25%);extracellular region (5%);cell (5%),GO:0005524 (20%);GO:0009029 (15%);GO:0046872 (10%),ATP binding (20%);tetraacyldisaccharide 4'-kinase activity (15%);metal ion binding (10%),GO:0035082 (20%);GO:0060294 (20%);GO:0009245 (15%),axoneme assembly (20%);cilium movement involved in cell motility (20%);lipid A biosynthetic process (15%),IPR006528 (17%);IPR039586 (17%);IPR003758 (13%),Phage head morphogenesis domain (17%);Cilia- and flagella-associated protein 46 (17%);Tetraacyldisaccharide 4'-kinase (13%)
GLLSGNEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.2.2 (100%),Pectate lyase (100%),GO:0005882 (79%);GO:0016021 (14%);GO:0005576 (7%),intermediate filament (79%);integral component of membrane (14%);extracellular region (7%),GO:0005198 (71%);GO:0046982 (36%);GO:0030570 (7%),structural molecule activity (71%);protein heterodimerization activity (36%);pectate lyase activity (7%),GO:0007568 (29%);GO:0031069 (29%);GO:0045109 (29%),aging (29%);hair follicle morphogenesis (29%);intermediate filament organization (29%),IPR002957 (92%);IPR039008 (92%);IPR042180 (92%),Keratin, type I (92%);Intermediate filament, rod domain (92%);Intermediate filament, rod domain, coil 1B (92%)
SHFCSQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (6%);3.6.4.12 (6%);2.3.2.27 (4%),Acting on ester bonds (6%);DNA helicase (6%);RING-type E3 ubiquitin transferase (4%),GO:0005737 (42%);GO:0016021 (17%);GO:0005886 (3%),cytoplasm (42%);integral component of membrane (17%);plasma membrane (3%),GO:0003723 (42%);GO:0005524 (8%);GO:0003677 (6%),RNA binding (42%);ATP binding (8%);DNA binding (6%),GO:0070929 (39%);GO:0016192 (2%);GO:0015969 (1%),trans-translation (39%);vesicle-mediated transport (2%);guanosine tetraphosphate metabolic process (1%),IPR000037 (35%);IPR023620 (35%);IPR020081 (32%),SsrA-binding protein (35%);Small protein B (35%);SsrA-binding protein, conserved site (32%)
LSGSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.7 (17%);2.7.6.1 (8%);3.6.-.- (7%),UDP-N-acetylglucosamine 1-carboxyvinyltransferase (17%);Ribose-phosphate diphosphokinase (8%);Acting on acid anhydrides (7%),GO:0016021 (16%);GO:0005737 (12%);GO:0005634 (3%),integral component of membrane (16%);cytoplasm (12%);nucleus (3%),GO:0050660 (21%);GO:0005524 (12%);GO:0003995 (12%),flavin adenine dinucleotide binding (21%);ATP binding (12%);acyl-CoA dehydrogenase activity (12%),GO:0051301 (4%);GO:0071555 (4%);GO:0007049 (4%),cell division (4%);cell wall organization (4%);cell cycle (4%),IPR009100 (18%);IPR037069 (17%);IPR036250 (17%),Acyl-CoA dehydrogenase/oxidase, N-terminal and middle domain superfamily (18%);Acyl-CoA dehydrogenase/oxidase, N-terminal domain superfamily (17%);Acyl-CoA dehydrogenase-like, C-terminal (17%)
LTFCR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.195 (15%);6.1.1.6 (13%);7.1.1.2 (13%),Cobalt-precorrin-5B (C(1))-methyltransferase (15%);Lysine--tRNA ligase (13%);NADH:ubiquinone reductase (H(+)-translocating) (13%),GO:0016021 (64%);GO:0005886 (48%);GO:0005737 (4%),integral component of membrane (64%);plasma membrane (48%);cytoplasm (4%),GO:0004984 (48%);GO:0004930 (46%);GO:0005524 (8%),olfactory receptor activity (48%);G protein-coupled receptor activity (46%);ATP binding (8%),GO:0007186 (8%);GO:0007608 (7%);GO:0042981 (4%),G protein-coupled receptor signaling pathway (8%);sensory perception of smell (7%);regulation of apoptotic process (4%),IPR000725 (38%);IPR017452 (38%);IPR000276 (37%),Olfactory receptor (38%);GPCR, rhodopsin-like, 7TM (38%);G protein-coupled receptor, rhodopsin-like (37%)
VLVVPPAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DGLSPGECALYR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GVTVARPR,Ceratocystis fimbriata,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,Hypocreomycetidae,,,Microascales,,,,,Ceratocystidaceae,,,,Ceratocystis,,,,Ceratocystis fimbriata,,,,,,,,,,,,,
LLEGEECR,Craniata,Eukaryota,Metazoa,,,Chordata,Craniata,,,,,,,,,,,,,,,,,,,,,,,2.7.7.41 (100%),Phosphatidate cytidylyltransferase (100%),GO:0045095 (81%);GO:0005882 (12%);GO:0005883 (7%),keratin filament (81%);intermediate filament (12%);neurofilament (7%),GO:0005198 (3%);GO:0097110 (3%);GO:0019901 (3%),structural molecule activity (3%);scaffold protein binding (3%);protein kinase binding (3%),GO:0061564 (5%);GO:0045104 (4%);GO:0033693 (3%),axon development (5%);intermediate filament cytoskeleton organization (4%);neurofilament bundle assembly (3%),IPR039008 (100%);IPR018039 (98%);IPR042180 (96%),Intermediate filament, rod domain (100%);Intermediate filament protein, conserved site (98%);Intermediate filament, rod domain, coil 1B (96%)
ASGLAAVSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MVYPNTGSLLTGSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCAAAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.1.7 (53%);3.1.3.16 (20%);2.3.1.- (7%),Cysteine desulfurase (53%);Protein-serine/threonine phosphatase (20%);Transferring groups other than amino-acyl groups (7%),GO:0019867 (21%);GO:0016021 (15%);GO:0031514 (6%),outer membrane (21%);integral component of membrane (15%);motile cilium (6%),GO:0004553 (21%);GO:0030170 (13%);GO:0031071 (12%),hydrolase activity, hydrolyzing O-glycosyl compounds (21%);pyridoxal phosphate binding (13%);cysteine desulfurase activity (12%),GO:0009254 (21%);GO:0006534 (12%);GO:0000160 (9%),peptidoglycan turnover (21%);cysteine metabolic process (12%);phosphorelay signal transduction system (9%),IPR005300 (17%);IPR010611 (17%);IPR026044 (17%),Lytic transglycosylase MltA, domain B (17%);3D domain (17%);Membrane-bound lytic murein transglycosylase A (17%)
PLNSATVDPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PNGALLALPFPLTASLQDYEANLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSFEDTEGQLDLLSGDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSLGAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.117 (20%);2.7.13.3 (13%);1.1.1.49 (10%),2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (20%);Histidine kinase (13%);Glucose-6-phosphate dehydrogenase (NADP(+)) (10%),GO:0016021 (29%);GO:0009279 (14%);GO:0005886 (4%),integral component of membrane (29%);cell outer membrane (14%);plasma membrane (4%),GO:0003677 (19%);GO:0005524 (10%);GO:0000287 (8%),DNA binding (19%);ATP binding (10%);magnesium ion binding (8%),GO:0009116 (5%);GO:0009165 (5%);GO:0006351 (3%),nucleoside metabolic process (5%);nucleotide biosynthetic process (5%);transcription, DNA-templated (3%),IPR037848 (23%);IPR004182 (22%);IPR011993 (17%),GEM-like protein (23%);GRAM domain (22%);PH-like domain superfamily (17%)
SSGTSYPDVLK,Bos,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Laurasiatheria,Artiodactyla,Ruminantia,Pecora,,,Bovidae,Bovinae,,,Bos,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (33%);GO:0097180 (33%),extracellular space (33%);serine protease inhibitor complex (33%),GO:0004252 (100%);GO:0004175 (33%);GO:0046872 (33%),serine-type endopeptidase activity (100%);endopeptidase activity (33%);metal ion binding (33%),GO:0006508 (33%);GO:0007586 (33%),proteolysis (33%);digestion (33%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
NLLQLLLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,
NPSLLLGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.16 (100%),Succinate-semialdehyde dehydrogenase (NAD(P)(+)) (100%),GO:0016459 (27%);GO:0005576 (7%);GO:0005832 (7%),myosin complex (27%);extracellular region (7%);chaperonin-containing T-complex (7%),GO:0004867 (53%);GO:0005524 (33%);GO:0003774 (27%),serine-type endopeptidase inhibitor activity (53%);ATP binding (33%);motor activity (27%),GO:0030212 (53%);GO:0006457 (7%);GO:0006540 (7%),hyaluronan metabolic process (53%);protein folding (7%);glutamate decarboxylation to succinate (7%),IPR008638 (81%);IPR011050 (81%);IPR012334 (80%),Filamentous haemagglutinin, N-terminal (81%);Pectin lyase fold/virulence factor (81%);Pectin lyase fold (80%)
EHHWVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (67%);GO:0016021 (33%),plasma membrane (67%);integral component of membrane (33%),GO:0015079 (67%);GO:0015299 (33%),potassium ion transmembrane transporter activity (67%);solute:proton antiporter activity (33%),,,IPR003148 (40%);IPR006036 (40%);IPR006037 (40%),Regulator of K+ conductance, N-terminal (40%);Potassium uptake protein TrkA (40%);Regulator of K+ conductance, C-terminal (40%)
GSTVNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.21 (25%);3.1.3.1 (25%);3.2.1.21 (25%),Polo kinase (25%);Alkaline phosphatase (25%);Beta-glucosidase (25%),GO:0016021 (34%);GO:0009279 (4%);GO:0005623 (1%),integral component of membrane (34%);cell outer membrane (4%);cell (1%),GO:0005524 (33%);GO:0016307 (28%);GO:0003677 (16%),ATP binding (33%);phosphatidylinositol phosphate kinase activity (28%);DNA binding (16%),GO:0006310 (11%);GO:0015074 (9%);GO:0006304 (4%),DNA recombination (11%);DNA integration (9%);DNA modification (4%),IPR002498 (23%);IPR027483 (22%);IPR023610 (21%),Phosphatidylinositol-4-phosphate 5-kinase, core (23%);Phosphatidylinositol-4-phosphate 5-kinase, C-terminal (22%);Phosphatidylinositol-4-phosphate 5-kinase (21%)
LLLLVFQEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LALTGEPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.25 (100%),Beta-mannosidase (100%),,,GO:0004553 (67%);GO:0003723 (17%);GO:0004567 (17%),hydrolase activity, hydrolyzing O-glycosyl compounds (67%);RNA binding (17%);beta-mannosidase activity (17%),GO:0005975 (83%);GO:0006396 (17%),carbohydrate metabolic process (83%);RNA processing (17%),IPR006102 (86%);IPR008979 (86%);IPR013783 (86%),Glycoside hydrolase, family 2, immunoglobulin-like beta-sandwich (86%);Galactose-binding-like domain superfamily (86%);Immunoglobulin-like fold (86%)
TAALLALQFGGNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLPLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.15 (19%);7.1.1.- (8%);2.1.1.182 (7%),Alpha,alpha-trehalose-phosphate synthase (UDP-forming) (19%);Hydron translocation or charge separation linked to oxidoreductase reactions (8%);16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase (7%),GO:0016021 (24%);GO:0005737 (11%);GO:0009535 (2%),integral component of membrane (24%);cytoplasm (11%);chloroplast thylakoid membrane (2%),GO:0005524 (15%);GO:0046872 (6%);GO:0003677 (6%),ATP binding (15%);metal ion binding (6%);DNA binding (6%),GO:0005975 (4%);GO:0005992 (4%);GO:0019354 (4%),carbohydrate metabolic process (4%);trehalose biosynthetic process (4%);siroheme biosynthetic process (4%),IPR027417 (11%);IPR036291 (9%);IPR001830 (5%),P-loop containing nucleoside triphosphate hydrolase (11%);NAD(P)-binding domain superfamily (9%);Glycosyl transferase, family 20 (5%)
LLSGLPMEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YDFMQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005887 (40%);GO:0043190 (40%);GO:0005739 (20%),integral component of plasma membrane (40%);ATP-binding cassette (ABC) transporter complex (40%);mitochondrion (20%),GO:0004197 (40%);GO:0042626 (40%);GO:0004672 (20%),cysteine-type endopeptidase activity (40%);ATPase-coupled transmembrane transporter activity (40%);protein kinase activity (20%),GO:0009405 (40%),pathogenesis (40%),IPR001626 (33%);IPR006473 (33%);IPR037294 (33%),ABC transporter, TroCD-like (33%);Peptidase C58, YopT-type domain (33%);ABC transporter, BtuC-like (33%)
SLEALLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (29%);6.1.1.16 (9%);2.7.13.3 (8%),DNA-directed DNA polymerase (29%);Cysteine--tRNA ligase (9%);Histidine kinase (8%),GO:0016021 (24%);GO:0005737 (11%);GO:0005654 (7%),integral component of membrane (24%);cytoplasm (11%);nucleoplasm (7%),GO:0003677 (25%);GO:0005524 (9%);GO:0002020 (7%),DNA binding (25%);ATP binding (9%);protease binding (7%),GO:0006260 (8%);GO:0045786 (7%);GO:0009058 (6%),DNA replication (8%);negative regulation of cell cycle (7%);biosynthetic process (6%),IPR006612 (14%);IPR038441 (12%);IPR001633 (9%),THAP-type zinc finger (14%);THAP-type zinc finger superfamily (12%);EAL domain (9%)
LDSLLADLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (50%),ribosome (50%),GO:0003735 (50%);GO:0003700 (30%);GO:0043565 (30%),structural constituent of ribosome (50%);DNA-binding transcription factor activity (30%);sequence-specific DNA binding (30%),GO:0006412 (50%);GO:0000160 (30%);GO:0005975 (10%),translation (50%);phosphorelay signal transduction system (30%);carbohydrate metabolic process (10%),IPR000039 (50%);IPR001196 (50%);IPR021131 (50%),Ribosomal protein L18e (50%);Ribosomal protein L15, conserved site (50%);Ribosomal protein L18e/L15P (50%)
AVDAGLPGTPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLVSLPGQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVQVFSR,Arthrobacter,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,Micrococcales,,,,,Micrococcaceae,,,,Arthrobacter,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR018076 (100%);IPR042094 (100%),Type II secretion system F domain (100%);Type II secretion system F domain superfamily (100%)
SFLVLSVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLEELEEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.100 (14%);1.2.4.1 (14%);2.1.2.2 (14%),3-oxoacyl-[acyl-carrier-protein] reductase (14%);Pyruvate dehydrogenase (acetyl-transferring) (14%);Phosphoribosylglycinamide formyltransferase (14%),GO:0005829 (11%);GO:0010494 (11%);GO:0016021 (9%),cytosol (11%);cytoplasmic stress granule (11%);integral component of membrane (9%),GO:0003723 (70%);GO:0003677 (8%);GO:0005524 (8%),RNA binding (70%);DNA binding (8%);ATP binding (8%),GO:0034063 (70%);GO:0051260 (11%);GO:0062029 (11%),stress granule assembly (70%);protein homooligomerization (11%);positive regulation of stress granule assembly (11%),IPR034377 (53%);IPR039539 (53%);IPR000504 (52%),Ras GTPase-activating protein-binding protein 2 (53%);Ras GTPase-activating protein-binding protein (53%);RNA recognition motif domain (52%)
QFLLNTLR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.21 (100%),Histidine--tRNA ligase (100%),GO:0005737 (50%),cytoplasm (50%),GO:0003677 (50%);GO:0003917 (50%);GO:0004821 (50%),DNA binding (50%);DNA topoisomerase type I (single strand cut, ATP-independent) activity (50%);histidine-tRNA ligase activity (50%),GO:0006265 (50%);GO:0006427 (50%),DNA topological change (50%);histidyl-tRNA aminoacylation (50%),IPR000380 (50%);IPR003601 (50%);IPR003602 (50%),DNA topoisomerase, type IA (50%);DNA topoisomerase, type IA, domain 2 (50%);DNA topoisomerase, type IA, DNA-binding domain (50%)
VLPAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.- (21%);1.-.-.- (9%);1.1.1.44 (6%),Hexosyltransferases (21%);Oxidoreductases (9%);Phosphogluconate dehydrogenase (NADP(+)-dependent, decarboxylating) (6%),GO:0016021 (7%);GO:0072687 (6%);GO:0005634 (2%),integral component of membrane (7%);meiotic spindle (6%);nucleus (2%),GO:0003676 (47%);GO:0016491 (7%);GO:0071949 (6%),nucleic acid binding (47%);oxidoreductase activity (7%);FAD binding (6%),GO:0031047 (49%);GO:0007283 (6%);GO:2001252 (6%),gene silencing by RNA (49%);spermatogenesis (6%);positive regulation of chromosome organization (6%),IPR032472 (43%);IPR036085 (42%);IPR012337 (41%),Argonaute linker 2 domain (43%);PAZ domain superfamily (42%);Ribonuclease H-like superfamily (41%)
PAAALLVLLFLNLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVPVSANK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFVGSTFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLLGLVSLHLWNQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPLTYNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.89 (98%);3.4.21.- (2%),Signal peptidase I (98%);Serine endopeptidases (2%),GO:0016021 (98%);GO:0009507 (2%);GO:0009570 (2%),integral component of membrane (98%);chloroplast (2%);chloroplast stroma (2%),GO:0008236 (86%);GO:0008233 (11%);GO:0008138 (2%),serine-type peptidase activity (86%);peptidase activity (11%);protein tyrosine/serine/threonine phosphatase activity (2%),GO:0005983 (2%);GO:0007623 (2%);GO:0046838 (2%),starch catabolic process (2%);circadian rhythm (2%);phosphorylated carbohydrate dephosphorylation (2%),IPR000223 (92%);IPR015927 (92%);IPR019756 (92%),Peptidase S26A, signal peptidase I (92%);Peptidase S24/S26A/S26B/S26C (92%);Peptidase S26A, signal peptidase I, serine active site (92%)
ANPDPHGS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPYQVSLNSG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSGGSS,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.25.1 (100%),Proteasome endopeptidase complex (100%),GO:0016021 (50%);GO:0005634 (17%);GO:0005737 (17%),integral component of membrane (50%);nucleus (17%);cytoplasm (17%),GO:0000155 (17%);GO:0003677 (17%);GO:0003824 (17%),phosphorelay sensor kinase activity (17%);DNA binding (17%);catalytic activity (17%),GO:0006511 (17%),ubiquitin-dependent protein catabolic process (17%),IPR010657 (33%);IPR000426 (17%);IPR001353 (17%),ImpA, N-terminal (33%);Proteasome alpha-subunit, N-terminal domain (17%);Proteasome, subunit alpha/beta (17%)
ATLGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.2.2 (75%);2.7.7.85 (1%);3.6.3.14 (1%),H(+)-transporting two-sector ATPase (75%);Diadenylate cyclase (1%);Transferred entry: 7.1.2.2 (1%),GO:0045261 (29%);GO:0005886 (25%);GO:0016021 (16%),proton-transporting ATP synthase complex, catalytic core F(1) (29%);plasma membrane (25%);integral component of membrane (16%),GO:0005524 (43%);GO:0046933 (31%);GO:0003677 (8%),ATP binding (43%);proton-transporting ATP synthase activity, rotational mechanism (31%);DNA binding (8%),GO:0015986 (30%);GO:0006310 (1%);GO:0015074 (1%),ATP synthesis coupled proton transport (30%);DNA recombination (1%);DNA integration (1%),IPR027417 (37%);IPR000194 (30%);IPR003593 (28%),P-loop containing nucleoside triphosphate hydrolase (37%);ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain (30%);AAA+ ATPase domain (28%)
ANGVMVGQVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PVGFGTLGFALPAGLGAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QQWLALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.181 (50%);3.6.4.- (50%),23S rRNA (adenine(1618)-N(6))-methyltransferase (50%);Acting on ATP; involved in cellular and subcellular movement (50%),GO:0005737 (29%);GO:0016021 (14%);GO:0042597 (14%),cytoplasm (29%);integral component of membrane (14%);periplasmic space (14%),GO:0016787 (29%);GO:0003682 (14%);GO:0003684 (14%),hydrolase activity (29%);chromatin binding (14%);damaged DNA binding (14%),GO:0000716 (14%);GO:0006355 (14%);GO:0015889 (14%),transcription-coupled nucleotide-excision repair, DNA damage recognition (14%);regulation of transcription, DNA-templated (14%);cobalamin transport (14%),IPR003598 (36%);IPR003599 (36%);IPR007110 (36%),Immunoglobulin subtype 2 (36%);Immunoglobulin subtype (36%);Immunoglobulin-like domain (36%)
LPYQVSLNSG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFGPNAFGGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GQGGGQGGR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (17%);GO:0015935 (17%),cytoplasm (17%);small ribosomal subunit (17%),GO:0003676 (33%);GO:0003743 (33%);GO:0003735 (17%),nucleic acid binding (33%);translation initiation factor activity (33%);structural constituent of ribosome (17%),GO:0006139 (17%);GO:0006412 (17%),nucleobase-containing compound metabolic process (17%);translation (17%),IPR006847 (33%);IPR027417 (33%);IPR000178 (17%),Translation initiation factor IF-2, N-terminal (33%);P-loop containing nucleoside triphosphate hydrolase (33%);Translation initiation factor aIF-2, bacterial-like (17%)
VATTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.4.2 (20%);3.6.4.12 (9%);2.1.1.163 (6%),Adenine deaminase (20%);DNA helicase (9%);Demethylmenaquinone methyltransferase (6%),GO:0005737 (73%);GO:0016021 (5%);GO:0016020 (1%),cytoplasm (73%);integral component of membrane (5%);membrane (1%),GO:0003677 (80%);GO:0016987 (78%);GO:0003700 (73%),DNA binding (80%);sigma factor activity (78%);DNA-binding transcription factor activity (73%),GO:0001123 (72%);GO:0009408 (72%);GO:0006352 (5%),transcription initiation from bacterial-type RNA polymerase promoter (72%);response to heat (72%);DNA-templated transcription, initiation (5%),IPR000943 (74%);IPR014284 (74%);IPR013325 (74%),RNA polymerase sigma-70 (74%);RNA polymerase sigma-70 like domain (74%);RNA polymerase sigma factor, region 2 (74%)
TNNPTML,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EQPTAPGSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SGAAMAQYSQDQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PNHPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPAQNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.3.1.12 (75%);3.6.4.- (25%),Ornithine cyclodeaminase (75%);Acting on ATP; involved in cellular and subcellular movement (25%),GO:0016021 (27%);GO:0036064 (9%),integral component of membrane (27%);ciliary basal body (9%),GO:0008473 (27%);GO:0003723 (18%);GO:0005524 (18%),ornithine cyclodeaminase activity (27%);RNA binding (18%);ATP binding (18%),GO:0055085 (18%);GO:0006306 (9%);GO:0006353 (9%),transmembrane transport (18%);DNA methylation (9%);DNA-templated transcription, termination (9%),IPR003462 (44%);IPR023401 (44%);IPR036291 (44%),Ornithine cyclodeaminase/mu-crystallin (44%);Ornithine cyclodeaminase, N-terminal (44%);NAD(P)-binding domain superfamily (44%)
QGLEAQDLSLFSLLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GGGLSGAGQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GGSGGS,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (33%),integral component of membrane (33%),GO:0003676 (67%),nucleic acid binding (67%),,,IPR012337 (50%);IPR036397 (50%);IPR021400 (25%),Ribonuclease H-like superfamily (50%);Ribonuclease H superfamily (50%);Protein of unknown function DUF3039 (25%)
LYLVFTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (30%);GO:0005634 (10%);GO:0008023 (10%),integral component of membrane (30%);nucleus (10%);transcription elongation factor complex (10%),GO:0008168 (50%),methyltransferase activity (50%),GO:0032259 (50%);GO:0006338 (10%);GO:0006368 (10%),methylation (50%);chromatin remodeling (10%);transcription elongation from RNA polymerase II promoter (10%),IPR001525 (56%);IPR029063 (56%);IPR001611 (11%),C-5 cytosine methyltransferase (56%);S-adenosyl-L-methionine-dependent methyltransferase (56%);Leucine-rich repeat (11%)
TLLDLALK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.7 (74%);3.6.1.22 (13%);1.17.7.3 (9%),DNA-directed DNA polymerase (74%);NAD(+) diphosphatase (13%);(E)-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase (flavodoxin) (9%),GO:0005737 (39%);GO:0005840 (14%);GO:0015934 (8%),cytoplasm (39%);ribosome (14%);large ribosomal subunit (8%),GO:0005524 (26%);GO:0043565 (24%);GO:0000156 (24%),ATP binding (26%);sequence-specific DNA binding (24%);phosphorelay response regulator activity (24%),GO:0006355 (24%);GO:0006808 (24%);GO:0009399 (24%),regulation of transcription, DNA-templated (24%);regulation of nitrogen utilization (24%);nitrogen fixation (24%),IPR009057 (27%);IPR002197 (25%);IPR001789 (24%),Homeobox-like domain superfamily (27%);DNA binding HTH domain,  Fis-type (25%);Signal transduction response regulator, receiver domain (24%)
AFMTDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.-.- (60%);2.1.1.297 (20%);6.3.5.11 (20%),Glycosylases (60%);Peptide chain release factor N(5)-glutamine methyltransferase (20%);Cobyrinate a,c-diamide synthase (glutamine-hydrolyzing) (20%),GO:0016021 (23%);GO:0005886 (15%);GO:0031012 (3%),integral component of membrane (23%);plasma membrane (15%);extracellular matrix (3%),GO:0016740 (31%);GO:0008233 (23%);GO:0022857 (18%),transferase activity (31%);peptidase activity (23%);transmembrane transporter activity (18%),GO:0006541 (33%);GO:0071705 (15%);GO:0009236 (5%),glutamine metabolic process (33%);nitrogen compound transport (15%);cobalamin biosynthetic process (5%),IPR029062 (60%);IPR002818 (58%);IPR006286 (58%),Class I glutamine amidotransferase-like (60%);DJ-1/PfpI (58%);Deglycase PfpI (58%)
QEGALDFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GGPPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.296 (19%);2.1.1.56 (19%);2.7.7.48 (19%),Methyltransferase cap2 (19%);mRNA (guanine-N(7)-)-methyltransferase (19%);RNA-directed RNA polymerase (19%),GO:0016021 (18%);GO:0005634 (7%);GO:0005737 (4%),integral component of membrane (18%);nucleus (7%);cytoplasm (4%),GO:0003723 (25%);GO:0005524 (17%);GO:0003676 (9%),RNA binding (25%);ATP binding (17%);nucleic acid binding (9%),GO:0006401 (5%);GO:0006364 (4%);GO:0006397 (2%),RNA catabolic process (5%);rRNA processing (4%);mRNA processing (2%),IPR012677 (10%);IPR035979 (10%);IPR027417 (10%),Nucleotide-binding alpha-beta plait domain superfamily (10%);RNA-binding domain superfamily (10%);P-loop containing nucleoside triphosphate hydrolase (10%)
VGHVPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.-.- (22%);5.1.1.3 (22%);5.2.1.8 (22%),Acting on ester bonds (22%);Glutamate racemase (22%);Peptidylprolyl isomerase (22%),GO:0016021 (14%);GO:0005737 (11%);GO:0005634 (3%),integral component of membrane (14%);cytoplasm (11%);nucleus (3%),GO:0003677 (8%);GO:0005524 (8%);GO:0008324 (8%),DNA binding (8%);ATP binding (8%);cation transmembrane transporter activity (8%),GO:0043571 (32%);GO:0006457 (5%);GO:0007049 (5%),maintenance of CRISPR repeat elements (32%);protein folding (5%);cell cycle (5%),IPR007139 (31%);IPR006482 (15%);IPR013419 (15%),Protein of unknown function DUF349 (31%);CRISPR-associated protein Cas7, subtype I-B/I-C (15%);CRISPR-associated protein Csh2 (15%)
NYYNYVTLLNLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGVLLSR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (23%);3.1.4.46 (15%);1.1.1.100 (8%),DNA helicase (23%);Glycerophosphodiester phosphodiesterase (15%);3-oxoacyl-[acyl-carrier-protein] reductase (8%),GO:0016021 (10%);GO:0005840 (3%);GO:0030286 (2%),integral component of membrane (10%);ribosome (3%);dynein complex (2%),GO:0003677 (34%);GO:0005524 (19%);GO:0003964 (16%),DNA binding (34%);ATP binding (19%);RNA-directed DNA polymerase activity (16%),GO:0006355 (30%);GO:0000160 (23%);GO:0006412 (3%),regulation of transcription, DNA-templated (30%);phosphorelay signal transduction system (23%);translation (3%),IPR001789 (20%);IPR011006 (20%);IPR036388 (19%),Signal transduction response regulator, receiver domain (20%);CheY-like superfamily (20%);Winged helix-like DNA-binding domain superfamily (19%)
LYNGAADALEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGNSLTWR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLSDAEQR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003824 (50%);GO:0016853 (50%);GO:0046872 (50%),catalytic activity (50%);isomerase activity (50%);metal ion binding (50%),,,IPR000380 (50%);IPR003601 (50%);IPR003602 (50%),DNA topoisomerase, type IA (50%);DNA topoisomerase, type IA, domain 2 (50%);DNA topoisomerase, type IA, DNA-binding domain (50%)
NGELLVVR,Natrialba aegyptia,Archaea,,,,Euryarchaeota,,,Halobacteria,,,,Natrialbales,,,,,Natrialbaceae,,,,Natrialba,,,,Natrialba aegyptia,,,,,,,,GO:0008410 (100%),CoA-transferase activity (100%),,,IPR003673 (100%);IPR023606 (100%),CoA-transferase family III (100%);CoA-transferase family III domain superfamily (100%)
LLANNGPTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NALKPPSK,Trichoderma arundinaceum,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,Hypocreomycetidae,,,Hypocreales,,,,,Hypocreaceae,,,,Trichoderma,,,,Trichoderma arundinaceum,,,,,,,,,,,,,
HLSNEGDLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GYLLLGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (24%);GO:0005765 (19%);GO:0030897 (19%),integral component of membrane (24%);lysosomal membrane (19%);HOPS complex (19%),GO:0046872 (19%);GO:0003676 (14%);GO:0016756 (14%),metal ion binding (19%);nucleic acid binding (14%);glutathione gamma-glutamylcysteinyltransferase activity (14%),GO:0006886 (24%);GO:0007033 (19%);GO:0010038 (14%),intracellular protein transport (24%);vacuole organization (19%);response to metal ion (14%),IPR038765 (30%);IPR000668 (21%);IPR013201 (21%),Papain-like cysteine peptidase superfamily (30%);Peptidase C1A, papain C-terminal (21%);Cathepsin propeptide inhibitor domain (I29) (21%)
HQGLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.2.3 (17%);3.6.4.13 (17%);4.3.1.19 (6%),Dihydroorotase (17%);RNA helicase (17%);Threonine ammonia-lyase (6%),GO:0016021 (19%);GO:0005634 (12%);GO:0005737 (9%),integral component of membrane (19%);nucleus (12%);cytoplasm (9%),GO:0005524 (26%);GO:0003677 (17%);GO:0004677 (11%),ATP binding (26%);DNA binding (17%);DNA-dependent protein kinase activity (11%),GO:0006303 (11%);GO:0044205 (4%);GO:0006401 (4%),double-strand break repair via nonhomologous end joining (11%);'de novo' UMP biosynthetic process (4%);RNA catabolic process (4%),IPR019179 (11%);IPR027417 (11%);IPR016024 (10%),Coiled-coil domain-containing protein 149-A (11%);P-loop containing nucleoside triphosphate hydrolase (11%);Armadillo-type fold (10%)
DSLSFSLFGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TEELNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.9 (29%);2.7.7.7 (12%);3.4.19.12 (10%),UTP--glucose-1-phosphate uridylyltransferase (29%);DNA-directed DNA polymerase (12%);Ubiquitinyl hydrolase 1 (10%),GO:0005882 (36%);GO:0016021 (31%);GO:0030054 (21%),intermediate filament (36%);integral component of membrane (31%);cell junction (21%),GO:0005198 (37%);GO:0004970 (21%);GO:0005524 (8%),structural molecule activity (37%);ionotropic glutamate receptor activity (21%);ATP binding (8%),GO:0097190 (6%);GO:1901222 (6%);GO:0007165 (4%),apoptotic signaling pathway (6%);regulation of NIK/NF-kappaB signaling (6%);signal transduction (4%),IPR039008 (37%);IPR002957 (37%);IPR042180 (36%),Intermediate filament, rod domain (37%);Keratin, type I (37%);Intermediate filament, rod domain, coil 1B (36%)
LAALPLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (56%);GO:0009295 (56%);GO:0005623 (11%),cytoplasm (56%);nucleoid (56%);cell (11%),GO:0003677 (56%);GO:0003700 (56%);GO:0003713 (11%),DNA binding (56%);DNA-binding transcription factor activity (56%);transcription coactivator activity (11%),GO:0051301 (44%);GO:0007165 (22%);GO:0006879 (11%),cell division (44%);signal transduction (22%);cellular iron ion homeostasis (11%),IPR003444 (42%);IPR007159 (42%);IPR020603 (42%),Transcriptional regulator MraZ (42%);SpoVT-AbrB domain (42%);MraZ domain (42%)
DGSVDVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.26.5 (100%),Ribonuclease P (100%),GO:0005737 (38%);GO:0005634 (16%);GO:0030677 (14%),cytoplasm (38%);nucleus (16%);ribonuclease P complex (14%),GO:0003746 (24%);GO:0000981 (16%);GO:0003677 (16%),translation elongation factor activity (24%);DNA-binding transcription factor activity, RNA polymerase II-specific (16%);DNA binding (16%),GO:0006351 (16%);GO:0001682 (14%);GO:0032955 (5%),transcription, DNA-templated (16%);tRNA 5'-leader removal (14%);regulation of division septum assembly (5%),IPR001816 (24%);IPR014039 (24%);IPR036402 (24%),Translation elongation factor EFTs/EF1B (24%);Translation elongation factor EFTs/EF1B, dimerisation (24%);Elongation factor Ts, dimerisation domain superfamily (24%)
YSTDSAQSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NTLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.11 (22%);3.6.4.12 (5%);3.1.-.- (4%),Serine--tRNA ligase (22%);DNA helicase (5%);Acting on ester bonds (4%),GO:0016021 (22%);GO:0005737 (9%);GO:0005886 (2%),integral component of membrane (22%);cytoplasm (9%);plasma membrane (2%),GO:0005524 (19%);GO:0003677 (15%);GO:0003700 (8%),ATP binding (19%);DNA binding (15%);DNA-binding transcription factor activity (8%),GO:0006355 (5%);GO:0007165 (5%);GO:0006434 (4%),regulation of transcription, DNA-templated (5%);signal transduction (5%);seryl-tRNA aminoacylation (4%),IPR036388 (7%);IPR027417 (7%);IPR036390 (7%),Winged helix-like DNA-binding domain superfamily (7%);P-loop containing nucleoside triphosphate hydrolase (7%);Winged helix DNA-binding domain superfamily (7%)
FLEVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (21%);2.3.1.1 (8%);2.3.1.35 (8%),Histidine kinase (21%);Amino-acid N-acetyltransferase (8%);Glutamate N-acetyltransferase (8%),GO:0016021 (21%);GO:0005737 (10%);GO:0009380 (6%),integral component of membrane (21%);cytoplasm (10%);excinuclease repair complex (6%),GO:0005524 (22%);GO:0003677 (12%);GO:0016887 (8%),ATP binding (22%);DNA binding (12%);ATPase activity (8%),GO:0006289 (7%);GO:0009432 (6%);GO:0009306 (4%),nucleotide-excision repair (7%);SOS response (6%);protein secretion (4%),IPR027417 (15%);IPR003439 (7%);IPR017871 (6%),P-loop containing nucleoside triphosphate hydrolase (15%);ABC transporter-like (7%);ABC transporter, conserved site (6%)
LLSLGNLPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSPSLLEDL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SAAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (10%);2.1.1.266 (7%);2.1.3.15 (7%),DNA helicase (10%);23S rRNA (adenine(2030)-N(6))-methyltransferase (7%);Acetyl-CoA carboxytransferase (7%),GO:0016021 (23%);GO:0005737 (9%);GO:0005886 (5%),integral component of membrane (23%);cytoplasm (9%);plasma membrane (5%),GO:0005524 (15%);GO:0003677 (11%);GO:0046872 (6%),ATP binding (15%);DNA binding (11%);metal ion binding (6%),GO:0006412 (2%);GO:0000398 (2%);GO:0006355 (2%),translation (2%);mRNA splicing, via spliceosome (2%);regulation of transcription, DNA-templated (2%),IPR027417 (9%);IPR015943 (3%);IPR036322 (3%),P-loop containing nucleoside triphosphate hydrolase (9%);WD40/YVTN repeat-like-containing domain superfamily (3%);WD40-repeat-containing domain superfamily (3%)
SAVVSGGSR,Cavia porcellus,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Euarchontoglires,Rodentia,Hystricomorpha,,,,Caviidae,,,,Cavia,,,,Cavia porcellus,,,,,,GO:0045095 (100%),keratin filament (100%),,,GO:0045104 (100%),intermediate filament cytoskeleton organization (100%),IPR003054 (100%);IPR018039 (100%);IPR032444 (100%),Keratin, type II (100%);Intermediate filament protein, conserved site (100%);Keratin type II head (100%)
SQLLPVVK,Fibrobacteres bacterium,Bacteria,,,,Fibrobacteres,,,,,,,,,,,,,,,,,,,,Fibrobacteres bacterium,,,,,,,,,,,,IPR036737 (100%),OmpA-like domain superfamily (100%)
LVVVPAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,GO:0031204 (83%),posttranslational protein targeting to membrane, translocation (83%),IPR001623 (83%);IPR004179 (83%);IPR014756 (83%),DnaJ domain (83%);Sec63 domain (83%);Immunoglobulin E-set (83%)
LPVALTQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLPPLLFLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VTLAGEAPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLPPNLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.129 (41%);5.3.1.24 (37%);2.1.1.297 (22%),Peptidoglycan glycosyltransferase (41%);Phosphoribosylanthranilate isomerase (37%);Peptide chain release factor N(5)-glutamine methyltransferase (22%),GO:0005887 (27%);GO:0016021 (5%);GO:0000786 (2%),integral component of plasma membrane (27%);integral component of membrane (5%);nucleosome (2%),GO:0008955 (27%);GO:0004640 (22%);GO:0003676 (20%),peptidoglycan glycosyltransferase activity (27%);phosphoribosylanthranilate isomerase activity (22%);nucleic acid binding (20%),GO:0008360 (27%);GO:0009252 (27%);GO:0051301 (27%),regulation of cell shape (27%);peptidoglycan biosynthetic process (27%);cell division (27%),IPR001182 (22%);IPR011923 (22%);IPR018365 (22%),Probable peptidoglycan glycosyltransferase FtsW/RodA (22%);Probable peptidoglycan glycosyltransferase RodA/MrdB (22%);Cell cycle, FtsW / RodA / SpoVE, conserved site (22%)
GFSVTNQYQDLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVPFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.- (49%);6.1.1.5 (14%);2.6.1.42 (6%),In phosphorus-containing anhydrides (49%);Isoleucine--tRNA ligase (14%);Branched-chain-amino-acid transaminase (6%),GO:0016021 (17%);GO:0005737 (10%);GO:0043190 (2%),integral component of membrane (17%);cytoplasm (10%);ATP-binding cassette (ABC) transporter complex (2%),GO:0016818 (15%);GO:0005524 (14%);GO:0008270 (7%),hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides (15%);ATP binding (14%);zinc ion binding (7%),GO:0006428 (5%);GO:0006797 (4%);GO:0055085 (3%),isoleucyl-tRNA aminoacylation (5%);polyphosphate metabolic process (4%);transmembrane transport (3%),IPR015797 (17%);IPR000086 (17%);IPR022927 (16%),NUDIX hydrolase-like domain superfamily (17%);NUDIX hydrolase domain (17%);RNA pyrophosphohydrolase RppH (16%)
VQPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.250 (16%);3.1.1.61 (7%);1.3.98.3 (7%),D-inositol-3-phosphate glycosyltransferase (16%);Protein-glutamate methylesterase (7%);Coproporphyrinogen dehydrogenase (7%),GO:0016021 (21%);GO:0005737 (10%);GO:0005840 (7%),integral component of membrane (21%);cytoplasm (10%);ribosome (7%),GO:0046872 (12%);GO:0003735 (9%);GO:0005524 (8%),metal ion binding (12%);structural constituent of ribosome (9%);ATP binding (8%),GO:0006412 (7%);GO:0006511 (6%);GO:0016579 (6%),translation (7%);ubiquitin-dependent protein catabolic process (6%);protein deubiquitination (6%),IPR012340 (7%);IPR000289 (7%);IPR001296 (7%),Nucleic acid-binding, OB-fold (7%);Ribosomal protein S28e (7%);Glycosyl transferase, family 1 (7%)
QLLSPQAK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0003824 (50%),catalytic activity (50%),,,IPR004328 (50%);IPR008928 (50%);IPR012341 (50%),BRO1 domain (50%);Six-hairpin glycosidase superfamily (50%);Six-hairpin glycosidase-like superfamily (50%)
FEVMTANNVVLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AHPELGVVLADDGLQHVHLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAFTEEELK,Desulfuromonas,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,Desulfuromonadales,,,,,Desulfuromonadaceae,,,,Desulfuromonas,,,,,,,,,,,,GO:0030170 (100%),pyridoxal phosphate binding (100%),GO:0006520 (100%),cellular amino acid metabolic process (100%),IPR000634 (100%);IPR001926 (100%);IPR004450 (100%),Serine/threonine dehydratase, pyridoxal-phosphate-binding site (100%);Pyridoxal-phosphate dependent enzyme (100%);Threonine synthase-like (100%)
CYTNGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),GO:0004372 (50%);GO:0008168 (50%);GO:0030170 (50%),glycine hydroxymethyltransferase activity (50%);methyltransferase activity (50%);pyridoxal phosphate binding (50%),GO:0019264 (50%);GO:0032259 (50%);GO:0035999 (50%),glycine biosynthetic process from serine (50%);methylation (50%);tetrahydrofolate interconversion (50%),IPR001085 (50%);IPR015422 (50%);IPR015424 (50%),Serine hydroxymethyltransferase (50%);Pyridoxal phosphate-dependent transferase domain 1 (50%);Pyridoxal phosphate-dependent transferase (50%)
LNWLLLSK,Paramecium tetraurelia,Eukaryota,,,,Ciliophora,Intramacronucleata,,Oligohymenophorea,,,,Peniculida,,,,,Parameciidae,,,,Paramecium,,,,Paramecium tetraurelia,,,,,,,,GO:0004672 (100%);GO:0005524 (100%),protein kinase activity (100%);ATP binding (100%),,,IPR000719 (100%);IPR008271 (100%);IPR011009 (100%),Protein kinase domain (100%);Serine/threonine-protein kinase, active site (100%);Protein kinase-like domain superfamily (100%)
TAATQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.13.239 (38%);1.6.5.11 (24%);1.6.99.5 (6%),Carnitine monooxygenase (38%);NADH dehydrogenase (quinone) (24%);Transferred entry: 1.6.5.11 (6%),GO:0016021 (47%);GO:0005737 (6%);GO:0005886 (5%),integral component of membrane (47%);cytoplasm (6%);plasma membrane (5%),GO:0008137 (20%);GO:0003677 (14%);GO:0005524 (12%),NADH dehydrogenase (ubiquinone) activity (20%);DNA binding (14%);ATP binding (12%),GO:0042773 (20%);GO:0009437 (7%);GO:0006396 (3%),ATP synthesis coupled electron transport (20%);carnitine metabolic process (7%);RNA processing (3%),IPR001750 (17%);IPR003918 (17%);IPR010227 (17%),NADH:quinone oxidoreductase/Mrp antiporter, membrane subunit (17%);NADH:ubiquinone oxidoreductase (17%);NADH-quinone oxidoreductase, chain M/4 (17%)
EVPVFVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.- (100%),Aminopeptidases (100%),GO:0042555 (25%),MCM complex (25%),GO:0003677 (50%);GO:0004177 (25%);GO:0005524 (25%),DNA binding (50%);aminopeptidase activity (25%);ATP binding (25%),GO:0006270 (25%);GO:0006306 (25%);GO:0009294 (25%),DNA replication initiation (25%);DNA methylation (25%);DNA mediated transformation (25%),IPR000787 (25%);IPR001208 (25%);IPR002052 (25%),Peptidase M29 (25%);MCM domain (25%);DNA methylase, N-6 adenine-specific, conserved site (25%)
NSLPYQVSLNS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLAQGGPELGMYLQQHGYEHASY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAQPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (14%);3.1.-.- (13%);2.3.3.9 (13%),DNA helicase (14%);Acting on ester bonds (13%);Malate synthase (13%),GO:0009279 (34%);GO:0046930 (30%);GO:0016021 (14%),cell outer membrane (34%);pore complex (30%);integral component of membrane (14%),GO:0015288 (33%);GO:0005198 (33%);GO:0005524 (11%),porin activity (33%);structural molecule activity (33%);ATP binding (11%),GO:0006811 (30%);GO:0006097 (2%);GO:0006099 (2%),ion transport (30%);glyoxylate cycle (2%);tricarboxylic acid cycle (2%),IPR000604 (31%);IPR035979 (6%);IPR012677 (6%),Major outer membrane protein, Chlamydia (31%);RNA-binding domain superfamily (6%);Nucleotide-binding alpha-beta plait domain superfamily (6%)
QANATK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.13 (36%);3.1.-.- (21%);3.4.24.- (21%),RNA helicase (36%);Acting on ester bonds (21%);Metalloendopeptidases (21%),GO:0016021 (24%);GO:0005886 (10%);GO:0005576 (6%),integral component of membrane (24%);plasma membrane (10%);extracellular region (6%),GO:0005524 (24%);GO:0046872 (12%);GO:0003724 (10%),ATP binding (24%);metal ion binding (12%);RNA helicase activity (10%),GO:0015031 (6%);GO:0033567 (6%);GO:0006412 (4%),protein transport (6%);DNA replication, Okazaki fragment processing (6%);translation (4%),IPR027417 (21%);IPR006427 (9%);IPR006944 (9%),P-loop containing nucleoside triphosphate hydrolase (21%);Phage portal protein, HK97 (9%);Bacteriophage/Gene transfer agent portal protein (9%)
LLGEGLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (15%);2.5.1.78 (12%);2.3.2.27 (9%),Transferring other groups (15%);6,7-dimethyl-8-ribityllumazine synthase (12%);RING-type E3 ubiquitin transferase (9%),GO:0016021 (22%);GO:0001650 (2%);GO:0005886 (2%),integral component of membrane (22%);fibrillar center (2%);plasma membrane (2%),GO:0005524 (22%);GO:0016887 (11%);GO:0003677 (10%),ATP binding (22%);ATPase activity (11%);DNA binding (10%),GO:0015833 (8%);GO:0006355 (7%);GO:0000160 (5%),peptide transport (8%);regulation of transcription, DNA-templated (7%);phosphorelay signal transduction system (5%),IPR027417 (14%);IPR003593 (11%);IPR003439 (10%),P-loop containing nucleoside triphosphate hydrolase (14%);AAA+ ATPase domain (11%);ABC transporter-like (10%)
VTGLSLNGVG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALLLLGGLLGLVLFN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTLGTPLSQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MDLNLSLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TALDLLDSVSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPFLLVVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLEMLLNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.- (100%),Transferring alkyl or aryl groups, other than methyl groups (100%),GO:0016021 (33%);GO:0005886 (17%),integral component of membrane (33%);plasma membrane (17%),GO:0000155 (17%);GO:0003677 (17%);GO:0003700 (17%),phosphorelay sensor kinase activity (17%);DNA binding (17%);DNA-binding transcription factor activity (17%),GO:0005975 (17%);GO:0009401 (17%);GO:0070329 (17%),carbohydrate metabolic process (17%);phosphoenolpyruvate-dependent sugar phosphotransferase system (17%);tRNA seleno-modification (17%),IPR000160 (13%);IPR000524 (13%);IPR001279 (13%),GGDEF domain (13%);Transcription regulator HTH, GntR (13%);Metallo-beta-lactamase (13%)
ETSLGFATNLHADDPSTPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MFVQSHTLGVDL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NWSDNLLMLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GYQPLYLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.5.1.88 (8%);2.1.1.354 (7%);4.1.1.50 (6%),Peptide deformylase (8%);[Histone H3]-lysine(4) N-trimethyltransferase (7%);Adenosylmethionine decarboxylase (6%),GO:0016021 (30%);GO:0005737 (7%);GO:0005886 (6%),integral component of membrane (30%);cytoplasm (7%);plasma membrane (6%),GO:0005524 (10%);GO:0003677 (8%);GO:0046872 (6%),ATP binding (10%);DNA binding (8%);metal ion binding (6%),GO:0006412 (3%);GO:0009306 (3%);GO:0044780 (2%),translation (3%);protein secretion (3%);bacterial-type flagellum assembly (2%),IPR027417 (9%);IPR036388 (4%);IPR036390 (4%),P-loop containing nucleoside triphosphate hydrolase (9%);Winged helix-like DNA-binding domain superfamily (4%);Winged helix DNA-binding domain superfamily (4%)
SHFCGGSLLN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVNSFNLAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAQMAELDYMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DGVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.2.10 (6%);2.4.99.17 (4%);1.17.4.1 (4%),UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (6%);S-adenosylmethionine:tRNA ribosyltransferase-isomerase (4%);Ribonucleoside-diphosphate reductase (4%),GO:0016021 (19%);GO:0005737 (11%);GO:0005886 (8%),integral component of membrane (19%);cytoplasm (11%);plasma membrane (8%),GO:0005524 (19%);GO:0016491 (10%);GO:0008270 (9%),ATP binding (19%);oxidoreductase activity (10%);zinc ion binding (9%),GO:0070395 (4%);GO:0071555 (2%);GO:0008360 (2%),lipoteichoic acid biosynthetic process (4%);cell wall organization (2%);regulation of cell shape (2%),IPR036291 (8%);IPR027417 (8%);IPR011032 (6%),NAD(P)-binding domain superfamily (8%);P-loop containing nucleoside triphosphate hydrolase (8%);GroES-like superfamily (6%)
GATCTLK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR012332 (100%),P22 tailspike-like, C-terminal domain superfamily (100%)
AYLQGDTLSDGVFL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAGGAYTPETGAGK,Methanococcales,Archaea,,,,Euryarchaeota,,,Methanococci,,,,Methanococcales,,,,,,,,,,,,,,,,,,,GO:0005840 (100%),ribosome (100%),GO:0003735 (100%);GO:0008270 (100%);GO:0070180 (100%),structural constituent of ribosome (100%);zinc ion binding (100%);large ribosomal subunit rRNA binding (100%),GO:0006412 (100%),translation (100%),IPR002674 (100%);IPR011331 (100%);IPR011332 (100%),Ribosomal protein L37ae (100%);Ribosomal protein L37ae/L37e (100%);Zinc-binding ribosomal protein (100%)
LEAAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.2.11 (12%);6.1.1.14 (8%);3.4.21.53 (6%),Glutamate 5-kinase (12%);Glycine--tRNA ligase (8%);Endopeptidase La (6%),GO:0016021 (23%);GO:0005737 (11%);GO:0005634 (3%),integral component of membrane (23%);cytoplasm (11%);nucleus (3%),GO:0005524 (19%);GO:0043565 (8%);GO:0003700 (7%),ATP binding (19%);sequence-specific DNA binding (8%);DNA-binding transcription factor activity (7%),GO:0006355 (3%);GO:0055129 (2%);GO:0007018 (2%),regulation of transcription, DNA-templated (3%);L-proline biosynthetic process (2%);microtubule-based movement (2%),IPR027417 (11%);IPR009057 (6%);IPR036465 (6%),P-loop containing nucleoside triphosphate hydrolase (11%);Homeobox-like domain superfamily (6%);von Willebrand factor A-like domain superfamily (6%)
NVSTKPK,Sporothrix insectorum,Eukaryota,Fungi,Dikarya,,Ascomycota,Pezizomycotina,,Sordariomycetes,Sordariomycetidae,,,Ophiostomatales,,,,,Ophiostomataceae,,,,Sporothrix,,,,Sporothrix insectorum,,,,2.7.7.6 (100%),DNA-directed RNA polymerase (100%),,,GO:0003677 (100%);GO:0003899 (100%),DNA binding (100%);DNA-directed 5'-3' RNA polymerase activity (100%),GO:0006351 (100%),transcription, DNA-templated (100%),IPR002092 (100%);IPR024075 (100%);IPR029262 (100%),DNA-directed RNA polymerase, phage-type (100%);DNA-directed RNA polymerase, helix hairpin domain superfamily (100%);DNA-directed RNA polymerase, N-terminal (100%)
CFGGSS,Cicer arietinum,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Magnoliopsida,,,,Fabales,,,,,Fabaceae,Papilionoideae,Cicereae,,Cicer,,,,Cicer arietinum,,,,,,,,GO:0043531 (100%),ADP binding (100%),,,IPR002182 (100%);IPR027417 (100%);IPR032675 (100%),NB-ARC (100%);P-loop containing nucleoside triphosphate hydrolase (100%);Leucine-rich repeat domain superfamily (100%)
DGVYTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.9 (25%);1.-.-.- (13%);1.1.1.85 (13%),Histidinol-phosphate transaminase (25%);Oxidoreductases (13%);3-isopropylmalate dehydrogenase (13%),GO:0016021 (35%);GO:0005737 (9%);GO:0005886 (3%),integral component of membrane (35%);cytoplasm (9%);plasma membrane (3%),GO:0003700 (12%);GO:0005524 (12%);GO:0000155 (9%),DNA-binding transcription factor activity (12%);ATP binding (12%);phosphorelay sensor kinase activity (9%),GO:0020012 (9%);GO:0000105 (6%);GO:0018298 (6%),evasion of host immune response (9%);histidine biosynthetic process (6%);protein-chromophore linkage (6%),IPR013783 (12%);IPR001789 (6%);IPR001812 (6%),Immunoglobulin-like fold (12%);Signal transduction response regulator, receiver domain (6%);Trypanosome variant surface glycoprotein, A-type, N-terminal domain (6%)
QLQFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (21%);1.2.4.1 (20%);2.7.3.- (6%),DNA-directed RNA polymerase (21%);Pyruvate dehydrogenase (acetyl-transferring) (20%);Phosphotransferases with a nitrogenous group as acceptor (6%),GO:0016021 (41%);GO:0005886 (8%);GO:0005737 (2%),integral component of membrane (41%);plasma membrane (8%);cytoplasm (2%),GO:0003677 (11%);GO:0005524 (10%);GO:0008270 (7%),DNA binding (11%);ATP binding (10%);zinc ion binding (7%),GO:0006352 (6%);GO:0007165 (4%);GO:0006935 (3%),DNA-templated transcription, initiation (6%);signal transduction (4%);chemotaxis (3%),IPR036291 (8%);IPR027417 (6%);IPR036388 (6%),NAD(P)-binding domain superfamily (8%);P-loop containing nucleoside triphosphate hydrolase (6%);Winged helix-like DNA-binding domain superfamily (6%)
LLLLN,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.1.1.- (30%);4.2.99.20 (10%);2.5.1.75 (7%),Hydron translocation or charge separation linked to oxidoreductase reactions (30%);2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase (10%);tRNA dimethylallyltransferase (7%),GO:0016021 (49%);GO:0005886 (16%);GO:0005737 (4%),integral component of membrane (49%);plasma membrane (16%);cytoplasm (4%),GO:0016301 (10%);GO:0008982 (9%);GO:0008234 (8%),kinase activity (10%);protein-N(PI)-phosphohistidine-sugar phosphotransferase activity (9%);cysteine-type peptidase activity (8%),GO:0009401 (10%);GO:0005975 (5%);GO:0019684 (4%),phosphoenolpyruvate-dependent sugar phosphotransferase system (10%);carbohydrate metabolic process (5%);photosynthesis, light reaction (4%),IPR026444 (10%);IPR001127 (8%);IPR001996 (8%),Secretion system C-terminal sorting domain (10%);Phosphotransferase system, sugar-specific permease EIIA type 1 (8%);Phosphotransferase system, IIB component, type 1 (8%)
VGFLEGGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLSGFDPVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVVWLVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSAGQVTTVVSGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HGGQAAPAGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
THGAGLGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DQETLLAYNVPSQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VALHFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.19 (43%);2.5.1.75 (29%);2.4.1.182 (14%),tRNA(Ile)-lysidine synthetase (43%);tRNA dimethylallyltransferase (29%);Lipid-A-disaccharide synthase (14%),GO:0005737 (21%);GO:0005840 (11%);GO:0005886 (5%),cytoplasm (21%);ribosome (11%);plasma membrane (5%),GO:0003924 (26%);GO:0005524 (26%);GO:0005525 (26%),GTPase activity (26%);ATP binding (26%);GTP binding (26%),GO:0007186 (21%);GO:0006400 (16%);GO:0006412 (11%),G protein-coupled receptor signaling pathway (21%);tRNA modification (16%);translation (11%),IPR027417 (18%);IPR000367 (12%);IPR001019 (12%),P-loop containing nucleoside triphosphate hydrolase (18%);G-protein alpha subunit, group S (12%);Guanine nucleotide binding protein (G-protein), alpha subunit (12%)
PTLNLNLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SVQAPVSQPDSLPTDGTSTDR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAAVVHHGLLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DGLTLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (31%);2.1.1.- (23%);2.7.7.7 (15%),Histidine kinase (31%);Methyltransferases (23%);DNA-directed DNA polymerase (15%),GO:0005737 (5%);GO:0016021 (4%);GO:0016020 (3%),cytoplasm (5%);integral component of membrane (4%);membrane (3%),GO:0008171 (38%);GO:0000155 (13%);GO:0005524 (6%),O-methyltransferase activity (38%);phosphorelay sensor kinase activity (13%);ATP binding (6%),GO:0032259 (35%);GO:0000160 (21%);GO:0000270 (4%),methylation (35%);phosphorelay signal transduction system (21%);peptidoglycan metabolic process (4%),IPR029063 (38%);IPR002935 (36%);IPR001789 (31%),S-adenosyl-L-methionine-dependent methyltransferase (38%);Class I-like SAM-dependent O-methyltransferase (36%);Signal transduction response regulator, receiver domain (31%)
APVVAALK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003824 (50%);GO:0004497 (50%);GO:0005506 (50%),catalytic activity (50%);monooxygenase activity (50%);iron ion binding (50%),,,IPR001509 (33%);IPR002397 (33%);IPR007555 (33%),NAD-dependent epimerase/dehydratase (33%);Cytochrome P450, B-class (33%);Protein of unknown function DUF499 (33%)
VSALATALPALSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DGLLAVAPTAVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NTLAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.17.4.1 (12%);2.7.7.6 (6%);2.1.1.228 (4%),Ribonucleoside-diphosphate reductase (12%);DNA-directed RNA polymerase (6%);tRNA (guanine(37)-N(1))-methyltransferase (4%),GO:0016021 (18%);GO:0015934 (14%);GO:0005840 (9%),integral component of membrane (18%);large ribosomal subunit (14%);ribosome (9%),GO:0070180 (22%);GO:0003735 (14%);GO:0005524 (10%),large ribosomal subunit rRNA binding (22%);structural constituent of ribosome (14%);ATP binding (10%),GO:0006412 (23%);GO:0042254 (22%);GO:0015074 (4%),translation (23%);ribosome biogenesis (22%);DNA integration (4%),IPR001790 (20%);IPR022973 (19%);IPR002363 (13%),Ribosomal protein L10P (20%);Ribosomal protein L10 (19%);Ribosomal protein L10, eubacterial, conserved site (13%)
GGPGQMGAASLLYLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NPLEEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.3 (76%);3.6.3.- (21%);3.1.-.- (5%),Adenosinetriphosphatase (76%);Acting on acid anhydrides; catalyzing transmembrane movement of substances (21%);Acting on ester bonds (5%),GO:0016021 (64%);GO:0005886 (7%);GO:0016020 (5%),integral component of membrane (64%);plasma membrane (7%);membrane (5%),GO:0005524 (54%);GO:0042626 (52%);GO:0016887 (48%),ATP binding (54%);ATPase-coupled transmembrane transporter activity (52%);ATPase activity (48%),GO:0009636 (7%);GO:0097254 (7%);GO:0055085 (5%),response to toxic substance (7%);renal tubular secretion (7%);transmembrane transport (5%),IPR011527 (45%);IPR036640 (45%);IPR027417 (44%),ABC transporter type 1, transmembrane domain (45%);ABC transporter type 1, transmembrane domain superfamily (45%);P-loop containing nucleoside triphosphate hydrolase (44%)
LAPVVK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.-.- (27%);2.6.99.2 (23%);5.1.1.1 (6%),Acting on peptide bonds (peptidases) (27%);Pyridoxine 5'-phosphate synthase (23%);Alanine racemase (6%),GO:0005737 (12%);GO:0016021 (11%);GO:0005634 (2%),cytoplasm (12%);integral component of membrane (11%);nucleus (2%),GO:0005524 (16%);GO:0000049 (10%);GO:0016491 (9%),ATP binding (16%);tRNA binding (10%);oxidoreductase activity (9%),GO:0008615 (7%);GO:0030632 (2%);GO:0006355 (2%),pyridoxine biosynthetic process (7%);D-alanine biosynthetic process (2%);regulation of transcription, DNA-templated (2%),IPR012340 (11%);IPR002547 (9%);IPR036282 (9%),Nucleic acid-binding, OB-fold (11%);tRNA-binding domain (9%);Glutathione S-transferase, C-terminal domain superfamily (9%)
TTDLTQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0000778 (67%);GO:0005623 (67%);GO:0005730 (67%),condensed nuclear chromosome kinetochore (67%);cell (67%);nucleolus (67%),GO:1990644 (67%);GO:0003824 (33%);GO:0046872 (33%),microtubule site clamp (67%);catalytic activity (33%);metal ion binding (33%),GO:0045143 (67%);GO:0045144 (67%);GO:0051315 (67%),homologous chromosome segregation (67%);meiotic sister chromatid segregation (67%);attachment of mitotic spindle microtubules to kinetochore (67%),IPR018635 (46%);IPR020981 (38%);IPR040349 (38%),Uncharacterised protein family UPF0319 (46%);Monopolin complex subunit Csm1/Pcs1, C-terminal (38%);Monopolin complex subunit Csm1/Pcs1 (38%)
NGTNELCWR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.97.1.12 (100%),Photosystem I (100%),GO:0009279 (90%);GO:0016021 (90%);GO:0016020 (10%),cell outer membrane (90%);integral component of membrane (90%);membrane (10%),GO:0015288 (5%);GO:0016491 (2%);GO:0003735 (0%),porin activity (5%);oxidoreductase activity (2%);structural constituent of ribosome (0%),GO:0006412 (0%);GO:0006811 (0%),translation (0%);ion transport (0%),IPR006664 (100%);IPR006665 (100%);IPR036737 (100%),Outer membrane protein, bacterial (100%);OmpA-like domain (100%);OmpA-like domain superfamily (100%)
LLVTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.23 (31%);1.2.1.16 (6%);1.1.1.22 (5%),Histidinol dehydrogenase (31%);Succinate-semialdehyde dehydrogenase (NAD(P)(+)) (6%);UDP-glucose 6-dehydrogenase (5%),GO:0016021 (20%);GO:0005737 (5%);GO:0005840 (3%),integral component of membrane (20%);cytoplasm (5%);ribosome (3%),GO:0005524 (10%);GO:0004399 (8%);GO:0008270 (8%),ATP binding (10%);histidinol dehydrogenase activity (8%);zinc ion binding (8%),GO:0000105 (7%);GO:0009450 (5%);GO:0000160 (3%),histidine biosynthetic process (7%);gamma-aminobutyric acid catabolic process (5%);phosphorelay signal transduction system (3%),IPR016161 (16%);IPR015590 (9%);IPR016162 (9%),Aldehyde/histidinol dehydrogenase (16%);Aldehyde dehydrogenase domain (9%);Aldehyde dehydrogenase, N-terminal (9%)
ALNYGSNNATGLF,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMSPNEAVSATAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TDLANAVVAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EATSVYQGEYDPSLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
APTLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (48%);3.1.-.- (46%);3.4.-.- (10%),DNA helicase (48%);Acting on ester bonds (46%);Acting on peptide bonds (peptidases) (10%),GO:0016021 (27%);GO:0005840 (17%);GO:0070772 (2%),integral component of membrane (27%);ribosome (17%);PAS complex (2%),GO:0003735 (17%);GO:0005524 (14%);GO:0003678 (9%),structural constituent of ribosome (17%);ATP binding (14%);DNA helicase activity (9%),GO:0006412 (17%);GO:0000724 (8%);GO:0006355 (6%),translation (17%);double-strand break repair via homologous recombination (8%);regulation of transcription, DNA-templated (6%),IPR000206 (18%);IPR013823 (18%);IPR014719 (18%),Ribosomal protein L7/L12 (18%);Ribosomal protein L7/L12, C-terminal (18%);Ribosomal protein L7/L12, C-terminal/adaptor protein ClpS-like (18%)
NDLLEVMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (89%);6.3.4.13 (11%),DNA-directed RNA polymerase (89%);Phosphoribosylamine--glycine ligase (11%),,,GO:0003677 (57%);GO:0003899 (57%);GO:0032549 (50%),DNA binding (57%);DNA-directed 5'-3' RNA polymerase activity (57%);ribonucleoside binding (50%),GO:0006351 (57%);GO:0006189 (7%);GO:0009113 (7%),transcription, DNA-templated (57%);'de novo' IMP biosynthetic process (7%);purine nucleobase biosynthetic process (7%),IPR007120 (53%);IPR007641 (53%);IPR007642 (53%),DNA-directed RNA polymerase, subunit 2, hybrid-binding domain (53%);RNA polymerase Rpb2, domain 7 (53%);RNA polymerase Rpb2, domain 2 (53%)
LLVLSTLLLLATLP,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVNEVTEFAK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005615 (73%);GO:0032991 (33%);GO:0005783 (31%),extracellular space (73%);protein-containing complex (33%);endoplasmic reticulum (31%),GO:0046872 (58%);GO:0005504 (34%);GO:1903981 (34%),metal ion binding (58%);fatty acid binding (34%);enterobactin binding (34%),GO:0009267 (33%);GO:0043066 (33%);GO:0051659 (33%),cellular response to starvation (33%);negative regulation of apoptotic process (33%);maintenance of mitochondrion location (33%),IPR000264 (100%);IPR014760 (100%);IPR020858 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin-like (100%)
TLPLLYLVGS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LHLTLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.13 (38%);2.7.7.6 (20%);2.7.7.65 (7%),Protein kinase C (38%);DNA-directed RNA polymerase (20%);Diguanylate cyclase (7%),GO:0016021 (20%);GO:0005634 (7%);GO:0005737 (6%),integral component of membrane (20%);nucleus (7%);cytoplasm (6%),GO:0016316 (41%);GO:0005524 (12%);GO:0016874 (9%),phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity (41%);ATP binding (12%);ligase activity (9%),GO:0035556 (5%);GO:0001881 (2%);GO:0060074 (2%),intracellular signal transduction (5%);receptor recycling (2%);synapse maturation (2%),IPR035892 (41%);IPR039034 (38%);IPR011762 (8%),C2 domain superfamily (41%);Inositol 3,4-bisphosphate 4-phosphatase (38%);Acetyl-coenzyme A carboxyltransferase, N-terminal (8%)
LSLFVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.1.37 (20%);1.1.1.49 (17%);2.3.3.8 (17%),Uroporphyrinogen decarboxylase (20%);Glucose-6-phosphate dehydrogenase (NADP(+)) (17%);ATP citrate synthase (17%),GO:0016021 (34%);GO:0019867 (4%);GO:0000123 (4%),integral component of membrane (34%);outer membrane (4%);histone acetyltransferase complex (4%),GO:0003677 (10%);GO:0003937 (10%);GO:0005524 (7%),DNA binding (10%);IMP cyclohydrolase activity (10%);ATP binding (7%),GO:0006188 (9%);GO:0016042 (5%);GO:0009306 (5%),IMP biosynthetic process (9%);lipid catabolic process (5%);protein secretion (5%),IPR020600 (8%);IPR036795 (8%);IPR003280 (5%),Inosine monophosphate cyclohydrolase-like (8%);Inosine monophosphate cyclohydrolase-like superfamily (8%);Two pore domain potassium channel (5%)
NVAAANPAVV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSTNMANTNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GGLGVNAVAPA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DMLKPGGTFVGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HQPHLTLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QATPGVAQAGAGDVAGH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DSVFPEGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLPLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.1.1.100 (33%);2.5.1.56 (7%);2.7.13.3 (4%),3-oxoacyl-[acyl-carrier-protein] reductase (33%);N-acetylneuraminate synthase (7%);Histidine kinase (4%),GO:0016021 (23%);GO:0005886 (3%);GO:0005737 (3%),integral component of membrane (23%);plasma membrane (3%);cytoplasm (3%),GO:0005524 (10%);GO:0003824 (8%);GO:0004316 (7%),ATP binding (10%);catalytic activity (8%);3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity (7%),GO:0016051 (8%);GO:0006396 (6%);GO:0006633 (5%),carbohydrate biosynthetic process (8%);RNA processing (6%);fatty acid biosynthetic process (5%),IPR036291 (14%);IPR002347 (12%);IPR011990 (9%),NAD(P)-binding domain superfamily (14%);Short-chain dehydrogenase/reductase SDR (12%);Tetratricopeptide-like helical domain superfamily (9%)
LLYTGVLCTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLPGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.5 (28%);3.1.3.- (28%);2.3.2.3 (5%),[Isocitrate dehydrogenase (NADP(+))] kinase (28%);Phosphoric monoester hydrolases (28%);Lysyltransferase (5%),GO:0016021 (22%);GO:0005737 (20%);GO:0005886 (4%),integral component of membrane (22%);cytoplasm (20%);plasma membrane (4%),GO:0005524 (20%);GO:0003746 (9%);GO:0003677 (8%),ATP binding (20%);translation elongation factor activity (9%);DNA binding (8%),GO:0006099 (6%);GO:0006097 (6%);GO:0006006 (5%),tricarboxylic acid cycle (6%);glyoxylate cycle (6%);glucose metabolic process (5%),IPR027417 (11%);IPR001816 (7%);IPR014039 (7%),P-loop containing nucleoside triphosphate hydrolase (11%);Translation elongation factor EFTs/EF1B (7%);Translation elongation factor EFTs/EF1B, dimerisation (7%)
TTVLADGGVR,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,1.1.2.3 (100%),L-lactate dehydrogenase (cytochrome) (100%),,,GO:0004460 (100%);GO:0010181 (100%),L-lactate dehydrogenase (cytochrome) activity (100%);FMN binding (100%),,,IPR000262 (100%);IPR008259 (100%);IPR012133 (100%),FMN-dependent dehydrogenase (100%);FMN-dependent alpha-hydroxy acid dehydrogenase, active site (100%);Alpha-hydroxy acid dehydrogenase, FMN-dependent (100%)
LTGGSVSQSQEMAMR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DGSPNLMGLYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GYVYPALPAPEELEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVFLFTGEGES,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AVAALLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004601 (50%);GO:0048037 (50%),peroxidase activity (50%);cofactor binding (50%),,,IPR000326 (25%);IPR005064 (25%);IPR007396 (25%),Phosphatidic acid phosphatase type 2/haloperoxidase (25%);Bordetella uptake gene (25%);Transcriptional regulator PAI 2-type (25%)
AEFVEVTK,Bos,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,Laurasiatheria,Artiodactyla,Ruminantia,Pecora,,,Bovidae,Bovinae,,,Bos,,,,,,,,,,GO:0005615 (77%);GO:0032991 (31%);GO:0005783 (23%),extracellular space (77%);protein-containing complex (31%);endoplasmic reticulum (23%),GO:0046872 (77%);GO:0003677 (31%);GO:0005504 (31%),metal ion binding (77%);DNA binding (31%);fatty acid binding (31%),GO:0009267 (31%);GO:0043066 (31%);GO:0051659 (31%),cellular response to starvation (31%);negative regulation of apoptotic process (31%);maintenance of mitochondrion location (31%),IPR000264 (100%);IPR014760 (100%);IPR020857 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin, conserved site (100%)
GANTVPYQVSLNSG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YGLGLDSS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EATSVYQLQGEYDPSLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WLGGTLTNNSQVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NSVTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.5.5 (78%);2.5.1.7 (3%);2.5.1.0 (1%),Carbamoyl-phosphate synthase (glutamine-hydrolyzing) (78%);UDP-N-acetylglucosamine 1-carboxyvinyltransferase (3%); (1%),GO:0016021 (14%);GO:0005737 (5%);GO:0005576 (2%),integral component of membrane (14%);cytoplasm (5%);extracellular region (2%),GO:0005524 (58%);GO:0046872 (53%);GO:0004088 (49%),ATP binding (58%);metal ion binding (53%);carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity (49%),GO:0006807 (27%);GO:0006541 (24%);GO:0006207 (23%),nitrogen compound metabolic process (27%);glutamine metabolic process (24%);'de novo' pyrimidine nucleobase biosynthetic process (23%),IPR011761 (46%);IPR005479 (46%);IPR005483 (46%),ATP-grasp fold (46%);Carbamoyl-phosphate synthetase large subunit-like, ATP-binding domain (46%);Carbamoyl-phosphate synthase large subunit, CPSase domain (46%)
YLHLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.1.1 (11%);1.1.1.103 (9%);3.6.4.- (7%),Glycogen phosphorylase (11%);L-threonine 3-dehydrogenase (9%);Acting on ATP; involved in cellular and subcellular movement (7%),GO:0016021 (29%);GO:0005840 (10%);GO:0005737 (4%),integral component of membrane (29%);ribosome (10%);cytoplasm (4%),GO:0005524 (15%);GO:0003735 (10%);GO:0003677 (7%),ATP binding (15%);structural constituent of ribosome (10%);DNA binding (7%),GO:0006412 (10%);GO:0005975 (8%);GO:0055085 (3%),translation (10%);carbohydrate metabolic process (8%);transmembrane transport (3%),IPR027417 (9%);IPR008195 (8%);IPR038562 (8%),P-loop containing nucleoside triphosphate hydrolase (9%);Ribosomal protein L34Ae (8%);Ribosomal protein L34Ae superfamily (8%)
ATGYWFPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (99%),integral component of membrane (99%),GO:0022857 (20%),transmembrane transporter activity (20%),GO:0055085 (67%),transmembrane transport (67%),IPR011701 (100%);IPR020846 (100%);IPR036259 (100%),Major facilitator superfamily (100%);Major facilitator superfamily domain (100%);MFS transporter superfamily (100%)
LPHER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.1.3 (13%);1.13.11.6 (7%);2.4.2.22 (7%),Glutamate racemase (13%);3-hydroxyanthranilate 3,4-dioxygenase (7%);Xanthine phosphoribosyltransferase (7%),GO:0016021 (15%);GO:0005737 (7%);GO:0005886 (3%),integral component of membrane (15%);cytoplasm (7%);plasma membrane (3%),GO:0005524 (16%);GO:0003677 (9%);GO:0046872 (5%),ATP binding (16%);DNA binding (9%);metal ion binding (5%),GO:0009252 (4%);GO:0008360 (3%);GO:0071555 (3%),peptidoglycan biosynthetic process (4%);regulation of cell shape (3%);cell wall organization (3%),IPR027417 (9%);IPR017850 (4%);IPR000917 (4%),P-loop containing nucleoside triphosphate hydrolase (9%);Alkaline-phosphatase-like, core domain superfamily (4%);Sulfatase, N-terminal (4%)
EHPGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.1.3.1 (27%);4.1.99.22 (17%);1.5.3.1 (8%),Isocitrate lyase (27%);GTP 3',8-cyclase (17%);Sarcosine oxidase (8%),GO:0016021 (17%);GO:0005737 (9%);GO:0019008 (5%),integral component of membrane (17%);cytoplasm (9%);molybdopterin synthase complex (5%),GO:0046872 (35%);GO:0004451 (25%);GO:0005524 (7%),metal ion binding (35%);isocitrate lyase activity (25%);ATP binding (7%),GO:0019752 (24%);GO:0006777 (5%);GO:0006260 (3%),carboxylic acid metabolic process (24%);Mo-molybdopterin cofactor biosynthetic process (5%);DNA replication (3%),IPR006254 (21%);IPR015813 (21%);IPR040442 (21%),Isocitrate lyase (21%);Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily (21%);Pyruvate kinase-like domain superfamily (21%)
FPSAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.22 (40%);6.2.1.54 (11%);3.6.4.12 (5%),Alpha-galactosidase (40%);D-alanine--[D-alanyl-carrier protein] ligase (11%);DNA helicase (5%),GO:0016021 (25%);GO:0005886 (7%);GO:0005737 (5%),integral component of membrane (25%);plasma membrane (7%);cytoplasm (5%),GO:0005524 (14%);GO:0003677 (10%);GO:0052692 (9%),ATP binding (14%);DNA binding (10%);raffinose alpha-galactosidase activity (9%),GO:0005975 (10%);GO:0032259 (6%);GO:0006313 (3%),carbohydrate metabolic process (10%);methylation (6%);transposition, DNA-mediated (3%),IPR029063 (10%);IPR017853 (9%);IPR027417 (8%),S-adenosyl-L-methionine-dependent methyltransferase (10%);Glycoside hydrolase superfamily (9%);P-loop containing nucleoside triphosphate hydrolase (8%)
HLLVSTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (56%);2.5.1.72 (44%),Peptidylprolyl isomerase (56%);Quinolinate synthase (44%),GO:0005737 (11%);GO:0016021 (11%);GO:0005801 (7%),cytoplasm (11%);integral component of membrane (11%);cis-Golgi network (7%),GO:0003755 (22%);GO:0003824 (15%);GO:0008987 (15%),peptidyl-prolyl cis-trans isomerase activity (22%);catalytic activity (15%);quinolinate synthetase A activity (15%),GO:0009435 (15%);GO:0120009 (11%);GO:0006886 (7%),NAD biosynthetic process (15%);intermembrane lipid transfer (11%);intracellular protein transport (7%),IPR002999 (35%);IPR015943 (14%);IPR000297 (11%),Tudor domain (35%);WD40/YVTN repeat-like-containing domain superfamily (14%);Peptidyl-prolyl cis-trans isomerase, PpiC-type (11%)
VALLEGLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009380 (62%);GO:0005737 (57%);GO:0016021 (14%),excinuclease repair complex (62%);cytoplasm (57%);integral component of membrane (14%),GO:0003677 (62%);GO:0005524 (62%);GO:0016887 (62%),DNA binding (62%);ATP binding (62%);ATPase activity (62%),GO:0006289 (62%);GO:0009432 (57%);GO:0007165 (10%),nucleotide-excision repair (62%);SOS response (57%);signal transduction (10%),IPR025997 (49%);IPR028082 (49%);IPR027417 (35%),Periplasmic binding protein (49%);Periplasmic binding protein-like I (49%);P-loop containing nucleoside triphosphate hydrolase (35%)
YASMCANDAEDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EGGGYLLGDDAHEAEALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TTGLTGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (28%);GO:0005840 (12%);GO:0005886 (8%),integral component of membrane (28%);ribosome (12%);plasma membrane (8%),GO:0005524 (20%);GO:0046872 (16%);GO:0003676 (12%),ATP binding (20%);metal ion binding (16%);nucleic acid binding (12%),GO:0006412 (12%);GO:0006364 (4%);GO:0019290 (4%),translation (12%);rRNA processing (4%);siderophore biosynthetic process (4%),IPR028082 (16%);IPR011047 (13%);IPR015943 (13%),Periplasmic binding protein-like I (16%);Quinoprotein alcohol dehydrogenase-like superfamily (13%);WD40/YVTN repeat-like-containing domain superfamily (13%)
PLLPMVR,Bacteroidales bacterium,Bacteria,,,,Bacteroidetes,,,Bacteroidia,,,,Bacteroidales,,,,,,,,,,,,,Bacteroidales bacterium,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0000155 (100%);GO:0046983 (100%),phosphorelay sensor kinase activity (100%);protein dimerization activity (100%),,,IPR003594 (100%);IPR005467 (100%);IPR011712 (100%),Histidine kinase/HSP90-like ATPase (100%);Histidine kinase domain (100%);Signal transduction histidine kinase, subgroup 3, dimerisation and phosphoacceptor domain (100%)
AGFTQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.8.33 (25%);2.6.1.1 (13%);2.7.7.43 (13%),UDP-N-acetylglucosamine--undecaprenyl-phosphatN-acetylglucosaminephosphotransferase (25%);Aspartate transaminase (13%);N-acylneuraminate cytidylyltransferase (13%),GO:0016021 (43%);GO:0005576 (5%);GO:0005887 (2%),integral component of membrane (43%);extracellular region (5%);integral component of plasma membrane (2%),GO:0022857 (32%);GO:0003677 (11%);GO:0005524 (6%),transmembrane transporter activity (32%);DNA binding (11%);ATP binding (6%),GO:0009405 (5%);GO:0055085 (4%);GO:0006260 (2%),pathogenesis (5%);transmembrane transport (4%);DNA replication (2%),IPR006043 (25%);IPR006042 (24%);IPR010982 (8%),Xanthine/uracil/vitamin C permease (25%);Xanthine/uracil permease (24%);Lambda repressor-like, DNA-binding domain superfamily (8%)
VTSANSVYAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VELMLSLMATSNTAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EAWNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.13.1 (13%);4.2.99.18 (13%);2.7.7.- (7%),Exoribonuclease II (13%);DNA-(apurinic or apyrimidinic site) lyase (13%);Nucleotidyltransferases (7%),GO:0016021 (25%);GO:0019031 (16%);GO:0055036 (16%),integral component of membrane (25%);viral envelope (16%);virion membrane (16%),GO:0005198 (12%);GO:0005524 (10%);GO:0003677 (9%),structural molecule activity (12%);ATP binding (10%);DNA binding (9%),GO:0019062 (16%);GO:0019064 (12%);GO:0019082 (12%),virion attachment to host cell (16%);fusion of virus membrane with host plasma membrane (12%);viral protein processing (12%),IPR036869 (13%);IPR001623 (12%);IPR000777 (11%),Chaperone J-domain superfamily (13%);DnaJ domain (12%);Human immunodeficiency virus 1, envelope glycoprotein Gp120 (11%)
SLAGGFPLAAVVGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NKPGVYTK,Metazoa,Eukaryota,Metazoa,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.- (66%);3.4.21.109 (18%);3.4.21.4 (13%),Serine endopeptidases (66%);Matriptase (18%);Trypsin (13%),GO:0016021 (28%);GO:0005576 (5%);GO:0005887 (5%),integral component of membrane (28%);extracellular region (5%);integral component of plasma membrane (5%),GO:0004252 (99%);GO:0005044 (25%);GO:0008236 (1%),serine-type endopeptidase activity (99%);scavenger receptor activity (25%);serine-type peptidase activity (1%),GO:0006508 (2%);GO:0031639 (2%);GO:0007586 (1%),proteolysis (2%);plasminogen activation (2%);digestion (1%),IPR001254 (100%);IPR009003 (100%);IPR033116 (96%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Serine proteases, trypsin family, serine active site (96%)
LLNLLPAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.13 (93%);6.1.1.16 (7%),RNA helicase (93%);Cysteine--tRNA ligase (7%),GO:0005737 (32%);GO:0016021 (3%),cytoplasm (32%);integral component of membrane (3%),GO:0005524 (79%);GO:0003676 (68%);GO:0003724 (37%),ATP binding (79%);nucleic acid binding (68%);RNA helicase activity (37%),GO:0042255 (26%);GO:0006423 (3%);GO:0009252 (3%),ribosome assembly (26%);cysteinyl-tRNA aminoacylation (3%);peptidoglycan biosynthetic process (3%),IPR027417 (72%);IPR000629 (69%);IPR001650 (69%),P-loop containing nucleoside triphosphate hydrolase (72%);ATP-dependent RNA helicase DEAD-box, conserved site (69%);Helicase, C-terminal (69%)
VTALPSALV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ETSDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.-.- (10%);6.1.1.9 (8%);5.3.1.8 (7%),Acting on acid anhydrides (10%);Valine--tRNA ligase (8%);Mannose-6-phosphate isomerase (7%),GO:0016021 (30%);GO:0005737 (9%);GO:0005634 (3%),integral component of membrane (30%);cytoplasm (9%);nucleus (3%),GO:0005524 (16%);GO:0003677 (7%);GO:0046872 (6%),ATP binding (16%);DNA binding (7%);metal ion binding (6%),GO:0019079 (3%);GO:0005975 (2%);GO:0006400 (2%),viral genome replication (3%);carbohydrate metabolic process (2%);tRNA modification (2%),IPR027417 (13%);IPR012338 (4%);IPR001460 (4%),P-loop containing nucleoside triphosphate hydrolase (13%);Beta-lactamase/transpeptidase-like (4%);Penicillin-binding protein, transpeptidase (4%)
KPALSAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.- (100%),Transferring other groups (100%),GO:0043625 (92%),delta DNA polymerase complex (92%),GO:0003887 (92%);GO:0003723 (8%);GO:0009982 (8%),DNA-directed DNA polymerase activity (92%);RNA binding (8%);pseudouridine synthase activity (8%),GO:0006260 (83%);GO:0001522 (8%);GO:0006271 (8%),DNA replication (83%);pseudouridine synthesis (8%);DNA strand elongation involved in DNA replication (8%),IPR019038 (79%);IPR041913 (21%);IPR039875 (14%),DNA polymerase delta subunit 3 (79%);DNA polymerase delta subunit 3 superfamily (21%);Leukocyte receptor cluster member 1-like (14%)
NDMLQFK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.10 (100%);3.2.1.48 (50%),Oligo-1,6-glucosidase (100%);Sucrose alpha-glucosidase (50%),GO:0016021 (74%);GO:0005903 (2%);GO:0016020 (2%),integral component of membrane (74%);brush border (2%);membrane (2%),GO:0030246 (98%);GO:0004553 (90%);GO:0004558 (4%),carbohydrate binding (98%);hydrolase activity, hydrolyzing O-glycosyl compounds (90%);alpha-1,4-glucosidase activity (4%),GO:0005975 (98%);GO:0009966 (2%);GO:0044245 (1%),carbohydrate metabolic process (98%);regulation of signal transduction (2%);polysaccharide digestion (1%),IPR000322 (98%);IPR011013 (98%);IPR013780 (98%),Glycoside hydrolase family 31 (98%);Galactose mutarotase-like domain superfamily (98%);Glycosyl hydrolase, all-beta (98%)
HSEDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.1.11 (9%);4.3.1.19 (8%);2.1.3.2 (7%),6-phosphofructokinase (9%);Threonine ammonia-lyase (8%);Aspartate carbamoyltransferase (7%),GO:0016021 (36%);GO:0005576 (24%);GO:0005886 (4%),integral component of membrane (36%);extracellular region (24%);plasma membrane (4%),GO:0008083 (25%);GO:0004930 (23%);GO:0005524 (12%),growth factor activity (25%);G protein-coupled receptor activity (23%);ATP binding (12%),GO:0016525 (24%);GO:0007166 (23%);GO:0007422 (4%),negative regulation of angiogenesis (24%);cell surface receptor signaling pathway (23%);peripheral nervous system development (4%),IPR032471 (23%);IPR008077 (23%);IPR015615 (22%),GAIN domain, N-terminal (23%);GPCR, family 2, brain-specific angiogenesis inhibitor (23%);Transforming growth factor-beta-related (22%)
ATLSTTLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004601 (100%);GO:0020037 (100%),peroxidase activity (100%);heme binding (100%),GO:0006979 (100%),response to oxidative stress (100%),IPR002016 (67%);IPR002207 (67%);IPR010255 (67%),Haem peroxidase (67%);Class I peroxidase (67%);Haem peroxidase superfamily (67%)
LPLVVLETLDHCSMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SFLAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.15 (4%);3.1.-.- (4%);6.1.1.15 (4%),Dihydropteroate synthase (4%);Acting on ester bonds (4%);Proline--tRNA ligase (4%),GO:0016021 (19%);GO:0005737 (6%);GO:0030286 (3%),integral component of membrane (19%);cytoplasm (6%);dynein complex (3%),GO:0005524 (28%);GO:0003677 (10%);GO:0016887 (7%),ATP binding (28%);DNA binding (10%);ATPase activity (7%),GO:0006355 (4%);GO:0007018 (3%);GO:0008299 (2%),regulation of transcription, DNA-templated (4%);microtubule-based movement (3%);isoprenoid biosynthetic process (2%),IPR027417 (22%);IPR003593 (13%);IPR036388 (5%),P-loop containing nucleoside triphosphate hydrolase (22%);AAA+ ATPase domain (13%);Winged helix-like DNA-binding domain superfamily (5%)
LPELLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (18%);5.4.2.7 (16%);2.8.4.3 (12%),Acting on ATP; involved in cellular and subcellular movement (18%);Phosphopentomutase (16%);tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase (12%),GO:0005737 (18%);GO:0005829 (10%);GO:0016021 (6%),cytoplasm (18%);cytosol (10%);integral component of membrane (6%),GO:0005524 (16%);GO:0046872 (11%);GO:0016787 (9%),ATP binding (16%);metal ion binding (11%);hydrolase activity (9%),GO:0006895 (10%);GO:0006777 (7%);GO:0006355 (5%),Golgi to endosome transport (10%);Mo-molybdopterin cofactor biosynthetic process (7%);regulation of transcription, DNA-templated (5%),IPR027417 (18%);IPR016024 (10%);IPR040314 (9%),P-loop containing nucleoside triphosphate hydrolase (18%);Armadillo-type fold (10%);Protein dopey (9%)
TGLDLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.14 (20%);6.4.1.2 (20%);1.-.-.- (10%),Biotin carboxylase (20%);Acetyl-CoA carboxylase (20%);Oxidoreductases (10%),GO:0005737 (24%);GO:0016021 (20%);GO:0005623 (2%),cytoplasm (24%);integral component of membrane (20%);cell (2%),GO:0005524 (40%);GO:0051082 (23%);GO:0016491 (7%),ATP binding (40%);unfolded protein binding (23%);oxidoreductase activity (7%),GO:0042026 (27%);GO:0044038 (4%);GO:0000160 (2%),protein refolding (27%);cell wall macromolecule biosynthetic process (4%);phosphorelay signal transduction system (2%),IPR002423 (27%);IPR027413 (27%);IPR027409 (27%),Chaperonin Cpn60/TCP-1 family (27%);GroEL-like equatorial domain superfamily (27%);GroEL-like apical domain superfamily (27%)
LTSYPAYY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLGVCTDELGAGSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AHRPGDR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.107 (83%);3.4.21.- (8%);6.3.4.19 (8%),Peptidase Do (83%);Serine endopeptidases (8%);tRNA(Ile)-lysidine synthetase (8%),GO:0016021 (91%);GO:0005840 (1%);GO:0005737 (0%),integral component of membrane (91%);ribosome (1%);cytoplasm (0%),GO:0004252 (92%);GO:0008233 (3%);GO:0016787 (2%),serine-type endopeptidase activity (92%);peptidase activity (3%);hydrolase activity (2%),GO:0006412 (1%);GO:0006400 (0%);GO:0030163 (0%),translation (1%);tRNA modification (0%);protein catabolic process (0%),IPR001478 (98%);IPR036034 (98%);IPR001940 (97%),PDZ domain (98%);PDZ superfamily (98%);Peptidase S1C (97%)
GDVASLYANVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLALTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.5.- (50%);1.1.1.3 (9%);3.1.3.2 (3%),Acting on GTP; involved in cellular and subcellular movement (50%);Homoserine dehydrogenase (9%);Acid phosphatase (3%),GO:0005737 (21%);GO:0016021 (17%);GO:0005886 (2%),cytoplasm (21%);integral component of membrane (17%);plasma membrane (2%),GO:0005525 (18%);GO:0003924 (17%);GO:0000287 (16%),GTP binding (18%);GTPase activity (17%);magnesium ion binding (16%),GO:0042254 (15%);GO:0009088 (3%);GO:0009097 (3%),ribosome biogenesis (15%);threonine biosynthetic process (3%);isoleucine biosynthetic process (3%),IPR027417 (23%);IPR006073 (14%);IPR031167 (14%),P-loop containing nucleoside triphosphate hydrolase (23%);GTP binding domain (14%);OBG-type guanine nucleotide-binding (G) domain (14%)
TGSPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.7 (10%);5.2.1.8 (8%);1.4.7.1 (6%),Acylphosphatase (10%);Peptidylprolyl isomerase (8%);Glutamate synthase (ferredoxin) (6%),GO:0016021 (21%);GO:0005576 (4%);GO:0005737 (3%),integral component of membrane (21%);extracellular region (4%);cytoplasm (3%),GO:0005524 (11%);GO:0003677 (9%);GO:0015930 (6%),ATP binding (11%);DNA binding (9%);glutamate synthase activity (6%),GO:0006537 (8%);GO:0006281 (4%);GO:0007165 (3%),glutamate biosynthetic process (8%);DNA repair (4%);signal transduction (3%),IPR019223 (9%);IPR027417 (7%);IPR013785 (6%),Domain of unknown function DUF2147 (9%);P-loop containing nucleoside triphosphate hydrolase (7%);Aldolase-type TIM barrel (6%)
VLPVLMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.2.1.5 (75%);2.5.1.15 (25%),Succinate--CoA ligase (ADP-forming) (75%);Dihydropteroate synthase (25%),GO:0016021 (50%);GO:0005886 (14%);GO:0005762 (2%),integral component of membrane (50%);plasma membrane (14%);mitochondrial large ribosomal subunit (2%),GO:0016757 (38%);GO:0005524 (26%);GO:0008982 (14%),transferase activity, transferring glycosyl groups (38%);ATP binding (26%);protein-N(PI)-phosphohistidine-sugar phosphotransferase activity (14%),GO:0006004 (38%);GO:0009058 (14%);GO:0009401 (14%),fucose metabolic process (38%);biosynthetic process (14%);phosphoenolpyruvate-dependent sugar phosphotransferase system (14%),IPR019378 (35%);IPR024709 (35%);IPR003352 (13%),GDP-fucose protein O-fucosyltransferase (35%);Putative O-fucosyltransferase, plant (35%);Phosphotransferase system, EIIC (13%)
LTTLPVSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR009612 (100%);IPR010623 (100%);IPR017731 (100%),IcmF-related (100%);Type VI secretion system IcmF, C-terminal (100%);Type VI secretion system, IcmF (100%)
PRPAALGLLFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NNELR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.27 (25%);2.7.13.3 (5%);2.7.7.56 (4%),RING-type E3 ubiquitin transferase (25%);Histidine kinase (5%);tRNA nucleotidyltransferase (4%),GO:0016021 (30%);GO:0005634 (7%);GO:0005737 (4%),integral component of membrane (30%);nucleus (7%);cytoplasm (4%),GO:0005524 (14%);GO:0046872 (8%);GO:0019894 (8%),ATP binding (14%);metal ion binding (8%);kinesin binding (8%),GO:0010390 (4%);GO:0051694 (3%);GO:0007018 (3%),histone monoubiquitination (4%);pointed-end actin filament capping (3%);microtubule-based movement (3%),IPR027417 (7%);IPR011989 (5%);IPR016024 (5%),P-loop containing nucleoside triphosphate hydrolase (7%);Armadillo-like helical (5%);Armadillo-type fold (5%)
MNLYEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.13.3 (15%);2.1.1.77 (7%);3.1.1.- (7%),Histidine kinase (15%);Protein-L-isoaspartate(D-aspartate) O-methyltransferase (7%);Carboxylic ester hydrolases (7%),GO:0016021 (20%);GO:0005737 (3%);GO:0000786 (0%),integral component of membrane (20%);cytoplasm (3%);nucleosome (0%),GO:0003677 (23%);GO:0051287 (15%);GO:0003700 (14%),DNA binding (23%);NAD binding (15%);DNA-binding transcription factor activity (14%),GO:0009058 (11%);GO:0000271 (11%);GO:0032259 (3%),biosynthetic process (11%);polysaccharide biosynthetic process (11%);methylation (3%),IPR015421 (12%);IPR015424 (12%);IPR036291 (11%),Pyridoxal phosphate-dependent transferase, major domain (12%);Pyridoxal phosphate-dependent transferase (12%);NAD(P)-binding domain superfamily (11%)
ATLHVDAGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVGGYTCGANTVPYQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTQALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.9 (15%);3.4.21.53 (7%);2.7.13.3 (5%),Histidinol-phosphate transaminase (15%);Endopeptidase La (7%);Histidine kinase (5%),GO:0016021 (20%);GO:0005737 (10%);GO:0005730 (5%),integral component of membrane (20%);cytoplasm (10%);nucleolus (5%),GO:0005524 (20%);GO:0003677 (14%);GO:0003755 (9%),ATP binding (20%);DNA binding (14%);peptidyl-prolyl cis-trans isomerase activity (9%),GO:0006364 (5%);GO:0006457 (5%);GO:0007018 (4%),rRNA processing (5%);protein folding (5%);microtubule-based movement (4%),IPR027417 (10%);IPR036390 (8%);IPR036388 (8%),P-loop containing nucleoside triphosphate hydrolase (10%);Winged helix DNA-binding domain superfamily (8%);Winged helix-like DNA-binding domain superfamily (8%)
GLGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.75 (11%);3.6.4.12 (7%);3.5.2.1 (6%),Uroporphyrinogen-III synthase (11%);DNA helicase (7%);Barbiturase (6%),GO:0016021 (23%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (23%);cytoplasm (5%);plasma membrane (3%),GO:0005524 (14%);GO:0003677 (11%);GO:0008080 (7%),ATP binding (14%);DNA binding (11%);N-acetyltransferase activity (7%),GO:0006260 (4%);GO:0006355 (3%);GO:0016556 (2%),DNA replication (4%);regulation of transcription, DNA-templated (3%);mRNA modification (2%),IPR027417 (10%);IPR016181 (7%);IPR000182 (6%),P-loop containing nucleoside triphosphate hydrolase (10%);Acyl-CoA N-acyltransferase (7%);GNAT domain (6%)
LLGLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.3 (14%);7.3.2.2 (10%);2.7.7.7 (7%),Aconitate hydratase (14%);ABC-type phosphonate transporter (10%);DNA-directed DNA polymerase (7%),GO:0016021 (30%);GO:0005737 (9%);GO:0005886 (7%),integral component of membrane (30%);cytoplasm (9%);plasma membrane (7%),GO:0005524 (17%);GO:0003677 (9%);GO:0046872 (6%),ATP binding (17%);DNA binding (9%);metal ion binding (6%),GO:0006281 (3%);GO:0006355 (3%);GO:0015074 (2%),DNA repair (3%);regulation of transcription, DNA-templated (3%);DNA integration (2%),IPR027417 (11%);IPR003593 (5%);IPR003439 (4%),P-loop containing nucleoside triphosphate hydrolase (11%);AAA+ ATPase domain (5%);ABC transporter-like (4%)
TLLLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.2.2.6 (16%);3.4.21.53 (9%);2.7.7.6 (8%),P-type K(+) transporter (16%);Endopeptidase La (9%);DNA-directed RNA polymerase (8%),GO:0016021 (35%);GO:0005886 (17%);GO:0005737 (6%),integral component of membrane (35%);plasma membrane (17%);cytoplasm (6%),GO:0005524 (27%);GO:0046872 (13%);GO:0019829 (10%),ATP binding (27%);metal ion binding (13%);ATPase-coupled cation transmembrane transporter activity (10%),GO:0055085 (7%);GO:0008360 (4%);GO:0007018 (2%),transmembrane transport (7%);regulation of cell shape (4%);microtubule-based movement (2%),IPR036412 (11%);IPR018303 (11%);IPR023299 (11%),HAD-like superfamily (11%);P-type ATPase, phosphorylation site (11%);P-type ATPase, cytoplasmic domain N (11%)
QEQLLQQHESTDTNFDLF,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NYDALGFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVMESLAGAFSDQPGGEGVLDSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASLSLVQR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.1.15 (100%),Nucleoside-triphosphate phosphatase (100%),GO:0016021 (96%);GO:0005886 (95%);GO:0005737 (1%),integral component of membrane (96%);plasma membrane (95%);cytoplasm (1%),GO:0003677 (99%);GO:0005524 (99%);GO:0004527 (0%),DNA binding (99%);ATP binding (99%);exonuclease activity (0%),GO:0051301 (97%);GO:0007049 (95%);GO:0007059 (95%),cell division (97%);cell cycle (95%);chromosome segregation (95%),IPR018541 (100%);IPR036388 (100%);IPR036390 (100%),FtsK gamma domain (100%);Winged helix-like DNA-binding domain superfamily (100%);Winged helix DNA-binding domain superfamily (100%)
HGATVVQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SDGLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.48 (36%);5.2.1.8 (9%);1.2.1.88 (5%),Histone acetyltransferase (36%);Peptidylprolyl isomerase (9%);L-glutamate gamma-semialdehyde dehydrogenase (5%),GO:0016021 (13%);GO:0005634 (7%);GO:0005737 (6%),integral component of membrane (13%);nucleus (7%);cytoplasm (6%),GO:0005524 (32%);GO:0016787 (30%);GO:0016301 (16%),ATP binding (32%);hydrolase activity (30%);kinase activity (16%),GO:0006974 (4%);GO:0015628 (4%);GO:0043618 (4%),cellular response to DNA damage stimulus (4%);protein secretion by the type II secretion system (4%);regulation of transcription from RNA polymerase II promoter in response to stress (4%),IPR029058 (26%);IPR040664 (24%);IPR006311 (23%),Alpha/Beta hydrolase fold (26%);AFL, C-terminal (24%);Twin-arginine translocation pathway, signal sequence (23%)
LVQLPPQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPLLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.- (24%);4.1.1.48 (7%);2.1.-.- (6%),Transaminases (24%);Indole-3-glycerol-phosphate synthase (7%);Transferring one-carbon groups (6%),GO:0016021 (37%);GO:0005886 (5%);GO:0005737 (3%),integral component of membrane (37%);plasma membrane (5%);cytoplasm (3%),GO:0005524 (9%);GO:0016491 (7%);GO:0003677 (6%),ATP binding (9%);oxidoreductase activity (7%);DNA binding (6%),GO:0009058 (5%);GO:0006520 (4%);GO:0006355 (2%),biosynthetic process (5%);cellular amino acid metabolic process (4%);regulation of transcription, DNA-templated (2%),IPR027417 (7%);IPR036188 (6%);IPR015424 (4%),P-loop containing nucleoside triphosphate hydrolase (7%);FAD/NAD(P)-binding domain superfamily (6%);Pyridoxal phosphate-dependent transferase (4%)
NLLEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.9 (5%);3.2.2.28 (3%);6.1.1.23 (3%),UTP--glucose-1-phosphate uridylyltransferase (5%);Double-stranded uracil-DNA glycosylase (3%);Aspartate--tRNA(Asn) ligase (3%),GO:0016021 (22%);GO:0005737 (10%);GO:0005886 (2%),integral component of membrane (22%);cytoplasm (10%);plasma membrane (2%),GO:0005524 (19%);GO:0003677 (12%);GO:0046872 (6%),ATP binding (19%);DNA binding (12%);metal ion binding (6%),GO:0006355 (5%);GO:0000160 (4%);GO:0005975 (3%),regulation of transcription, DNA-templated (5%);phosphorelay signal transduction system (4%);carbohydrate metabolic process (3%),IPR027417 (12%);IPR011006 (4%);IPR001789 (4%),P-loop containing nucleoside triphosphate hydrolase (12%);CheY-like superfamily (4%);Signal transduction response regulator, receiver domain (4%)
MVDTNSQANTSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PPGTQFGLT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TAFVTLQSLDLEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QFTSALDADSNPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QTLGDPELR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVTTANQALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EASLEQAR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (93%),integral component of membrane (93%),GO:0008233 (7%),peptidase activity (7%),,,IPR039562 (89%);IPR001539 (7%);IPR032525 (7%),Membrane fusion protein, biotin-lipoyl like domain (89%);Peptidase U32 (7%);Peptidase family U32, C-terminal (7%)
NPLGDALNL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GMMPVFLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LTENTMPSMLSGDVFEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLLSNK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.37 (35%);5.3.1.30 (8%);1.7.1.17 (6%),DNA (cytosine-5-)-methyltransferase (35%);5-deoxy-glucuronate isomerase (8%);FMN-dependent NADH-azoreductase (6%),GO:0016021 (32%);GO:0005737 (6%);GO:0005886 (5%),integral component of membrane (32%);cytoplasm (6%);plasma membrane (5%),GO:0005524 (13%);GO:0003886 (10%);GO:0003677 (4%),ATP binding (13%);DNA (cytosine-5-)-methyltransferase activity (10%);DNA binding (4%),GO:0006534 (3%);GO:0006412 (3%);GO:0006885 (3%),cysteine metabolic process (3%);translation (3%);regulation of pH (3%),IPR029063 (9%);IPR001525 (8%);IPR018117 (8%),S-adenosyl-L-methionine-dependent methyltransferase (9%);C-5 cytosine methyltransferase (8%);DNA methylase, C-5 cytosine-specific, active site (8%)
AALTDAEK,Actinobacteria,Bacteria,,,,Actinobacteria,,,Actinobacteria,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR013491 (50%);IPR016040 (50%);IPR036291 (50%),Caudovirus, tape measure, N-terminal (50%);NAD(P)-binding domain (50%);NAD(P)-binding domain superfamily (50%)
LLLLVLDLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005525 (50%);GO:0008081 (50%);GO:0046872 (50%),GTP binding (50%);phosphoric diester hydrolase activity (50%);metal ion binding (50%),GO:0000917 (50%);GO:0006629 (50%),division septum assembly (50%);lipid metabolic process (50%),IPR005225 (50%);IPR006073 (50%);IPR017946 (50%),Small GTP-binding protein domain (50%);GTP binding domain (50%);PLC-like phosphodiesterase, TIM beta/alpha-barrel domain superfamily (50%)
LQPPQLLQFLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVVAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.- (12%);6.1.1.4 (10%);2.7.7.4 (8%),Methyltransferases (12%);Leucine--tRNA ligase (10%);Sulfate adenylyltransferase (8%),GO:0016021 (15%);GO:0005737 (9%);GO:0030288 (8%),integral component of membrane (15%);cytoplasm (9%);outer membrane-bounded periplasmic space (8%),GO:0003677 (15%);GO:0005524 (15%);GO:0046872 (3%),DNA binding (15%);ATP binding (15%);metal ion binding (3%),GO:0071705 (7%);GO:0002949 (4%);GO:0035556 (3%),nitrogen compound transport (7%);tRNA threonylcarbamoyladenosine modification (4%);intracellular signal transduction (3%),IPR001638 (9%);IPR018313 (9%);IPR005768 (8%),Solute-binding protein  family 3/N-terminal domain of MltF (9%);Solute-binding protein family 3, conserved site (9%);Specific amino acids and opine-binding periplasmic protein, ABC transporter (8%)
GYDLALNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QVLDGLPQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGTECLLSGWGNTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YNQVTVDTALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVVDNGSGMK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLPPETQMVESTLNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LGELLSASNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QGESNNGMAYYQLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LHQLLLPAVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPDNTLLLTDSFAN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TFENVSSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPQVLTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (60%);1.14.11.- (20%);2.7.1.90 (20%),DNA-directed RNA polymerase (60%);With 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (20%);Diphosphate--fructose-6-phosphate 1-phosphotransferase (20%),GO:0005634 (8%);GO:0016021 (7%);GO:0005737 (5%),nucleus (8%);integral component of membrane (7%);cytoplasm (5%),GO:0003677 (77%);GO:0003700 (38%);GO:0003899 (8%),DNA binding (77%);DNA-binding transcription factor activity (38%);DNA-directed 5'-3' RNA polymerase activity (8%),GO:0006351 (10%);GO:0006310 (7%);GO:0015074 (7%),transcription, DNA-templated (10%);DNA recombination (7%);DNA integration (7%),IPR000847 (44%);IPR005119 (44%);IPR036388 (44%),Transcription regulator HTH, LysR (44%);LysR, substrate-binding (44%);Winged helix-like DNA-binding domain superfamily (44%)
LLHAVEGR,Puniceicoccaceae bacterium,Bacteria,,,,Verrucomicrobia,,,Opitutae,,,,Puniceicoccales,,,,,Puniceicoccaceae,,,,,,,,Puniceicoccaceae bacterium,,,,,,,,GO:0004476 (100%);GO:0008270 (100%),mannose-6-phosphate isomerase activity (100%);zinc ion binding (100%),GO:0005975 (100%),carbohydrate metabolic process (100%),IPR001250 (100%);IPR011051 (100%);IPR014628 (100%),Mannose-6-phosphate isomerase, type I (100%);RmlC-like cupin domain superfamily (100%);Mannose-6-phosphate isomerase, Firmicutes type, short form (100%)
TAAAALGLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLLPLPLTVMQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NFLFSGGTMDAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EMLALGLAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MLLLKPLN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAGLWVR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.136 (100%);5.1.99.6 (100%),ADP-dependent NAD(P)H-hydrate dehydratase (100%);NAD(P)H-hydrate epimerase (100%),GO:0016021 (25%),integral component of membrane (25%),GO:0005524 (100%);GO:0046872 (75%);GO:0052855 (75%),ATP binding (100%);metal ion binding (75%);ADP-dependent NAD(P)H-hydrate dehydratase activity (75%),GO:0046496 (75%);GO:0006355 (25%),nicotinamide nucleotide metabolic process (75%);regulation of transcription, DNA-templated (25%),IPR004443 (67%);IPR036652 (67%);IPR000631 (50%),YjeF N-terminal domain (67%);YjeF N-terminal domain superfamily (67%);ATP-dependent (S)-NAD(P)H-hydrate dehydratase (50%)
PNTPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005623 (25%),cell (25%),GO:0003779 (50%);GO:0017048 (50%);GO:0016491 (25%),actin binding (50%);Rho GTPase binding (50%);oxidoreductase activity (25%),GO:0008360 (50%);GO:0016477 (50%);GO:0030036 (50%),regulation of cell shape (50%);cell migration (50%);actin cytoskeleton organization (50%),IPR010472 (50%);IPR010473 (50%);IPR014768 (50%),Formin, FH3 domain (50%);Formin, GTPase-binding domain (50%);Rho GTPase-binding/formin homology 3 (GBD/FH3) domain (50%)
NELMR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.10 (15%);1.17.4.1 (14%);7.1.1.- (6%),Methionine--tRNA ligase (15%);Ribonucleoside-diphosphate reductase (14%);Hydron translocation or charge separation linked to oxidoreductase reactions (6%),GO:0016021 (25%);GO:0005737 (10%);GO:0005886 (7%),integral component of membrane (25%);cytoplasm (10%);plasma membrane (7%),GO:0005524 (24%);GO:0003677 (10%);GO:0046872 (6%),ATP binding (24%);DNA binding (10%);metal ion binding (6%),GO:0006260 (5%);GO:0006935 (4%);GO:0071973 (4%),DNA replication (5%);chemotaxis (4%);bacterial-type flagellum-dependent cell motility (4%),IPR027417 (14%);IPR011009 (6%);IPR000719 (5%),P-loop containing nucleoside triphosphate hydrolase (14%);Protein kinase-like domain superfamily (6%);Protein kinase domain (5%)
DEVAPVAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FNYVLMCNK,Fluviicola chungangensis,Bacteria,,,,Bacteroidetes,,,Flavobacteriia,,,,Flavobacteriales,,,,,Crocinitomicaceae,,,,Fluviicola,,,,Fluviicola chungangensis,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,IPR002429 (100%);IPR008972 (100%);IPR011759 (100%),Cytochrome c oxidase subunit II-like C-terminal (100%);Cupredoxin (100%);Cytochrome C oxidase subunit II, transmembrane domain (100%)
QCGLNLKPPQLLNNNSGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLGVNVTK,Epulopiscium,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Lachnospiraceae,,,,Epulopiscium,,,,,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),GO:0022857 (100%),transmembrane transporter activity (100%),,,IPR000522 (100%);IPR037294 (100%),ABC transporter, permease protein, BtuC-like (100%);ABC transporter, BtuC-like (100%)
SQPGAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0016628 (100%),oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (100%),GO:0016126 (100%),sterol biosynthetic process (100%),IPR001171 (100%);IPR018083 (100%),Ergosterol biosynthesis ERG4/ERG24 (100%);Sterol reductase, conserved site (100%)
LNNQTLTAGYWMER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HELTQADVTAAFEK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VALGPER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.24.- (100%),Metalloendopeptidases (100%),GO:0016021 (86%);GO:0005886 (75%);GO:0016020 (1%),integral component of membrane (86%);plasma membrane (75%);membrane (1%),GO:0005524 (92%);GO:0008270 (75%);GO:0016887 (75%),ATP binding (92%);zinc ion binding (75%);ATPase activity (75%),GO:0030163 (75%);GO:0051301 (33%);GO:0005975 (1%),protein catabolic process (75%);cell division (33%);carbohydrate metabolic process (1%),IPR037219 (91%);IPR000642 (90%);IPR041569 (89%),Peptidase M41-like (91%);Peptidase M41 (90%);AAA ATPase, AAA+ lid domain (89%)
LPLVVAFLTA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDGNTLAASCVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GGYYFFK,Cyclobacteriaceae,Bacteria,,,,Bacteroidetes,,,Cytophagia,,,,Cytophagales,,,,,Cyclobacteriaceae,,,,,,,,,,,,,,,,,,,,,
LLLLPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.- (76%);2.1.1.56 (76%);2.7.7.48 (76%),Nucleotidyltransferases (76%);mRNA (guanine-N(7)-)-methyltransferase (76%);RNA-directed RNA polymerase (76%),GO:0005737 (51%);GO:0019012 (18%);GO:0030430 (18%),cytoplasm (51%);virion (18%);host cell cytoplasm (18%),GO:0016149 (51%);GO:0005524 (20%);GO:0003968 (18%),translation release factor activity, codon specific (51%);ATP binding (20%);RNA-directed 5'-3' RNA polymerase activity (18%),GO:0019062 (3%);GO:0039654 (3%);GO:0075512 (3%),virion attachment to host cell (3%);fusion of virus membrane with host endosome membrane (3%);clathrin-dependent endocytosis of virus by host cell (3%),IPR005139 (49%);IPR000352 (49%);IPR004373 (48%),Peptide chain release factor (49%);Peptide chain release factor class I (49%);Peptide chain release factor 1 (48%)
LEATLEVPANAGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVLPLSA,Desulfovibrio ferrophilus,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,Desulfovibrionales,,,,,Desulfovibrionaceae,,,,Desulfovibrio,,,,Desulfovibrio ferrophilus,,,,,,GO:0016021 (100%),integral component of membrane (100%),GO:0004673 (100%);GO:0005524 (100%),protein histidine kinase activity (100%);ATP binding (100%),GO:0007165 (100%),signal transduction (100%),IPR000014 (100%);IPR000700 (100%);IPR001610 (100%),PAS domain (100%);PAS-associated, C-terminal (100%);PAC motif (100%)
LPPYLFSELAALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGGDLDK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (29%);GO:0005737 (14%);GO:0031520 (14%),integral component of membrane (29%);cytoplasm (14%);plasma membrane of cell tip (14%),GO:0008168 (29%);GO:0003824 (14%);GO:0004108 (14%),methyltransferase activity (29%);catalytic activity (14%);citrate (Si)-synthase activity (14%),GO:0000160 (14%);GO:0006099 (14%);GO:0008610 (14%),phosphorelay signal transduction system (14%);tricarboxylic acid cycle (14%);lipid biosynthetic process (14%),IPR008869 (93%);IPR042245 (93%);IPR006311 (2%),Toluene tolerance Ttg2/phospholipid-binding protein MlaC (93%);Tgt2/MlaC superfamily (93%);Twin-arginine translocation pathway, signal sequence (2%)
ALANFQPDADAAVK,Acinetobacter soli,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,Pseudomonadales,,,,,Moraxellaceae,,,,Acinetobacter,,,,Acinetobacter soli,,,,,,,,,,,,IPR008869 (100%);IPR042245 (100%),Toluene tolerance Ttg2/phospholipid-binding protein MlaC (100%);Tgt2/MlaC superfamily (100%)
LGLLTR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (26%);2.4.1.25 (13%);3.1.3.- (8%),DNA helicase (26%);4-alpha-glucanotransferase (13%);Phosphoric monoester hydrolases (8%),GO:0016021 (16%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (16%);cytoplasm (5%);plasma membrane (3%),GO:0016787 (30%);GO:0005524 (16%);GO:0003677 (13%),hydrolase activity (30%);ATP binding (16%);DNA binding (13%),GO:0006281 (4%);GO:0051301 (4%);GO:0006270 (3%),DNA repair (4%);cell division (4%);DNA replication initiation (3%),IPR036412 (27%);IPR023214 (27%);IPR006439 (25%),HAD-like superfamily (27%);HAD superfamily (27%);HAD hydrolase, subfamily IA (25%)
LLAQEDGFGCR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GPLFLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.37 (25%);3.5.1.23 (25%);1.8.1.7 (8%),DNA (cytosine-5-)-methyltransferase (25%);Ceramidase (25%);Glutathione-disulfide reductase (8%),GO:0016021 (43%);GO:0031227 (12%);GO:0031234 (12%),integral component of membrane (43%);intrinsic component of endoplasmic reticulum membrane (12%);extrinsic component of cytoplasmic side of plasma membrane (12%),GO:0008289 (23%);GO:0005524 (17%);GO:0016740 (8%),lipid binding (23%);ATP binding (17%);transferase activity (8%),GO:0006869 (28%);GO:0061817 (27%);GO:0046514 (3%),lipid transport (28%);endoplasmic reticulum-plasma membrane tethering (27%);ceramide catabolic process (3%),IPR000008 (24%);IPR035892 (24%);IPR039010 (23%),C2 domain (24%);C2 domain superfamily (24%);Synaptotagmin, SMP domain (23%)
NLPLYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.11 (28%);3.4.21.89 (15%);3.4.11.- (8%),Phosphopyruvate hydratase (28%);Signal peptidase I (15%);Aminopeptidases (8%),GO:0016021 (21%);GO:0009538 (6%);GO:0000015 (4%),integral component of membrane (21%);photosystem I reaction center (6%);phosphopyruvate hydratase complex (4%),GO:0046872 (23%);GO:0016624 (12%);GO:0008270 (9%),metal ion binding (23%);oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor (12%);zinc ion binding (9%),GO:0009767 (6%);GO:0031222 (5%);GO:0006096 (5%),photosynthetic electron transport chain (6%);arabinan catabolic process (5%);glycolytic process (5%),IPR031100 (27%);IPR001017 (10%);IPR005475 (10%),LOG family (27%);Dehydrogenase, E1 component (10%);Transketolase-like, pyrimidine-binding domain (10%)
LPPYLLALMAALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.11.1 (7%);2.7.13.3 (6%);2.7.7.72 (3%),Non-specific serine/threonine protein kinase (7%);Histidine kinase (6%);CCA tRNA nucleotidyltransferase (3%),GO:0016021 (17%);GO:0005737 (8%);GO:0005634 (3%),integral component of membrane (17%);cytoplasm (8%);nucleus (3%),GO:0005524 (23%);GO:0003677 (13%);GO:0046872 (5%),ATP binding (23%);DNA binding (13%);metal ion binding (5%),GO:0015937 (4%);GO:0006355 (4%);GO:0006633 (3%),coenzyme A biosynthetic process (4%);regulation of transcription, DNA-templated (4%);fatty acid biosynthetic process (3%),IPR007157 (12%);IPR027417 (10%);IPR014319 (6%),PspA/IM30 (12%);P-loop containing nucleoside triphosphate hydrolase (10%);Phage shock protein, PspA (6%)
LQLLLLLLL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TVDPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.3.16 (6%);3.1.3.5 (6%);2.7.1.90 (5%),Citrate synthase (unknown stereospecificity) (6%);5'-nucleotidase (6%);Diphosphate--fructose-6-phosphate 1-phosphotransferase (5%),GO:0016021 (39%);GO:0005737 (6%);GO:0005886 (2%),integral component of membrane (39%);cytoplasm (6%);plasma membrane (2%),GO:0047617 (6%);GO:0005524 (6%);GO:0046912 (6%),acyl-CoA hydrolase activity (6%);ATP binding (6%);transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer (6%),GO:0006637 (6%);GO:0006099 (4%);GO:0006011 (2%),acyl-CoA metabolic process (6%);tricarboxylic acid cycle (4%);UDP-glucose metabolic process (2%),IPR003772 (9%);IPR029069 (6%);IPR003703 (6%),Large ribosomal RNA subunit accumulation protein YceD (9%);HotDog domain superfamily (6%);Acyl-CoA thioesterase (6%)
GNCPLHYQK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PGAVLSVPFALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FHVVLVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005840 (25%);GO:0016021 (25%),ribosome (25%);integral component of membrane (25%),GO:0003677 (50%);GO:0015299 (25%),DNA binding (50%);solute:proton antiporter activity (25%),GO:0006310 (50%);GO:0015074 (50%),DNA recombination (50%);DNA integration (50%),IPR002104 (50%);IPR011010 (50%);IPR013762 (50%),Integrase, catalytic domain (50%);DNA breaking-rejoining enzyme, catalytic core (50%);Integrase-like, catalytic domain superfamily (50%)
HLAAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.2.1.1 (25%);3.1.1.61 (14%);2.1.1.79 (7%),Transketolase (25%);Protein-glutamate methylesterase (14%);Cyclopropane-fatty-acyl-phospholipid synthase (7%),GO:0005737 (10%);GO:0016021 (9%);GO:0005634 (3%),cytoplasm (10%);integral component of membrane (9%);nucleus (3%),GO:0008168 (14%);GO:0046872 (11%);GO:0005524 (9%),methyltransferase activity (14%);metal ion binding (11%);ATP binding (9%),GO:0008610 (19%);GO:0032259 (16%);GO:0006935 (4%),lipid biosynthetic process (19%);methylation (16%);chemotaxis (4%),IPR029063 (22%);IPR003333 (19%);IPR027417 (8%),S-adenosyl-L-methionine-dependent methyltransferase (22%);Mycolic acid cyclopropane synthase (19%);P-loop containing nucleoside triphosphate hydrolase (8%)
AVDAGFGHPEQHLTR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VLKPNVFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003824 (82%);GO:0051536 (82%);GO:0016491 (18%),catalytic activity (82%);iron-sulfur cluster binding (82%);oxidoreductase activity (18%),,,IPR007197 (84%);IPR013785 (84%);IPR036485 (16%),Radical SAM (84%);Aldolase-type TIM barrel (84%);Glutamate synthase, alpha subunit, C-terminal domain superfamily (16%)
AVTVSAVLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SVELDLEAAAATA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FDLPSELSPGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMADWTLFR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LEESGTLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0003700 (40%);GO:0036094 (40%);GO:0043565 (40%),DNA-binding transcription factor activity (40%);small molecule binding (40%);sequence-specific DNA binding (40%),GO:0005975 (20%),carbohydrate metabolic process (20%),IPR013783 (50%);IPR003598 (38%);IPR003599 (38%),Immunoglobulin-like fold (50%);Immunoglobulin subtype 2 (38%);Immunoglobulin subtype (38%)
LDVLEGNEQF,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NAVLAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.1.4.11 (21%);2.1.1.198 (7%);2.7.7.7 (6%),Phosphoinositide phospholipase C (21%);16S rRNA (cytidine(1402)-2'-O)-methyltransferase (7%);DNA-directed DNA polymerase (6%),GO:0016021 (17%);GO:0005737 (8%);GO:0005887 (3%),integral component of membrane (17%);cytoplasm (8%);integral component of plasma membrane (3%),GO:0005524 (13%);GO:0003677 (7%);GO:0016491 (6%),ATP binding (13%);DNA binding (7%);oxidoreductase activity (6%),GO:0016042 (4%);GO:0006351 (4%);GO:0035556 (4%),lipid catabolic process (4%);transcription, DNA-templated (4%);intracellular signal transduction (4%),IPR036322 (9%);IPR000664 (9%);IPR013577 (9%),WD40-repeat-containing domain superfamily (9%);Lethal(2) giant larvae protein (9%);Lethal giant larvae homologue 2 (9%)
AQQQPQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (36%),integral component of membrane (36%),GO:0005524 (36%);GO:0004674 (29%);GO:0003676 (14%),ATP binding (36%);protein serine/threonine kinase activity (29%);nucleic acid binding (14%),GO:0031047 (14%),gene silencing by RNA (14%),IPR000719 (38%);IPR008271 (38%);IPR011009 (38%),Protein kinase domain (38%);Serine/threonine-protein kinase, active site (38%);Protein kinase-like domain superfamily (38%)
MSLTSLADLTLLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NGVVLGQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVGGYTCVSLNS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPFAAALR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (67%);5.4.2.2 (33%),DNA helicase (67%);Phosphoglucomutase (alpha-D-glucose-1,6-bisphosphate-dependent) (33%),GO:0016021 (57%);GO:0005737 (14%),integral component of membrane (57%);cytoplasm (14%),GO:0000287 (14%);GO:0003677 (14%);GO:0003678 (14%),magnesium ion binding (14%);DNA binding (14%);DNA helicase activity (14%),GO:0005975 (14%);GO:0006268 (14%);GO:0000162 (7%),carbohydrate metabolic process (14%);DNA unwinding involved in DNA replication (14%);tryptophan biosynthetic process (7%),IPR000212 (20%);IPR005751 (20%);IPR005843 (20%),DNA helicase, UvrD/REP type (20%);ATP-dependent DNA helicase PcrA (20%);Alpha-D-phosphohexomutase, C-terminal (20%)
DGFYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.2.2 (51%);5.2.1.8 (16%);6.3.5.3 (4%),Gamma-glutamyltransferase (51%);Peptidylprolyl isomerase (16%);Phosphoribosylformylglycinamidine synthase (4%),GO:0016021 (19%);GO:0009279 (4%);GO:0030286 (2%),integral component of membrane (19%);cell outer membrane (4%);dynein complex (2%),GO:0036374 (30%);GO:0016740 (17%);GO:0005524 (15%),glutathione hydrolase activity (30%);transferase activity (17%);ATP binding (15%),GO:0006751 (30%);GO:0006865 (3%);GO:0006457 (3%),glutathione catabolic process (30%);amino acid transport (3%);protein folding (3%),IPR029055 (33%);IPR000101 (25%);IPR027417 (12%),Nucleophile aminohydrolases, N-terminal (33%);Gamma-glutamyltranspeptidase (25%);P-loop containing nucleoside triphosphate hydrolase (12%)
NSADK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.43 (8%);2.4.1.21 (7%);3.1.-.- (7%),Transferred entry: 2.1.1.354 (8%);Starch synthase (7%);Acting on ester bonds (7%),GO:0016021 (35%);GO:0005737 (8%);GO:0000922 (5%),integral component of membrane (35%);cytoplasm (8%);spindle pole (5%),GO:0005524 (14%);GO:0003677 (7%);GO:0046872 (5%),ATP binding (14%);DNA binding (7%);metal ion binding (5%),GO:0007020 (4%);GO:0055085 (2%);GO:0006412 (2%),microtubule nucleation (4%);transmembrane transport (2%);translation (2%),IPR027417 (7%);IPR040457 (4%);IPR042241 (4%),P-loop containing nucleoside triphosphate hydrolase (7%);Gamma tubulin complex component, C-terminal (4%);Gamma-tubulin complex, C-terminal domain superfamily (4%)
LAAHLVET,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NALLSPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.16 (69%);2.1.1.- (15%);3.4.24.- (8%),Spermidine synthase (69%);Methyltransferases (15%);Metalloendopeptidases (8%),GO:0016021 (57%);GO:0005886 (30%);GO:0005634 (8%),integral component of membrane (57%);plasma membrane (30%);nucleus (8%),GO:0016740 (25%);GO:0004766 (23%);GO:0008658 (15%),transferase activity (25%);spermidine synthase activity (23%);penicillin binding (15%),GO:0008295 (23%);GO:0018026 (5%);GO:0005975 (3%),spermidine biosynthetic process (23%);peptidyl-lysine monomethylation (5%);carbohydrate metabolic process (3%),IPR001045 (20%);IPR029063 (20%);IPR030374 (20%),Spermidine/spermine synthases (20%);S-adenosyl-L-methionine-dependent methyltransferase (20%);Polyamine biosynthesis  domain (20%)
LLASK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.15 (16%);3.6.4.12 (6%);1.2.1.11 (6%),Glycerol-3-phosphate 1-O-acyltransferase (16%);DNA helicase (6%);Aspartate-semialdehyde dehydrogenase (6%),GO:0016021 (20%);GO:0005737 (7%);GO:0005886 (5%),integral component of membrane (20%);cytoplasm (7%);plasma membrane (5%),GO:0005524 (15%);GO:0003677 (10%);GO:0016757 (6%),ATP binding (15%);DNA binding (10%);transferase activity, transferring glycosyl groups (6%),GO:0016024 (3%);GO:0006281 (2%);GO:0006886 (2%),CDP-diacylglycerol biosynthetic process (3%);DNA repair (2%);intracellular protein transport (2%),IPR027417 (10%);IPR016024 (5%);IPR036291 (5%),P-loop containing nucleoside triphosphate hydrolase (10%);Armadillo-type fold (5%);NAD(P)-binding domain superfamily (5%)
LGGKPPYLVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GALLLAVLLDGR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GGAPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.13 (13%);5.4.99.- (7%);3.6.4.12 (6%),RNA helicase (13%);Transferring other groups (7%);DNA helicase (6%),GO:0016021 (20%);GO:0005737 (5%);GO:0005886 (4%),integral component of membrane (20%);cytoplasm (5%);plasma membrane (4%),GO:0004252 (16%);GO:0005524 (13%);GO:0003723 (13%),serine-type endopeptidase activity (16%);ATP binding (13%);RNA binding (13%),GO:0008295 (4%);GO:0006597 (3%);GO:0006364 (3%),spermidine biosynthetic process (4%);spermine biosynthetic process (3%);rRNA processing (3%),IPR036852 (13%);IPR000209 (13%);IPR015500 (12%),Peptidase S8/S53 domain superfamily (13%);Peptidase S8/S53 domain (13%);Peptidase S8, subtilisin-related (12%)
LDHQQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.2.1.70 (17%);2.4.-.- (17%);2.7.3.9 (17%),Glutamyl-tRNA reductase (17%);Glycosyltransferases (17%);Phosphoenolpyruvate--protein phosphotransferase (17%),GO:0016021 (24%);GO:0043190 (6%);GO:0005694 (2%),integral component of membrane (24%);ATP-binding cassette (ABC) transporter complex (6%);chromosome (2%),GO:0003677 (36%);GO:0005524 (31%);GO:0008094 (29%),DNA binding (36%);ATP binding (31%);DNA-dependent ATPase activity (29%),GO:0006281 (31%);GO:0055085 (6%);GO:0006265 (2%),DNA repair (31%);transmembrane transport (6%);DNA topological change (2%),IPR027417 (35%);IPR013632 (32%);IPR020588 (32%),P-loop containing nucleoside triphosphate hydrolase (35%);DNA recombination and repair protein Rad51-like, C-terminal (32%);DNA recombination and repair protein RecA-like, ATP-binding domain (32%)
GYLTLDTSDDNLLPDDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FMPLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.3.4.18 (24%);2.1.1.- (13%);4.3.2.1 (11%),5-(carboxyamino)imidazole ribonucleotide synthase (24%);Methyltransferases (13%);Argininosuccinate lyase (11%),GO:0016021 (24%);GO:0015935 (11%);GO:0005840 (4%),integral component of membrane (24%);small ribosomal subunit (11%);ribosome (4%),GO:0046872 (21%);GO:0003735 (14%);GO:0005524 (14%),metal ion binding (21%);structural constituent of ribosome (14%);ATP binding (14%),GO:0006412 (17%);GO:0055085 (5%);GO:0006397 (4%),translation (17%);transmembrane transport (5%);mRNA processing (4%),IPR002222 (12%);IPR023575 (12%);IPR005713 (11%),Ribosomal protein S19/S15 (12%);Ribosomal protein S19, superfamily (12%);Ribosomal protein S19A/S15e (11%)
ASVAAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.15 (22%);2.1.1.72 (6%);2.7.2.4 (5%),Dihydropteroate synthase (22%);Site-specific DNA-methyltransferase (adenine-specific) (6%);Aspartate kinase (5%),GO:0016021 (17%);GO:0005737 (3%);GO:0005887 (3%),integral component of membrane (17%);cytoplasm (3%);integral component of plasma membrane (3%),GO:0003677 (23%);GO:0005524 (14%);GO:0016987 (11%),DNA binding (23%);ATP binding (14%);sigma factor activity (11%),GO:0006352 (10%);GO:0006355 (2%);GO:0046654 (2%),DNA-templated transcription, initiation (10%);regulation of transcription, DNA-templated (2%);tetrahydrofolate biosynthetic process (2%),IPR036388 (11%);IPR027417 (9%);IPR007627 (8%),Winged helix-like DNA-binding domain superfamily (11%);P-loop containing nucleoside triphosphate hydrolase (9%);RNA polymerase sigma-70 region 2 (8%)
LHLALTAYLLAV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLLSSSSLPLS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVMLRPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.3.- (100%),Acting on phosphates (100%),GO:0009279 (50%);GO:0016021 (50%),cell outer membrane (50%);integral component of membrane (50%),GO:0015344 (50%);GO:0016829 (50%);GO:0038023 (50%),siderophore uptake transmembrane transporter activity (50%);lyase activity (50%);signaling receptor activity (50%),,,IPR000531 (50%);IPR008949 (50%);IPR010105 (50%),TonB-dependent receptor-like, beta-barrel (50%);Isoprenoid synthase domain superfamily (50%);TonB-dependent siderophore receptor (50%)
QVATLVAALK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLGVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.53 (63%);4.3.99.3 (8%);4.2.1.3 (3%),Endopeptidase La (63%);7-carboxy-7-deazaguanine synthase (8%);Aconitate hydratase (3%),GO:0016021 (26%);GO:0005737 (21%);GO:0005886 (8%),integral component of membrane (26%);cytoplasm (21%);plasma membrane (8%),GO:0005524 (24%);GO:0004252 (22%);GO:0004176 (18%),ATP binding (24%);serine-type endopeptidase activity (22%);ATP-dependent peptidase activity (18%),GO:0006515 (17%);GO:0034605 (17%);GO:0055117 (5%),protein quality control for misfolded or incompletely synthesized proteins (17%);cellular response to heat (17%);regulation of cardiac muscle contraction (5%),IPR027417 (19%);IPR003593 (16%);IPR003959 (15%),P-loop containing nucleoside triphosphate hydrolase (19%);AAA+ ATPase domain (16%);ATPase, AAA-type, core (15%)
NLLAGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.3.1.179 (42%);2.7.6.5 (7%);2.7.7.7 (7%),Beta-ketoacyl-[acyl-carrier-protein] synthase II (42%);GTP diphosphokinase (7%);DNA-directed DNA polymerase (7%),GO:0016021 (15%);GO:0005886 (6%);GO:0005737 (5%),integral component of membrane (15%);plasma membrane (6%);cytoplasm (5%),GO:0005524 (15%);GO:0033817 (15%);GO:0003677 (9%),ATP binding (15%);beta-ketoacyl-acyl-carrier-protein synthase II activity (15%);DNA binding (9%),GO:0006633 (18%);GO:0015969 (5%);GO:0006260 (4%),fatty acid biosynthetic process (18%);guanosine tetraphosphate metabolic process (5%);DNA replication (4%),IPR016039 (16%);IPR014030 (16%);IPR014031 (15%),Thiolase-like (16%);Beta-ketoacyl synthase, N-terminal (16%);Beta-ketoacyl synthase, C-terminal (15%)
VLATEGGPVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YNFTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.60 (19%);2.7.7.6 (10%);3.1.21.5 (7%),2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (19%);DNA-directed RNA polymerase (10%);Type III site-specific deoxyribonuclease (7%),GO:0016021 (26%);GO:0009279 (6%);GO:0005737 (5%),integral component of membrane (26%);cell outer membrane (6%);cytoplasm (5%),GO:0003677 (38%);GO:0003700 (29%);GO:0046872 (12%),DNA binding (38%);DNA-binding transcription factor activity (29%);metal ion binding (12%),GO:0010628 (3%);GO:0010976 (3%);GO:0019288 (2%),positive regulation of gene expression (3%);positive regulation of neuron projection development (3%);isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (2%),IPR036390 (26%);IPR037171 (26%);IPR014036 (26%),Winged helix DNA-binding domain superfamily (26%);NagB/RpiA transferase-like (26%);DeoR C-terminal sensor domain (26%)
ADHAGQGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLPVLMLTAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0030428 (8%);GO:0016021 (3%),cell septum (8%);integral component of membrane (3%),GO:0003677 (77%);GO:0000156 (11%);GO:0000155 (2%),DNA binding (77%);phosphorelay response regulator activity (11%);phosphorelay sensor kinase activity (2%),GO:0000160 (87%);GO:0006355 (74%);GO:0006817 (11%),phosphorelay signal transduction system (87%);regulation of transcription, DNA-templated (74%);phosphate ion transport (11%),IPR001789 (100%);IPR011006 (100%);IPR039420 (89%),Signal transduction response regulator, receiver domain (100%);CheY-like superfamily (100%);Transcriptional regulatory protein WalR-like (89%)
HNLDVLEGNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SNNALNNLYSLLMSGGNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EQMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.8.3.10 (12%);4.1.3.6 (12%);6.3.4.14 (12%),Citrate CoA-transferase (12%);Citrate (pro-3S)-lyase (12%);Biotin carboxylase (12%),GO:0016021 (19%);GO:0005737 (5%);GO:0005634 (4%),integral component of membrane (19%);cytoplasm (5%);nucleus (4%),GO:0003677 (26%);GO:0005524 (12%);GO:0008270 (5%),DNA binding (26%);ATP binding (12%);zinc ion binding (5%),GO:0006633 (3%);GO:0006084 (3%);GO:2001295 (3%),fatty acid biosynthetic process (3%);acetyl-CoA metabolic process (3%);malonyl-CoA biosynthetic process (3%),IPR009057 (9%);IPR001647 (9%);IPR036271 (8%),Homeobox-like domain superfamily (9%);DNA-binding HTH domain, TetR-type (9%);Tetracyclin repressor-like, C-terminal domain superfamily (8%)
QETVNFGSQNLYNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVLANAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.99.12 (75%);1.2.1.2 (25%),Lipid IV(A) 3-deoxy-D-manno-octulosonic acid transferase (75%);Transferred entry: 1.17.1.9 (25%),GO:0016021 (24%);GO:0005886 (14%),integral component of membrane (24%);plasma membrane (14%),GO:0000155 (31%);GO:0005524 (31%);GO:0016740 (10%),phosphorelay sensor kinase activity (31%);ATP binding (31%);transferase activity (10%),GO:0006355 (28%);GO:0009244 (10%);GO:0006284 (7%),regulation of transcription, DNA-templated (28%);lipopolysaccharide core region biosynthetic process (10%);base-excision repair (7%),IPR000014 (36%);IPR035965 (36%);IPR003594 (27%),PAS domain (36%);PAS domain superfamily (36%);Histidine kinase/HSP90-like ATPase (27%)
HVLDHALLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPGVNPLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPSAPK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.3 (93%);4.2.1.99 (90%);3.1.4.4 (1%),Aconitate hydratase (93%);2-methylisocitrate dehydratase (90%);Phospholipase D (1%),GO:0005829 (56%);GO:0005840 (15%);GO:0016021 (6%),cytosol (56%);ribosome (15%);integral component of membrane (6%),GO:0051539 (54%);GO:0003994 (54%);GO:0047780 (54%),4 iron, 4 sulfur cluster binding (54%);aconitate hydratase activity (54%);citrate dehydratase activity (54%),GO:0006099 (54%);GO:0006412 (17%);GO:0006265 (1%),tricarboxylic acid cycle (54%);translation (17%);DNA topological change (1%),IPR004406 (52%);IPR015931 (52%);IPR036008 (52%),Aconitase B (52%);Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha, subdomain 1/3 (52%);Aconitase, iron-sulfur domain (52%)
LALAFSLAAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DLQAVQR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.228 (50%);3.6.4.12 (50%),tRNA (guanine(37)-N(1))-methyltransferase (50%);DNA helicase (50%),GO:0005737 (9%),cytoplasm (9%),GO:0003700 (27%);GO:0008920 (27%);GO:0003824 (18%),DNA-binding transcription factor activity (27%);lipopolysaccharide heptosyltransferase activity (27%);catalytic activity (18%),GO:0009244 (27%);GO:0009116 (9%),lipopolysaccharide core region biosynthetic process (27%);nucleoside metabolic process (9%),IPR027417 (38%);IPR001845 (23%);IPR002201 (23%),P-loop containing nucleoside triphosphate hydrolase (38%);HTH ArsR-type DNA-binding domain (23%);Glycosyl transferase, family 9 (23%)
LLESGVSPNLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPLVSDLK,Fusobacterium,Bacteria,,,,Fusobacteria,,,Fusobacteriia,,,,Fusobacteriales,,,,,Fusobacteriaceae,,,,Fusobacterium,,,,,,,,,,GO:0009279 (100%);GO:0016021 (100%),cell outer membrane (100%);integral component of membrane (100%),,,,,IPR000531 (100%);IPR010917 (100%);IPR012910 (100%),TonB-dependent receptor-like, beta-barrel (100%);TonB-dependent receptor, conserved site (100%);TonB-dependent receptor, plug domain (100%)
NLNGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.9 (8%);2.1.2.1 (5%);3.6.4.12 (4%),Glucose-6-phosphate isomerase (8%);Glycine hydroxymethyltransferase (5%);DNA helicase (4%),GO:0005737 (32%);GO:0009380 (27%);GO:0016021 (21%),cytoplasm (32%);excinuclease repair complex (27%);integral component of membrane (21%),GO:0005524 (34%);GO:0003677 (32%);GO:0016887 (27%),ATP binding (34%);DNA binding (32%);ATPase activity (27%),GO:0006289 (28%);GO:0009432 (28%);GO:0006396 (4%),nucleotide-excision repair (28%);SOS response (28%);RNA processing (4%),IPR027417 (26%);IPR001650 (23%);IPR004807 (22%),P-loop containing nucleoside triphosphate hydrolase (26%);Helicase, C-terminal (23%);UvrABC system, subunit B (22%)
NMLLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.33 (18%);3.5.1.88 (11%);4.1.2.40 (5%),3-isopropylmalate dehydratase (18%);Peptide deformylase (11%);Tagatose-bisphosphate aldolase (5%),GO:0016021 (22%);GO:0016459 (8%);GO:0005737 (8%),integral component of membrane (22%);myosin complex (8%);cytoplasm (8%),GO:0005524 (21%);GO:0046872 (10%);GO:0003779 (8%),ATP binding (21%);metal ion binding (10%);actin binding (8%),GO:0009098 (4%);GO:0006412 (4%);GO:0006281 (2%),leucine biosynthetic process (4%);translation (4%);DNA repair (2%),IPR027417 (17%);IPR001609 (7%);IPR036961 (7%),P-loop containing nucleoside triphosphate hydrolase (17%);Myosin head, motor domain (7%);Kinesin motor domain superfamily (7%)
VLNGAK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.25 (20%);2.2.1.6 (18%);3.1.4.52 (8%),tRNA pseudouridine(55) synthase (20%);Acetolactate synthase (18%);Cyclic-guanylate-specific phosphodiesterase (8%),GO:0016021 (30%);GO:0005886 (15%);GO:0005737 (3%),integral component of membrane (30%);plasma membrane (15%);cytoplasm (3%),GO:0016787 (11%);GO:0003676 (11%);GO:0016616 (9%),hydrolase activity (11%);nucleic acid binding (11%);oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (9%),GO:0051301 (21%);GO:0008360 (15%);GO:0009252 (14%),cell division (21%);regulation of cell shape (15%);peptidoglycan biosynthetic process (14%),IPR001182 (18%);IPR018365 (17%);IPR013437 (12%),Probable peptidoglycan glycosyltransferase FtsW/RodA (18%);Cell cycle, FtsW / RodA / SpoVE, conserved site (17%);Probable peptidoglycan glycosyltransferase FtsW (12%)
ALATTGPK,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR005064 (100%);IPR042100 (100%);IPR006311 (9%),Bordetella uptake gene (100%);Bordetella uptake gene, domain 1 (100%);Twin-arginine translocation pathway, signal sequence (9%)
YEELQLTAG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDPLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.16.3.1 (14%);2.4.1.- (6%);2.7.7.7 (5%),Ferroxidase (14%);Hexosyltransferases (6%);DNA-directed DNA polymerase (5%),GO:0016021 (27%);GO:0005737 (8%);GO:0005886 (6%),integral component of membrane (27%);cytoplasm (8%);plasma membrane (6%),GO:0005524 (12%);GO:0003677 (8%);GO:0003676 (6%),ATP binding (12%);DNA binding (8%);nucleic acid binding (6%),GO:0006260 (5%);GO:0015074 (3%);GO:0006355 (3%),DNA replication (5%);DNA integration (3%);regulation of transcription, DNA-templated (3%),IPR027417 (11%);IPR011990 (5%);IPR019734 (4%),P-loop containing nucleoside triphosphate hydrolase (11%);Tetratricopeptide-like helical domain superfamily (5%);Tetratricopeptide repeat (4%)
SSTAGANPLLNTTATASSESR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TLGFESYFLTVADLTDMAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VVGTGQER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLAGAGGK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005886 (17%);GO:0016021 (17%),plasma membrane (17%);integral component of membrane (17%),GO:0000287 (50%);GO:0003924 (50%);GO:0005525 (50%),magnesium ion binding (50%);GTPase activity (50%);GTP binding (50%),GO:0002229 (17%);GO:0006520 (17%);GO:0015979 (17%),defense response to oomycetes (17%);cellular amino acid metabolic process (17%);photosynthesis (17%),IPR006169 (29%);IPR036726 (29%);IPR006073 (21%),GTP1/OBG domain (29%);GTP1/OBG domain superfamily (29%);GTP binding domain (21%)
SFVFTGFR,Mimiviridae,Viruses,,,,,,,,,,,,,,,,Mimiviridae,,,,,,,,,,,,,,,,GO:0000166 (100%);GO:0003911 (100%),nucleotide binding (100%);DNA ligase (NAD+) activity (100%),GO:0006260 (100%);GO:0006281 (100%),DNA replication (100%);DNA repair (100%),IPR001357 (100%);IPR004150 (100%);IPR010995 (100%),BRCT domain (100%);NAD-dependent DNA ligase, OB-fold (100%);DNA repair Rad51/transcription factor NusA, alpha-helical (100%)
ESMTSVNLNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VALGMYYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FLNPM,Desulfuromonadaceae,Bacteria,,,,Proteobacteria,delta/epsilon subdivisions,,Deltaproteobacteria,,,,Desulfuromonadales,,,,,Desulfuromonadaceae,,,,,,,,,,,,,,,,,,,,IPR025420 (100%);IPR027417 (50%);IPR041682 (50%),Domain of unknown function DUF4143 (100%);P-loop containing nucleoside triphosphate hydrolase (50%);AAA domain, group 14 (50%)
NVADLEQVALR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NLQDLVLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (50%),integral component of membrane (50%),,,GO:0055085 (50%),transmembrane transport (50%),IPR011990 (50%);IPR013026 (50%);IPR018389 (50%),Tetratricopeptide-like helical domain superfamily (50%);Tetratricopeptide repeat-containing domain (50%);TRAP transporter solute receptor DctP/TeaA (50%)
FLHGDHER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VGLQSLGVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSVGEQVTPG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LDVLEQNGE,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NVLYTGT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
TALFFTGGTLK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFDLTAGAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AAGSHTGMGNLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSHYPEVR,Proteobacteria,Bacteria,,,,Proteobacteria,,,,,,,,,,,,,,,,,,,,,,,,2.7.4.25 (100%),(d)CMP kinase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0004127 (100%);GO:0005524 (100%),cytidylate kinase activity (100%);ATP binding (100%),GO:0006220 (100%),pyrimidine nucleotide metabolic process (100%),IPR003136 (100%);IPR011994 (100%);IPR027417 (100%),Cytidylate kinase (100%);Cytidylate kinase domain (100%);P-loop containing nucleoside triphosphate hydrolase (100%)
GLGLDGCGGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPVER,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.5.1.120 (22%);2.1.1.14 (12%);5.4.99.- (5%),Aminodeoxyfutalosine synthase (22%);5-methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (12%);Transferring other groups (5%),GO:0016021 (25%);GO:0005737 (5%);GO:0005886 (3%),integral component of membrane (25%);cytoplasm (5%);plasma membrane (3%),GO:0005524 (14%);GO:0051539 (8%);GO:0003677 (7%),ATP binding (14%);4 iron, 4 sulfur cluster binding (8%);DNA binding (7%),GO:0009234 (6%);GO:0032259 (4%);GO:0009086 (3%),menaquinone biosynthetic process (6%);methylation (4%);methionine biosynthetic process (3%),IPR013785 (8%);IPR007197 (7%);IPR027417 (6%),Aldolase-type TIM barrel (8%);Radical SAM (7%);P-loop containing nucleoside triphosphate hydrolase (6%)
TLAVNAAQDATDLVAK,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005737 (74%);GO:0005634 (2%);GO:0005832 (2%),cytoplasm (74%);nucleus (2%);chaperonin-containing T-complex (2%),GO:0005524 (100%);GO:0051082 (96%);GO:0003677 (2%),ATP binding (100%);unfolded protein binding (96%);DNA binding (2%),GO:0006457 (96%),protein folding (96%),IPR002423 (100%);IPR027413 (100%);IPR027409 (98%),Chaperonin Cpn60/TCP-1 family (100%);GroEL-like equatorial domain superfamily (100%);GroEL-like apical domain superfamily (98%)
NLMLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.12 (37%);6.1.1.23 (27%);3.3.2.9 (7%),Aspartate--tRNA ligase (37%);Aspartate--tRNA(Asn) ligase (27%);Microsomal epoxide hydrolase (7%),GO:0005737 (28%);GO:0016021 (20%);GO:0005789 (3%),cytoplasm (28%);integral component of membrane (20%);endoplasmic reticulum membrane (3%),GO:0005524 (40%);GO:0004815 (25%);GO:0003676 (24%),ATP binding (40%);aspartate-tRNA ligase activity (25%);nucleic acid binding (24%),GO:0006422 (24%);GO:0032259 (4%);GO:0006396 (3%),aspartyl-tRNA aminoacylation (24%);methylation (4%);RNA processing (3%),IPR012340 (25%);IPR006195 (22%);IPR004524 (22%),Nucleic acid-binding, OB-fold (25%);Aminoacyl-tRNA synthetase, class II (22%);Aspartate-tRNA ligase, type 1 (22%)
YGGEPLVQLAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LAVEYFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.21 (50%);4.2.1.70 (50%),Beta-glucosidase (50%);Pseudouridylate synthase (50%),GO:0016021 (24%);GO:0005886 (16%);GO:0005634 (4%),integral component of membrane (24%);plasma membrane (16%);nucleus (4%),GO:0004553 (32%);GO:0004730 (16%);GO:0008422 (16%),hydrolase activity, hydrolyzing O-glycosyl compounds (32%);pseudouridylate synthase activity (16%);beta-glucosidase activity (16%),GO:0005975 (48%);GO:0046113 (16%);GO:0006352 (4%),carbohydrate metabolic process (48%);nucleobase catabolic process (16%);DNA-templated transcription, initiation (4%),IPR001764 (43%);IPR002772 (43%);IPR008979 (43%),Glycoside hydrolase, family 3, N-terminal (43%);Glycoside hydrolase family 3 C-terminal domain (43%);Galactose-binding-like domain superfamily (43%)
AQGFK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.3.1.5 (38%);2.6.1.87 (5%);2.7.7.6 (4%),Xylose isomerase (38%);UDP-4-amino-4-deoxy-L-arabinose aminotransferase (5%);DNA-directed RNA polymerase (4%),GO:0005737 (15%);GO:0016021 (11%);GO:0016020 (3%),cytoplasm (15%);integral component of membrane (11%);membrane (3%),GO:0000287 (12%);GO:0009045 (10%);GO:0046872 (9%),magnesium ion binding (12%);xylose isomerase activity (10%);metal ion binding (9%),GO:0042732 (10%);GO:0005975 (7%);GO:0042981 (3%),D-xylose metabolic process (10%);carbohydrate metabolic process (7%);regulation of apoptotic process (3%),IPR013126 (10%);IPR018181 (10%);IPR042054 (9%),Heat shock protein 70 family (10%);Heat shock protein 70, conserved site (10%);YegD-like (9%)
LEFQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.2.1.23 (12%);3.6.4.12 (11%);2.7.7.7 (7%),Beta-galactosidase (12%);DNA helicase (11%);DNA-directed DNA polymerase (7%),GO:0016021 (22%);GO:0016459 (14%);GO:0005737 (7%),integral component of membrane (22%);myosin complex (14%);cytoplasm (7%),GO:0005524 (31%);GO:0003774 (14%);GO:0051015 (11%),ATP binding (31%);motor activity (14%);actin filament binding (11%),GO:0006233 (3%);GO:0007224 (3%);GO:0006281 (2%),dTDP biosynthetic process (3%);smoothened signaling pathway (3%);DNA repair (2%),IPR027417 (24%);IPR000048 (11%);IPR036961 (11%),P-loop containing nucleoside triphosphate hydrolase (24%);IQ motif, EF-hand binding site (11%);Kinesin motor domain superfamily (11%)
LLQLVLGHLQ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HLLVVCLLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CTLGELSDALEK,Halobacteriovorax marinus,Bacteria,,,,Proteobacteria,,,Oligoflexia,,,,Bacteriovoracales,,,,,Halobacteriovoraceae,,,,Halobacteriovorax,,,,Halobacteriovorax marinus,,,,,,,,GO:0004494 (100%);GO:0031419 (100%);GO:0046872 (100%),methylmalonyl-CoA mutase activity (100%);cobalamin binding (100%);metal ion binding (100%),,,IPR006098 (100%);IPR006099 (100%);IPR006158 (100%),Methylmalonyl-CoA mutase, alpha chain, catalytic (100%);Methylmalonyl-CoA mutase, alpha/beta chain, catalytic (100%);Cobalamin (vitamin B12)-binding domain (100%)
GMHLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7.6.2.- (21%);2.7.7.7 (11%);2.3.2.8 (9%),Linked to the hydrolysis of a nucleoside triphosphate (21%);DNA-directed DNA polymerase (11%);Arginyltransferase (9%),GO:0016021 (21%);GO:0005737 (6%);GO:0005886 (6%),integral component of membrane (21%);cytoplasm (6%);plasma membrane (6%),GO:0005524 (23%);GO:0004252 (6%);GO:0003677 (6%),ATP binding (23%);serine-type endopeptidase activity (6%);DNA binding (6%),GO:0006541 (6%);GO:0009058 (3%);GO:0006355 (2%),glutamine metabolic process (6%);biosynthetic process (3%);regulation of transcription, DNA-templated (2%),IPR027417 (12%);IPR014729 (8%);IPR003593 (5%),P-loop containing nucleoside triphosphate hydrolase (12%);Rossmann-like alpha/beta/alpha sandwich fold (8%);AAA+ ATPase domain (5%)
TLAKPAVK,Sphingomonadales,Bacteria,,,,Proteobacteria,,,Alphaproteobacteria,,,,Sphingomonadales,,,,,,,,,,,,,,,,,,,,,GO:0016740 (100%),transferase activity (100%),,,IPR018762 (100%);IPR036890 (100%),Histidine phosphotransferase ChpT, C-terminal (100%);Histidine kinase/HSP90-like ATPase superfamily (100%)
LRPLQPAK,Anaeromassilibacillus,Bacteria,,,,Firmicutes,,,Clostridia,,,,Clostridiales,,,,,Ruminococcaceae,,,,Anaeromassilibacillus,,,,,,,,,,GO:0016021 (100%),integral component of membrane (100%),,,,,,
PFNLLPAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLESLGGLGAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LATVDGAVVR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,